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Abstract 
 Fluorescence fluctuation spectroscopy (FFS) is a powerful technique for 
quantitatively analyzing protein interactions. Using brightness analysis methods, we are 
uniquely able to measure the stoichiometry of protein complexes. FFS is particularly 
valuable because it allows measurements within living cells. This thesis demonstrates that 
measuring in very small volumes, such as E. coli cells, introduces a bias into the 
measured brightness. We show that this bias is a result of accumulative sample loss, or 
photodepletion, and that we can account for this effect and recover correct brightness 
values. Similarly, very thin samples, such as cell cytoplasm, introduce a bias due to the 
sample being shorter along the vertical axis than the volume of the excitation light. We 
introduce z-scan FFS and theory to identify and model thin samples and to recover 
unbiased data. Although measuring in cells is a primary strength of the FFS technique, 
some studies require the greater degree of experimental control afforded by solution 
measurements. Thus, we characterize cell-free expression solution for FFS 
measurements, an environment that offers increased control but permits genetic 
fluorescent labeling. We take advantage of this system to perform chromophore 
maturation experiments as a function of temperature on three common fluorescent 
proteins: EGFP, EYFP and mCherry. Our results prove that EGFP has fast maturation 
and is a good reporter for fluorescence experiments. Finally, we apply FFS and 
brightness analysis to the enzyme, APOBEC3G. We reveal that APOBEC3G interactions 
with RNA and single-stranded DNA are sequence dependent, which has important 
implications for the mechanism by which APOBEC3G packages itself into HIV-1 viral 
particles and restricts the virus to prevent infection. 
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1.  Introduction 
1.1  Quantifying protein interactions 
 The human being is an amazingly complex organism. As cellular and 
microbiological studies advance, it has become clear that cells are not simply miniature 
test tubes filled with           reactions. The developing picture indicates that 
living organisms, at the core, are networks of biochemical assembly lines composed of 
large protein machines, molecular motors, and powered valves.
1
 With molecular 
complexes of 10 or more proteins performing many critical functions, the quantitative 
study of protein interactions is both much more important and much more difficult. 
Proteins are truly the building blocks of cellular and biological function, and fluorescence 
microscopy has proved to be one of the most valuable tools in penetrating down to 
ground level to parse the complexity into comprehensible and individual protein 
mechanisms. At the heart of the approach is this: fluorescently-labeled proteins can be 
“seen.” It’s a way to tag and locate molecules in a discrete fashion. Fluorescently-labeled 
proteins can be imaged and localized as a population distributed through the cell, or 
tracked individually as they perform their functions. Protein interactions can be studied in 
real-time and their strength, frequency, and protein ingredients can be identified. The 
ability both to discover and to quantify this information makes fluorescence microscopy 
one of the most powerful tools for studying biological function. 
 
1.2  Fluorescence fluctuation spectroscopy 
Fluorescence fluctuation spectroscopy (FFS) is a powerful method for examining protein 
interactions. The technique is based on the idea that focusing laser light into a sample 
creates only a very small volume in which fluorescently-labeled particles are excited and 
observed. Fluorescent molecules diffusing through this volume give rise to signal 
fluctuations (Figure 1.1).
2,3
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Figure 1.1  A diffusing fluorophore gives rise to fluctuations.  
(A) Focused laser light creates a small excitation volume through which fluorescent 
particles diffuse. (B) An example of an intensity trace showing how the fluorescence 
intensity fluctuates around an average value as particles move into and out of the 
excitation volume. The fluctuating signal contains information about the sample that can 
be extracted through statistical analysis. 
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The averaged fluorescence intensity is stable, but as individual molecules move 
into and out of the excitation volume, they generate small fluctuations about that average. 
FFS characterizes static and dynamic properties of the sample by exploiting the 
information embedded in the fluctuating signal.
4,5
 We will discuss some of the various 
statistical methods for extracting that information in the next chapter. 
One valuable parameter determined from an FFS measurement is brightness. 
Brightness is a measure of the fluorescence per particle, generally expressed in units of 
photon counts per second per molecule (cpsm). Because brightness is a property of the 
molecule—as opposed to intensity which is a property of the ensemble—it is a powerful 
tool for studying molecular interactions. Consider the fluorescent label by itself (Figure 
1.2A). For a given fluorescence instrument and under a given excitation power, that label 
has a brightness  . The average fluorescence intensity 〈 〉 depends on the average 
number of particles present in the excitation volume. This label may then be attached to a 
protein of interest (Figure 1.2B). If the protein exists as a monomer, then the brightness 
of the sample remains equal to  . However, if the protein forms dimers, then the 
brightness will be equal to   , because the protein complex carries two fluorophores 
which produce, on average, twice the signal. 
Consider another example where protein X and protein Y are both tagged with the 
same fluorescent label. If, when performing a series of experiments, protein X alone has 
brightness    protein Y has brightness  , and mixture of X and Y has brightness   , we 
have direct evidence of interaction between X and Y. This experiment employed uniform, 
identical labels. By labeling only one protein at a time, or using labels of more than one 
color it becomes possible to identify more complicated stoichiometries as, for instance, 
X3Y. Brightness is a straightforward parameter that lends itself extremely well to the 
study of protein complexes. 
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Figure 1.2  The concept of brightness. 
(A) A depiction of three fluorescent labels in the observation volume, each with a 
brightness of 100 counts per second per molecule and a total average intensity of 300 
counts per second. This fluorescent label can be attached to a protein of interest in order 
to study its behavior. Note that while the average intensity is complicated by protein 
concentration, brightness easily identifies (B) a monomeric and (C) a dimeric protein 
sample. Brightness is a straightforward and powerful tool for quantifying protein 
interactions. 
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Because of its ability to characterize protein-protein interactions, brightness 
analysis forms the main drive behind this thesis.  One spectacular aspect of FFS and 
brightness analysis is that this approach can probe directly into living organisms, 
detecting and measuring the association of proteins in intact cells to identify interactions 
and stoichiometries. This information contributes to the development of a molecular 
understanding of the protein machinery and its role in the biological organism.
1
  
Brightness analysis of protein complexes in cells has been successfully demonstrated for 
both homocomplexes, where all proteins carry the same fluorophore,
6
 and developed into 
dual-color analysis to study heterocomplexes.
7,8
 This thesis, however, focuses almost 
exclusively on some of the ways single-color brightness analysis can be used to study 
protein interactions. 
 
1.3  An historical reflection: GFP and biological fluorescence 
In many ways it was the jellyfish that set brightness analysis on the road to 
success. In December of 2008, the Nobel Prize in Chemistry was awarded jointly to 
Osamu Shimomura, Martin Chalfie and Roger Y. Tsien "for the discovery and 
development of the green fluorescent protein, GFP." Shimomura identified and purified 
GFP and later elucidated the structure of the GFP chromophore.
9,10
 Martin Chalfie 
applied it as a marker to study gene expression in C. elegans,
11
 demonstrating the power 
of GFP for scientific study in living organisms. Finally, Roger Tsien showed that oxygen 
is the only external reagent necessary for GFP fluorescence, developed the brighter and 
more photostable enhanced green fluorescent protein (EGFP), and went on to generate a 
variety of fluorescent proteins of various colors, stabilities, and folding speeds, including 
CFP (cyan) and EYFP (yellow), as well as mCherry (red) and a set of other red-shifted 
fluorescent proteins termed the mFruits.
12–15
 
However, it was Douglas Prasher, working at a car dealership at the time of the 
Nobel prize awarding, who initially had the vision of GFP as a fluorescent marker,
16
 
though even he may not have foreseen the full scope of its effect on biological 
fluorescence. After failing to obtain a new grant, he was forced to leave the field and go 
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in other directions, although not before inspiring Chalfie and Tsien to push forward on 
GFP and supplying them with the protein vector. An unlucky series of canceled projects 
and downsizing drove him from job to job and further away from science, the expenses of 
family and children forcing him to take an immediately available job. The full tragedy 
culminated in his position as the courtesy van driver at a Toyota dealership when he was 
invited to the 2008 Nobel prize ceremony—as a guest.17 Prasher eventually returned to 
science, but perhaps without the full honors due him for the initial insight and the 
eventual wonder of the green fluorescent protein. 
Wild-type GFP, EGFP, and their many variations effectively revolutionized the 
field of biological fluorescence.  For the most part, they are monomeric labels that can be 
genetically-tagged to proteins in a huge variety of organisms because they don’t require 
any additional proteins or chemicals to generate fluorescence, merely oxygen. All in all, 
the palette of fluorescent proteins available has proven, and continues to prove, 
immensely useful for cellular applications. EGFP, for instance, is an amazingly robust 
fluorescent protein. Shaped as a barrel with the fluorescence-generating chromophore 
tucked inside, EGFP is largely insensitive to changes in the local environment, provided 
that the pH remains stable. The brightness of EGFP doesn’t change when it is tagged to 
another protein, nor when it is measured in the nucleus, cytoplasm or aqueous solution.
18
 
It is this property that makes EGFP such a valuable tool, and offers the scope to push 
brightness experiments in new directions. 
 
1.4  Extending brightness analysis: New sample environments 
 We first explore the challenges of applying FFS in small sample compartments. 
Photodepletion, or sample attrition from excitation light photodamage, is a non-trivial 
problem for small sample volumes.  In a related vein, we explore what happens if the 
sample compartment being measured is smaller than the focus of the excitation light. We 
provide methods and corrections to surmount both of these sample compartment 
challenges. The next sections move the focus away from cellular compartments to show 
the value of FFS for in vitro experiments.  We demonstrate that FFS can be used in 
combination with cell-free expression systems to study the maturation of fluorescent 
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proteins, by controlling the start and stop of the expression reaction. Finally, we 
demonstrate the utility of FFS and brightness analysis when applied to protein-nucleotide 
interactions in aqueous solution. The interactions of APOBEC proteins with DNA and 
RNA have important biological significance, but cannot be studied directly in cells 
because of the lack of control over fluorescent labeling, specific DNA/RNA sequences, 
and other reaction parameters inside the cell.  
On a broader level, developing FFS into a tool that probes protein behavior both 
in cell and aqueous solution environments can help us to gain insight into the differences 
between these two sample environments. For example, a developing issue in protein 
studies, is the effect of macromolecular crowding.
19
 The insides of cells are dense with an 
thousands of assorted types of proteins, as well as DNA and RNA. This crowding has 
been shown to have various functional effects from changes in diffusion to altered protein 
binding affinity and specificity.
20–22
 For example, the GroEL chaperonin protein assists 
protein folding in E. coli in a cyclic fashion, triggered by the binding and release of its 
cofactor GroES. It has been demonstrated that a release of partially-folded peptides 
between cycles does not occur in the presence of macromolecular crowding,
23
 indicating 
that GroEL is designed for a crowded environment, and may function abnormally in 
simple aqueous solution. This result suggests that earlier, purely in vitro studies of GroEL 
drew some invalid conclusions regarding the immature peptide release. A vast number of 
protein assays are performed in vitro, so it is important that we be able to carefully study 
how the environment shapes protein behavior in order to properly relate in vivo and in 
vitro experiments. FFS is uniquely placed to apply the same technique to both cellular 
and solution environments, and to recover quantitative data on protein binding and 
concentration.  This thesis extends FFS and develops a flexible measurement platform 
from which such issues as macromolecular crowding can be investigated.  
Whenever a technique is pushed in new directions or into new territories, a fresh 
set of challenges are encountered. Here, we present a more detailed introduction for the 
first part of this thesis and a closer look at the challenges associated with small sample 
geometries. Many biophysical fields of study have a somewhat non-standard mission 
statement: Think small! This approach is growing in popularity as new technologies 
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provide access to nanoparticles, microfluidic devices and microdroplets, as well as the 
more naturally occurring microorganisms. Chapter 3 addresses one of the complications 
encountered when trying to apply FFS to such small sample volumes. Fluorescence 
techniques are plagued by the phenomenon of photobleaching, wherein the absorption of 
photons has a finite probability of destroying fluorescence instead of exciting it. Most 
researchers simply decrease the excitation power to a point where the effect of 
photobleaching is negliglible, although the need for good signal statistics imposes a lower 
limit on this approach. However, in very small sample volumes (~ 1 picoliter), even weak 
photobleaching accumulates in a process we term photodepletion, and because of the 
limited sample reservoir, causes the destruction of a statistically significant fraction of the 
sample population. FFS analysis requires that the average fluorescence intensity be 
stable, a condition that is not met in a gradually shrinking sample population. We adapt 
theory and technique to incorporate the effects of photodepletion into FFS brightness 
analysis and extract accurate quantitative information. 
 We explore a related question when the sample is small in height rather than in 
volume. Chapter 4 deals with thin layer sample geometries, like cell cytoplasm. When the 
focal volume of the excitation light is taller than the sample, the measured brightness is 
biased. To avoid this artifact, we introduce z-scan FFS which consists of scanning the 
laser along the vertical axis through the sample, followed by a stationary FFS 
measurement. We fit the z-scan intensity trace to a model to determine the geometry of 
the sample, which information can then be used to calculate an accurate brightness from 
the FFS data.  
 Beginning in chapter 5, we will return to the importance of the sample 
environment. Proteins operate in cells, making cellular measurements most suited to 
forming a true understanding of protein function. However, because precise experimental 
control of the cell environment is typically not feasible, it is still necessary to investigate 
many open questions through direct measurements in aqueous solution. In this chapter, 
we develop a compromise between these two approaches by employing cell-free protein 
expression. Cell-free expression systems essentially strip the cytoplasm and ribosomal 
machinery out of the cell, and so provide the researcher with an in vitro system that can 
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still transform DNA plasmids into proteins. Such a system allows direct experimental 
control just as with in vitro experiments, while maintaining the elegance and efficiency of 
genetic fluorescent protein labeling. We take advantage of this combination to study the 
chromophore maturation time, which is the time required for a fluorescent protein to go 
from an unfolded state to a fluorescence-generating molecule. Addressing the issues 
inherent in developing a new system, chapter 5 characterizes the application of FFS in 
cell-free expression solutions. We demonstrate that all EGFP proteins fully mature in 
minutes in cell-free solution, that brightness is a robust parameter specifying 
stoichiometry, and  conclude that combining cell-free expression and FFS provides a 
powerful technique for quick, quantitative study of chromophore maturation and protein-
protein interaction. 
The final chapter uses FFS and brightness analysis to study APOBEC3G, a DNA 
cytosine deaminase enzyme with innate immune activity against retroviruses, notably 
HIV-1. We were surprised to discover through brightness analysis that the 
oligomerization of APOBEC3G is more complex than anticipated. The homo-interactions 
of the enzyme with itself are influenced by several environmental factors including 
temperature and solution environment, although these phenomena require further study. 
Most excitingly, we identify differences between APOBEC3G interactions with DNA 
versus RNA, as well as a sequence dependence to these interactions. These results may 
help to explain how the enzyme accommodates packaging into the virus and fulfills its 
role in restricting HIV-1. 
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2.  FFS  
 In this chapter, we provide some background information about the techniques 
and instrumentation used throughout this work.  
 
2.1  Concepts of FFS 
FFS utilizes the intensity fluctuations of fluorescent molecules passing through a 
very small optical observation volume to determine concentration, diffusion coefficient, 
and brightness of the molecules.
24
 Consider the burst of photons that is detected each 
time a fluorescent molecule crosses the observation volume. The frequency of the bursts 
provides a measure of the particle density or concentration within the observation 
volume. The duration of a burst correlates with the time it takes the particle to cross the 
observation volume, characterizing the diffusion. Lastly, the amplitude of a burst yields 
information about the number of fluorescent particles clustered together in a single 
molecule (Figure 2.1, left panel). This burst model is a simplified picture. In general, the 
number of particles present in the observation volume does not permit the identification 
of individual bursts (Figure 2.1, right panel), but statistical analysis can extract the same 
information. Statistical methods tools such as fluorescence correlation spectroscopy 
(FCS)
4,25
, photon counting histogram (PCH)
26,27
, and many others, are available to 
analyze the signal fluctuations.
28
  FCS uses the correlation function to capture the 
temporal information of the physical process, while PCH uses the amplitude distribution 
of the fluctuations to characterize the concentration and brightness of each fluorescent 
species.  Moment analysis was originally developed in the late 80s and early 90s
29–31
 and 
is an alternative technique for studying the brightness of fluorophores.
32,33
 We will 
introduce these techniques in more detail below. 
 
2.2  Instrumentation 
 Our lab focuses primarily on two-photon excitation wherein two photons, each 
carrying half the necessary energy, must reach the fluorophore simultaneously in order to 
excite fluorescence.
34,35
 Here, simultaneously means within the Heisenberg energy-time 
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uncertainty. To achieve this excitation, there must be a large number of photons focused 
both in space and in time. We use a Zeiss Axiovert 200 microscope (Thornwood, NY) 
and a mode-locked Ti:sapphire laser (Tsunami or MaiTai, Spectra Physics, Mountain 
View, CA). The laser has a pulse width of ~100 fs and a frequency of 80 MHz, and the 
wavelength can be tuned from 700-1000 nm. The laser is directed through a beam 
expander before passing into the microscope. It is then reflected up through the objective 
by a dichroic mirror (#740DCSPXR, Chroma, Rockingham, VT). A Zeiss 63x C-
Apochromat water immersion objective (NA = 1.2) focuses the excitation light onto the 
sample. The resulting fluorescence light is collected by the same objective and passed 
through the dichroic mirror which transmits from 400-750 nm. An additional bandpass 
filter (FF01-750/SP-25) removes scattered laser light. In the detection compartment of the 
instrument, an optional dichroic mirror allows the fluorescence signal to be split by 
emission color into two detection channels. Each channel is equipped with an avalanche 
photodiode (APD) (SPCM-AQ-14, Perkin-Elmer, Dumberry, Québec) that records 
photon counts. The TTL pulse signal generated by the APD is connected directly to a 
data acquisition card (FLEX02, Correlator.com, Bridgewater, NJ or ISS, Champagne, 
IL). The photon counts are stored and later analyzed using programs written in IDL, 
version 5.4 or later (Exelis Visual Information Solutions, Boulder, CO). 
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Figure 2.1  The information in fluorescence fluctuations.  
The left panel shows a cartoon of fluorescence bursts from molecules passing through the 
observation volume. The frequency of the bursts provides information about 
concentration, the duration is correlated with the diffusion coefficient, and the amplitude 
provides a measure of the brightness. As the right panel shows, the cartoon of individual 
bursts is a simplified picture. Most FFS data have many overlapping bursts, but the same 
information can be extracted through statistical analysis. 
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Figure 2.2  Instrument setup.  
Pulsed laser light is steered through a beam expander onto a dichroic mirror which 
reflects the excitation light up through an objective onto the sample. The same objective 
collects the fluorescence light, which passes through the dichroic mirror down to the 
detection pathway. Here, a second (optional) dichroic mirror permits the color separation 
of the fluorescence light onto avalanche photodiode detectors. The data from the APDs is 
recorded to computer memory for further analysis and storage.  
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2.3  Brightness and stoichiometry 
 Brightness is a unique FFS parameter that specifies the average rate of photon 
counts per fluorescent particle. We focus in this section on brightness, because brightness 
experiments are central to this thesis. While there are many techniques that detect protein 
interactions, brightness is unique in its ability to quantify interactions and protein 
stoichiometry both in vitro and in vivo. Thus, FFS is a vital tool in providing quantitative 
data that help clarify the molecular interactions that drive cellular processes.  The 
relationship between brightness and stoichiometry is very straightforward. To emphasize 
this point and to simplify the discussion, we introduce the concept of dimensionless 
brightness (also referred to as normalized brightness),   
 
 
 
sample
label
b


  (2.1) 
where         is the brightness of the sample and        is the brightness of the label 
alone (Figure 2.3A). Note that   in this thesis has units of photon counts per second. We 
will also employ the “” brightness notation which has units of photon counts per data 
bin, and is thus dependent on sampling frequency  . The two values are related by 
      in the absence of undersampling.33  
By either definition, normalized brightness provides information about the 
average number of proteins in a complex. The best fluorophores for brightness 
experiments, e.g. EGFP, are resistant to quenching, and so are unaffected by proximity to 
other proteins. Thus an EGFP-labeled protein sample that forms monomers also returns 
    (Figure 2.3B). For a dimeric protein sample,      (Figure 2.3C), as each protein 
complex now contains two EGFP labels, and so on and so forth for higher order 
oligomers (Figure 2.3D). Nor is the approach limited to small complexes; other work 
from our lab uses an identical formulation to investigate self-assembling viral proteins 
and calculates b-values or “copy numbers” over 1000.36 The concept of brightness 
analysis is very simple and very powerful, and has been successfully used to quantify 
biologically relevant stoichiometry in both cells and solution.
37,38
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Figure 2.3  Single-species and apparent brightness.  
Experimental brightness is normalized by establishing the inherent brightness of the 
monomeric fluorescent label (A). Then, the label is attached to a protein of interest and 
the measured normalized brightness will return (A) a value of 1 for a monomeric sample, 
(B) 2 for a dimeric sample, (C) etc. In the case of a mixed brightness species sample, the 
situation is not quite as clear cut. The simplest—and sometimes only—brightness 
measurement available is the average or apparent brightness. As shown in Eq. 2.10, 
apparent brightness returns a fractional intensity weighted average of the mixture 
(E & F). 
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Figure 2.4  Autocorrelation curve. 
 
The plot displays a sample autocorrelation curve. On short time scales, most of the same 
particles are still in the excitation volume and so correlations are strong and the amplitude 
is large. Over time, as the starting particle population diffuses away, the amplitude decays 
to zero. From the extrapolated      value, we get information about concentration and so 
can calculate a brightness. From the decay, we gain information about diffusion of the 
particles. Diffusion time   , the time it takes for the amplitude to halve, is defined as the 
characteristic time that a particle stays in the excitation volume. 
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2.4  Analysis 
 We briefly present some common analysis methods used to calculate brightness 
from FFS data, as well as a few sources of error common to all brightness experiments 
and the corrections thereof, as used in this thesis.  
2.4.1  Photon count moments 
Access to the raw photon counts of an FFS experiment allows a direct calculation 
of the photon count moments. Each data point represents the number of photons   
detected during a time interval  . The first two moments of the photon counts determine 
Mandel’s Q-parameter  
 
2
2
TT
T
T
k k
Q T
k
 
 
   (2.2) 
which in turn can be related to the brightness    ̃. The subscript   is included to 
highlight that moments were calculated from photon counts sampled with a time interval 
 . Note that unlike Mandel’s Q-parameter the apparent brightness is model dependent, 
because the value of the shape factor 
2  is determined by the point spread function (PSF) 
model, as will be the case in the other analysis methods presented. Three different PSF 
models are widely used. The three-dimensional Gaussian PSF with  2 1 2 2  , the 
two-dimensional Gaussian PSF with 
2 1 2  , and the squared Gaussian-Lorentzian PSF 
with 
2 3 16  . Additional modifications to these PSF models or any other PSF model 
require an explicit calculation of the shape factor 
2  for consistent interpretation of 
brightness values. This thesis uses the squared Gaussian-Lorentzian PSF unless otherwise 
indicated. 
2.4.2  Photon counting histogram 
 The origins of brightness analysis in our lab stem from an analysis method called 
the photon counting histogram (PCH).
26
  As the name implies, the raw photon count data 
is plotted as a histogram and then fit to a theoretical model. PCH assumes that the 
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particles are effectively stationary during the acquisition of each data point, thus PCH 
data must be taken with a fast sampling frequency. Importantly, the technique can 
distinguish species by concentration and brightness, making it complementary to 
autocorrelation analysis which may distinguish species by diffusion time.
4,39
 Since 
brightness is a more sensitive parameter than diffusion time, PCH is frequently a better 
technique for resolving species. However, as most of the work in this thesis only requires 
measurement of the average brightness, our analysis mostly consists of the 
straightforward and more easily implemented autocorrelation analysis. 
2.4.3  Autocorrelation analysis 
The time-dependent fluorescence intensity ( )F t  of the FFS measurement is used 
to determine its autocorrelation function (ACF),  
  
   
 
2
F t F t
G
F t
  


   (2.3) 
where            〈 〉 is the fluctuation in fluorescence intensity about the average. 
The ACF measures self-similarity of a times series and emphasizes the characteristic time 
constants of underlying processes.
40,41
 Thus the decay of the ACF provides information 
about molecular diffusion. Specifically, the diffusion time   , defined as the time 
required for the autocorrelation amplitude to fall to half its initial value (shown in Figure 
2.4), characterizes the average duration a particle remains in the excitation volume. A fit 
of the autocorrelation function to a simple diffusion model determines    and the 
autocorrelation amplitude     , which is related to the average number of molecules 
PSFN  present in the excitation volume, 
   20
PSF
G
N

   (2.4) 
with    representing the shape factor of the FFS observation volume.
39
 We convert 
PSFN  
into a concentration by           ⁄ . The value of PSFV  is determined from an FFS 
measurement of a dye sample with known concentration.
6
 The brightness is calculated 
from the fluctuation amplitude and the average fluorescence intensity,  
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2
(0)G F



    (2.5) 
and reflects the average fluorescence intensity received per particle. The brightness of a 
monomeric fluorescent protein, such as 
EGFP , serves as reference value and is 
determined by a calibration measurement of a sample containing only the fluorescent 
protein. Recall that the normalized brightness b provides an experimental measure of the 
stoichiometry of the protein complex, e.g., b = 2 indicates a dimeric protein. 
 
2.4.4  Deadtime, afterpulsing and background 
Although brightness analysis is straightforward, there are a few challenges. First 
and foremost, correct identification of the fluctuation amplitude requires proper treatment 
of deadtime and afterpulsing effects from the detector when fitting the autocorrelation 
function. Second, both the cellular environment and the solution environment can give 
rise to a background signal that biases the data, particularly at low intensities.  
Photodetectors used in photon counting experiments are never ideal.
33,42,43
  Here 
we will focus specifically on avalanche photodiodes (APDs) because they are the detector 
most commonly used in fluorescence fluctuation experiments.  All brightness 
experiments that employ APDs must contend with two primary artifacts, deadtime and 
afterpulsing.  Deadtime is a fixed period after the collection of a photon during which the 
detector cannot register any other events. This temporary “blindness” leads to a decrease 
in the number of photons detected and is of particular concern in high count rate 
experiments. Deadtime has the effect of narrowing the photon count distribution.  At high 
count rates more events are lost since there is a greater probability of additional photons 
arriving while the detector is blind to new events.  Typical APDs have deadtimes of 50 
ns, although newer models have deadtimes as low as 20 ns.  For an average intensity of 
850 kilocounts/second and a detector with 50-ns deadtime, the uncorrected brightness 
will be 15% lower than the true brightness. Thus in high count rate experiments, the 
effect of deadtime on brightness is not negligible and will result in lower brightness if 
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there is no correction applied. For the autocorrelation brightness values in this thesis, we 
employ the following correction:
44
 
 
†
†1 3
corr
F T

 

  (2.6) 
where    is the deadtime-effected brightness and    is the deadtime of the detector. 
Simply calculating the brightness directly from the raw data will result in   , a brightness 
that includes the effects of deadtime. However, we have previously characterized the 
detector to identify the deadtime    and knowing the average fluorescence 〈 〉, it is 
simple to use the above formula to calculate the corrected brightness value. 
Afterpulses are spurious events that occur with a small probability after the 
detection of an actual photon. This leads to an increase in the number of apparent photons 
detected. Afterpulses will have the effect of broadening the photon count distribution 
because the afterpulses will artificially increase the counts in the higher channels, which 
leads to an artificially high brightness.  For newer APD detectors the afterpulse 
probability can be sufficiently low that its effect on many experiments is negligible.  For 
instance, APDs used in our lab typically have an afterpulse probability of 0.2% to 0.5%. 
It is important to be aware of the background signal in any brightness 
measurement, especially with a low brightness or low concentration sample. The 
background signal, defined as any low brightness signal of non-sample origin, is nearly 
impossible to eliminate and comes from multiple sources. Detectors have a certain level 
of dark counts. There is an additional level of room light counts, since it is generally 
difficult to shield all other sources of light around an experimental setup. Finally, there is 
the background autofluorescence from the sample itself. Aqueous buffers have low but 
non-zero background counts.  Cells are notoriously autofluorescent although this can be 
greatly reduced by carefully selecting cell lines, cellular location and excitation 
wavelength. Thus, particularly when beginning a new series of experiments, FFS 
measurements should be taken of the buffer alone or of an untransfected cell. On a known 
system these measurement are less crucial unless the experiments are conducted at a low 
concentration that is close to the background level, in which case it is again very 
important to have parallel and freshly-prepared “blank” controls. When the fluorescence 
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signal exceeds the background by a factor of 10, background effects will be less than 
10% and may be considered negligible as they fall within the expected noise of 
brightness experiments. At higher percentages of background, the recovered brightness 
will be artificially reduced and, in this thesis, is corrected by a first order approximation, 
 
*
corr
background
F
F F





  (2.7) 
where    is the background effected brightness, and 〈           〉 is the total background 
signal. 
 
2.5  Apparent brightness 
 Most experiments are conducted on samples representing a mixture of brightness 
species. The signal statistics from a single FFS measurement are frequently insufficient to 
directly resolve a mixture of two or more brightness species, particularly in cellular FFS 
experiments. Given these constraints the best approach is to forgo direct resolution of 
brightness species in favor of calculating the apparent brightness   of the sample. The 
apparent brightness for a mixture of   species with brightness 
i  and number of 
molecules 
iN  for the i-th species is defined by  
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 (2.8) 
Because this equation is quadratic in the brightness 
i , it is useful to rewrite it using the 
fractional intensity 
if  of species i,  
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, (2.9) 
where iF  is the fluorescence intensity of species i and F  is the total fluorescence of 
the sample. Combining these two equations demonstrates that the apparent brightness 
reflects a fractional intensity weighted brightness of the sample,  
  22 
 
1
N
i i
i
f 

 . (2.10) 
The final panels (E & F) of Figure 2.3 display the normalized apparent brightness for two 
mixed samples of monomer and dimer species, and illustrate how the ratio of the 
subpopulations affects the brightness value. For the remainder of the thesis we will 
consider brightness synonymous with apparent brightness.  
 
2.6  Brightness titration 
Because apparent brightness reduces the complexity of the sample to a single 
numerical value, it is prudent to couple it with another observable that leads to 
predictable changes in apparent brightness. In this thesis, we are interested in protein 
association. Because protein association is concentration dependent, a binding curve of 
the association process can be constructed by systematic variation of the protein 
concentration and simultaneous brightness measurements of the sample.
6
 Since cells vary 
in the level of protein expressed, we take advantage of the wide concentration range by 
selecting cells from low, medium, and high expression levels. For each cell, the 
normalized apparent brightness   is graphed as a function of the fluorescently-labeled 
protein concentration. Such a plot characterizes the binding curve of a cellular protein in 
its native environment and is referred to as brightness titration.
45
 In a hypothetical 
monomer-dimer protein equilibrium (Figure 2.5), the normalized brightness is close to 1 
at low concentrations, which indicates a monomeric protein state. Because higher 
concentrations favor dimerization, the normalized brightness climbs with increasing 
concentration and saturates at      , indicating the presence of a dimeric protein 
population. The brightness values at intermediate concentrations are between 1 and 2, 
which indicates a sample containing a mixture of monomeric and dimeric proteins (as in 
Figure 2.3E&F). Thus the brightness titration curve provides information about the 
average degree of association of a protein sample and the midpoint of the curve indicates 
the strength of interaction.
46
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Figure 2.5  Monomer-Dimer Titration 
A conceptual brightness titration in cells of an EGFP-labeled protein with a dissociation 
constant        . At low concentrations, the sample is predominantly monomeric and 
has an apparent brightness close to 1. At high concentrations the equilibrium favors the 
dimeric form and    . By measuring multiple cells expressing different levels of the 
protein, we can generate a curve that provides a more reliable picture of the protein 
behavior and identifies the affinity. 
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2.7  Droplet sample protocol 
 Most of the solution experiments in the later chapters are conducted in droplet 
samples. We present here a protocol for free-standing droplets placed on a glass surface 
(Figure 2.6A). Due to the difficulty of purification or the expense of cell-free solution, 
small sample volumes represent important savings in time and expense. In the case of the 
cell-free samples, small droplets also permit efficient oxygen exchange with the sample 
which is important for fluorophore maturation, as will be discussed in chapter 5. We 
developed a droplet protocol for FFS experiments that represents the best compromise 
between small sample volumes and practical considerations such as sample manipulation 
and evaporation. 
 We typically perform FFS measurements in 8-well chambered coverglass slides. 
By covering the top opening of the 8-well with a microscope slide, sealed down with 
vacuum grease, we create small, isolated chambers that exhibit minimal evaporation over 
a period of ~6 hours. Within each well, we first silanize the bottom surface to prevent 
sample adhesion. A volume (~150 µL) of SigmaCote sufficient to cover the surface is 
added to a well and left to react for 30 seconds. We then tilt the 8-well and remove the 
SigmaCote from one corner, endeavoring to prevent excess SigmaCote from evaporating 
off the surface of glass. Such evaporation can leave behind a residue that may interact 
with the sample. After the SigmaCote is removed, we rinse the well to remove 
byproducts of the silanization reaction.  
We have found 4 µL samples to be small enough to save material while being 
large enough to prevent strong evaporation. In samples of 1 µL or less, evaporation is 
very difficult to prevent and the sample becomes difficult to mix, dilute or otherwise 
manipulate with standard pipettes. To further assist with sample manipulation, we make 
small measurement wells on the glass surface by drawing 3-4 mm diameter circles with a 
vacuum grease filled syringe.  Such circles may also be generated through a stamp 
approach, but the syringe method creates slightly higher “walls” that prevent spillover 
when moving the 8-well or when diluting a sample.   
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We also perform titration experiments in the droplet form, but because of the 
small volumes used, a typical titration is not feasible. Instead a series of droplets are 
created at different interaction mixtures and are then measured individually as in the cell 
titration. Figure 2.6B depicts such an experiment to study the interaction of sample X and 
sample Y. Sample X is fluorescently labeled and a single stock solution is prepared. 
Sample X will be held at a fixed concentration in all the droplets in order to maintain the 
same fluorescence intensity. A series of Y dilutions are generated before being mixed 1:1 
with X in their respective droplets. Brightness measurements in each droplet create a 
titration curve of the concentration-dependent stoichiometry of the labeled sample X as it 
interacts with Y. 
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Figure 2.6  Protein Interaction Droplet Protocol 
(A) The cartoon displays the droplet sample preparation. A circle of vacuum grease 
prevents the droplet from moving or spreading. A coverslip and some additional vacuum 
grease seal the top surface to prevent evaporation. The free standing droplet provides 
good oxygen exchange for chemical reactions as well as allowing easy access for further 
mixing or dilution.  (B) In chapter 6, we perform several protein interaction titrations in a 
droplet assay. Because we work with very small sample volumes to save material, a 
standard titration is not feasible. Consider the interaction of sample X with sample Y. 
Sample X is fluorescently labeled and held at a fixed concentration. Sample Y is not 
labeled and is mixed into different droplets at different concentrations. A brightness 
measurement of all the droplets creates a titration curve that identifies the stoichiometry 
of X in interactions with Y. The labeling situation can be reversed for additional 
information. 
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3.  Photodepletion 
 In order to extend FFS into other environments, we must be able to deal with the 
constraints imposed by those environments. Small sample environments have a finite 
reservoir of fluorescence material. When that reservoir is on the order of picoliters, mild 
photobleaching leads to non-trivial sample depletion. This depletion biases FFS 
measurements because FFS analysis relies on a stationary average fluorescence signal. 
For instance, any FFS experiments performed in E. coli—with a volume on the order of a 
femtoliter—will exhibit unavoidable photodepletion and a significant bias in brightness. 
To combat this, we develop protocols and theory that allow us to account for the presence 
of the bias and to extract the corrected brightness value. This chapter describes the 
theoretical model and its validation both in solution droplets and in mammalian cell 
nuclei. I collaborated with my colleague Kwang Ho Hur, who applied the photodepletion 
model to E. coli cells. I include one figure showing preliminary E. coli results from his 
work. 
 
3.1  Introduction 
Although photobleaching is not noticeable as a direct effect in most FFS 
measurements, it nevertheless occurs with a small probability and reduces the number of 
fluorophores in the sample.  In vitro FFS experiments are typically conducted with a 
sample volume that exceeds the optical volume by many orders of magnitude, thus 
providing a large enough reservoir so that the concentration of fluorophores in the sample 
is virtually constant.  In contrast, a biological cell may be viewed as a picoliter cuvette 
with a finite amount of fluorophores. The cumulative reduction of the fluorophore 
concentration by photobleaching will be referred to as photodepletion throughout the rest 
of the paper.  
Photodepletion results in a decreasing fluorescence intensity which biases the 
interpretation of FFS data.  We develop and verify a simple model that takes the 
influence of photodepletion on brightness into account.  Some FFS experiments in cells 
require long data acquisition times to gather the necessary statistics for quantifying 
protein interactions.  Photodepletion effects that are completely negligible for short data 
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acquisition times will become apparent once the measurement time exceeds a certain 
limit.
47
  As a model system, we use Alexa 488 in microdroplets created from a water-oil 
emulsion. We then perform photodepletion experiments on EGFP in cells to demonstrate 
that the model is sufficiently robust for in vivo applications. Finally, we apply this 
approach to a biological system.  
In E. coli cells, short data acquisition times can no longer be used to prevent 
photodepletion effects. The E. coli sample volumes are small enough that the 
photodepletion effects are very strong. If the data acquisition time is reduced to avoid the 
photodepletion bias, there is no longer sufficient statistics for good brightness calculation. 
In this regime, there is an estimation bias
48
 inherent in correlation data that prevents the 
extraction of accurate brightness data. Thus, an approach that accounts for photodepletion 
is required for quantitative brightness analysis of FFS experiments in E. coli.  
Throughout this thesis we will employ nuclear transport factor 2 (NTF2) as a 
model system of a functional dimer. In later chapters, the oligomerization state of NTF2 
will have biological relevance, but as it is not an E. coli protein, it is simply a test for 
brightness doubling in this chapter. We apply our photodepletion model to identify the 
brightness of NTF2 and EGFP in E. coli cells. 
 
3.2  Theory 
 We briefly review brightness analysis using the “” brightness notation, recalling 
that  is defined as photon counts per data acquisition bin, rather than per second. This 
notation is simpler for this application. We subsequently introduce FFS theory to account 
for photodepletion in the cases of stationary and non-stationary fluorescence signals. 
3.2.1  Brightness analysis 
We only consider samples containing a single type of fluorophore, i.e., the green 
fluorescent protein EGFP.  In single-channel FFS each species is specified by its 
brightness ε and its occupation number N.  Moment analysis determines the brightness 
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and number of molecules in the observation volume from the first two moments of the 
photon counts, k  and 2k .  For a single species the average photon count is  
 k N . (3.1) 
The brightness of the sample is determined by the Q-factor
49
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where   is a shape factor that depends on the form of the point spread function (PSF).39  
These two equations uniquely determine the brightness and occupation number.  The 
brightness ε is a function of the sampling frequency f, and is related to the absolute 
brightness by f   . 
In the presence of multiple species, each with its own brightness εi and occupation 
number Ni, the first two moments determine an apparent brightness and occupation 
number via 
 app appk N , (3.3) 
 appQ  . (3.4) 
The apparent parameters are determined by the brightness and occupation number of all 
species,
29,39
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Here we define the normalized brightness as appb   , where the measured 
brightness app  is divided by the brightness ε of a single EGFP. This definition is exactly 
equivalent to that defined earlier, i.e., the normalized brightness of an n-mer is 
mernb n  .  
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In the following sections, we consider how photodepletion affects brightness analysis in 
cells. 
 
 
 
3.2.2  The effect of photodepletion on brightness for a stationary signal 
           For simplicity we will assume a two-state model to describe bleaching, kA D . 
The brightness of the molecule in the fluorescent state A is  , while it is zero in the 
bleached state D.  The reaction A D  is described by a rate coefficient k, which 
depends on the fluorophore, the excitation power, and other experimental parameters.  
While it is possible to evoke more complex bleaching models, the simple two-state 
process is sufficient to describe the data presented in this paper. 
Photodepletion leads to a decay in the average fluorescence intensity I k f  
where f is the sampling frequency, as demonstrated in Figure 3.1A for measurements of 
EGFP inside the nucleus of a cell.  Thus, data acquired in the presence of photodepletion 
is non-stationary.  Because FFS analysis requires a stationary signal, we consider a 
sufficiently short time interval of duration T so that the fluorescence signal may be 
regarded as stationary over that time interval.  The fluorescence moments at time t are 
defined by a time average over the interval T,  
    
2
2
1
t T
r r
t T
k t k t dt
T


   . (3.7) 
This approach allows us to determine the mean  k t  and  Q t  for each segment of the 
measured fluorescence signal.  If the signal is approximately stationary over the data 
segment, the brightness  t  and the occupation number  N t  are determined by 
Eqs. 3.3 and 3.4.  Because photodepletion reduces the concentration of fluorophores, the 
occupation number of EGFP molecules  N t  decreases with time (Figure 3.1B).  The 
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brightness  t  is time independent in the case where a single, monomeric fluorescent 
species, such as EGFP, is present (Figure 3.1C).  
Photobleaching of individual chromophores is statistically independent.  From the 
viewpoint of a single chromophore, photodepletion is described by a probability ( )p t  to 
remain fluorescent at time t, and a probability 1 ( )p t  to be.  If a single rate coefficient k 
describes bleaching then  
 ( ) ktp t e . (3.8) 
The fluorescence intensity at time t is described by 0( ) ( )I t k f p t N f   with 0N  
denoting the total number of chromophores in the observation volume at time 0.  The 
remaining intensity fraction is defined by  
 
( )
( )
(0)
I
I t
r p t
I
  . (3.9) 
We also define the lost intensity fraction 1 Ir , and will refer to these two quantities 
throughout the remainder of the work.  
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Figure 3.1  FFS data in the presence of photodepletion.   
EGFP is transiently transfected into COS cells and a prolonged measurement is taken in 
the nucleus using two-photon excitation (left panels). Fluorescence intensity (A), 
occupation number (B), and brightness (C) are plotted as a function of time, after having 
divided the data into segments and analyzing each segment independently to extract the 
aforementioned parameters. Note that while the overall sample population is being 
depleted, the brightness remains stable. Panels (D), (E), and (F) show the fluorescence 
intensity, occupation number, and brightness of Alexa 488 in a microdroplet in the 
presence of severe photodepletion. 
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Figure 3.2  Conceptual picture of monomer/dimer sample photodepletion effects.   
(A) Bleaching of a monomer population has no effect on brightness, because bleached 
molecules are not contributing to the fluorescence signal. The normalized brightness 
remains b = 1. (B) In the case of a dimer population, bleaching introduces a population 
with one of the two fluorophores surviving, thereby creating a mixed brightness 
population with an apparent brightness smaller than the original. 
  
  34 
 
In contrast to fluorescence intensity, the influence of photodepletion on brightness 
is more complex.  Consider first a monomeric fluorescent protein A with brightness ε.  
Bleaching will lead to two populations, A and D.  The brightness of the remaining 
population in state A is ε, while the brightness of the bleached state D is zero.  Because 
the population D does not contribute to the fluorescence signal, the brightness of the 
sample remains unchanged (see Figure 3.2A).  A population of dimers A2, on the other 
hand, has a brightness of 2ε (Figure 3.2B).  Bleaching of one or two chromophores of A2 
leads to the states AD and D2.  Because bleaching is a stochastic event, a statistical mix 
of proteins in each of the three states is attained.  The brightness of AD is half that of the 
dimer A2, which leads, according to Eq. 3.5, to an apparent brightness for the sample of 
less than 2ε (Figure 3.2B).  Thus, the brightness of the dimer decreases if photodepletion 
is present.  
Let us explicitly treat the case of a pure n-mer species An.  Bleaching of n – s 
chromophores leads to the species AsDn-s with brightness sε.  Its fractional population is 
determined by the probability  
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According to Eq. 3.5, all species contribute to the normalized brightness of the sample.  
Evaluation of Eq. 3.5 for fractional populations given by Eq. 3.10 reveals a simple linear 
dependence of the brightness of the n-mer on the remaining intensity fraction
Ir ,  
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The normalized brightness starts at a value of n in the absence of photodepletion ( 1Ir  ) 
and decreases linearly to a value of one as the remaining intensity fraction approaches 
zero.  This result reflects that the last surviving fluorescent population of an n-mer An is 
A1Dn-1 with exactly one functioning fluorophore, which implies a normalized brightness 
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of one.  As a consequence, the normalized brightness of a monomeric protein species (n = 
1) is independent of photodepletion as shown for EGFP in Figure 3.1.  
In cells, however, one frequently encounters the simultaneous presence of protein 
species in different oligomeric states.  We now extend our result to an arbitrary mixture 
of oligomeric states.  Consider a sample of An , An-1 , … , A0 with a fractional population 
of 
i  for the oligomer Ai.  By definition, 1ii  .  Depletion of the oligomer Ai due to 
bleaching leads to the species AsDi-s with a normalized brightness of s and a fractional 
population , ,( ) ( )i s i i sp t p t  .  The sum over all fractional populations equals one at all 
times.  The apparent brightness of the mixture is calculated analogously to the case of the 
n-mer An (Eq. 3.11) by summing up the contributions from all oligomers in all of their 
bleached states,  
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where  ,0 1app app Ib b r   is the apparent brightness of the mixture in the absence of 
photobleaching,  
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Again, the slope plus one of the normalized brightness versus 
Ir  curve is a measure of the 
normalized brightness ,0appb  of the sample in the absence of photodepletion.   
 
3.2.3  The effect of photodepletion on brightness for a non-stationary signal 
The theory presented so far assumes a stationary signal.  In other words, the data 
segment chosen must be short enough that the fluorescence intensity is approximately 
constant.  Choosing a longer data segment is often advantageous from an experimental 
point of view as it increases the signal-to-noise ratio (SNR).  But if the intensity 
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decreases over the duration of the segment, the condition of stationarity is violated, which 
leads to a bias in the parameters obtained from Eqs. 3.3 and 3.4.  We now describe how 
to account for the bias introduced by the non-stationary signal.  
The photon count moments for a data segment of duration T are obtained by  
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The biased apparent brightness app  and occupation number appN  are defined by  
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Expressing the moments k  and 2k  in terms of the brightness and occupation number 
of each species and evaluating Eq. 3.14 yields the photon count moments 
s
rK .  The 
first moment is given by ( ) ( )i iik t N t  and its square is 
2
,
( ) ( ) ( )i j i ji jk t N t N t  .  The second moment is written as 
22
2( ) ( ) ( ) ( )i iik t N t k t k t    , where we made use of the factorial cumulant 
  22 ( )i ii N t    .
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  To write the result in a compact format we introduce  
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The general relationship between the correct and biased brightness of the sample in the 
presence of photodepletion is  
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For a single monomeric species with brightness 
1  Eq. 3.19 simplifies to  
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We will now assume an exponential decay model, ( ) ktp t e , and determine the 
normalized brightness of a monomer (n = 1) from Eq. 3.20, 
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with 
Ir  defined by Eq. 3.9.  The same method is used for determining the brightness of 
any n-mer of interest.  Because the expressions become lengthy as n increases, only the 
Taylor expansion of the brightness to 2
nd
 order in T is given  
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3.3  Materials and methods 
Experimental Setup. A mode-locked Ti:sapphire laser (Tsunami, Spectra-Physics, 
Mountain View, CA) pumped by an intracavity doubled Nd:YVO4 laser (Millenia, 
Spectra Physics) serves as a source for two-photon excitation.  The experiments were 
carried out with a modified Zeiss Axiovert 200 microscope (Thornwood, NY) as 
previously described.
29
  One photon photobleaching was conducted with a FluoArc 
mercury lamp (Zeiss) run between 80% and 100% power with light filtered by a (450- 
490 nm) optical bandpass filter (Chroma Technology, Rockingham, VT).  Two photon 
measurements were taken for ~50 seconds with a 63x Plan Apochromat oil immersion 
objective (NA = 1.4).  The excitation power measured at the objective ranged from  0.8-
1.0 mW at 905 nm and 0.65-0.9 mW at 970 nm.  These powers were chosen to be 
sufficiently low to avoid saturation.  Photon counts were detected with an avalanche 
photodiode (APD) (Perkin-Elmer, SPCM-AQ-14) and recorded by a data acquisition card 
(ISS, Champaign, IL), which stores the complete sequence of photon counts using 
sampling frequencies ranging from 20 to 200 kHz.  The recorded photon counts were 
stored and analyzed with programs written in IDL 6.0 (Research Systems, Boulder, CO). 
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Microdroplets. Alexa-488 (Molecular Probes, Eugene, OR) was diluted in water to a 
concentration of 160 nM.  A volume of 100 µL of this solution was combined with 
900 µL of silicon oil (Fisher Scientific, Fairlawn, NJ), pippetted for 5 seconds and then 
vortexed for 20 seconds.  The emulsion was allowed to stand for three minutes while the 
larger droplets settled before removing 10 µL from the top and transferring it onto a two 
inch square glass slide (Chemglass, Vineland, NJ).  A coverglass (12-544F, Fisher 
Scientific, Fairlawn, NJ) was pressed down on top and affixed at the corners with nail 
polish to prevent shear motion.  
 
Expression Vectors, Cell Lines, and Cell Measurements.  Construction of the tandem 
dimeric EGFP (EGFP2) was described previously.
6
  COS-1 cells were obtained from 
American Type Culture Collection (ATCC) and maintained in 10% fetal bovine serum 
(Hyclone Laboratories, Logan, UT) and DMEM (without phenol red) media.  MRC-5 and 
CV-1 cells were obtained from ATCC and similarly maintained.  For CV-1 and MRC-5 
cells, transfection was carried out using TransFectin reagent (Bio-Rad, Hercules, CA) 
according to the manufacturer’s instructions 24 hours before measurement.  For COS-1 
cells, G418-resistant cells were selected by culturing cells in media with 250 µg/mL 
gentamicin sulfate (Mediatech, Hernandon, VA) and measured the second week after 
transfection.  All cells were subcultured into eight-well coverglass chamber slides (Nagle 
Nunc International, Rochester, NY) with the media replaced by Leibovitz L15 medium 
(Gibco, Auckland, NZ) immediately before measurement. 
  
Data Analysis. We used moment analysis
31,32
 with deadtime corrections
8
 to determine 
brightness and occupation number in this work.  We also calculated the brightness of cell 
data using Q-analysis.
44
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3.4  Results  
We measured the fluorescence of EGFP inside the nucleus of living cells with 
two-photon excitation at 905 nm.  The decrease in the fluorescence intensity with time 
reveals the presence of photobleaching (Figure 3.1A).  We also performed in vitro 
measurements of Alexa 488 in microdroplets with sizes similar to that of cells.  
Measuring in microdroplets ensures a limited fluorescent population so that we can 
examine the effects of photodepletion on a model system.  The decaying fluorescence 
intensity of Alexa 488 in a droplet is shown in Figure 3.1D.  For further analysis we 
divide the recorded fluorescence signal into data segments of ~1.6 s each.  Because the 
fluorescence intensity is approximately constant within a segment, brightness analysis is 
performed separately on each segment.  The number of molecules N of EGFP in the 
observation volume (Figure 3.1B) decreases, because bleaching reduces the overall 
concentration of fluorophores in the sample.  The brightness λ, however, remains 
constant throughout the measurement (Figure 3.1C), because the bleached molecules are 
not contributing to the fluorescence, while the brightness of the remaining fluorophores is 
unchanged as illustrated in Figure 3.2A.  The number of molecules of Alexa 488 and 
their brightness is shown in Figures 3.1E-F.  Again, the brightness is time-independent, 
while the number of fluorophores decreases as a consequence of bleaching.  Alexa 488 is 
significantly brighter than EGFP, which leads to a better signal-to-noise ratio, and is 
useful for comparing data with the theoretical model.  Also, because we are able to 
expose microdroplets to higher laser powers than used in cell measurements, the effects 
of bleaching are more pronounced in the droplets than in cells.  
FFS analysis of the data set as a whole without segmenting leads to an apparent 
brightness of 50 kilocounts per second.  This value is 800% higher than the brightness 
recovered from the segmented data and illustrates the bias introduced into the analysis by 
the non-stationary fluorescence signal.  The bias is similar in the case of the microdroplet 
sample, where analysis of the whole data set leads to a ~700% increase in the brightness 
compared to the value recovered from the segmented data.  Thus, segmenting of the data 
is an efficient method for eliminating the bias introduced by the non-stationary signal.   
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Figure 3.3  Brightness bias as a function of time and lost intensity fraction. 
The triangles represent the normalized brightness of increasingly longer data segments of 
Alexa 488 dye in a microdroplet and EGFP in the nucleus of a cell. The brightness values 
are determined using moment analysis. (A) The brightness bias from the Alexa data of 
Figure 3.1 is plotted as a function of time. The inset shows the same data plotted as a 
function of lost intensity fraction since the behavior of the brightness with respect to this 
parameter is independent of bleaching rate. (B) The EGFP brightness, also from 
Figure 3.1, is plotted with normalized brightness against the lost intensity fraction and fit 
with Eq. 3.21.  
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Figure 3.4  Brightness bias at two different fluorophore concentrations.   
The normalized brightness of two Alexa 488 microdroplets with different concentrations 
is plotted versus the lost intensity fraction, 1 Ir . The legend provides the measured 
average occupation number, prior to bleaching, for each droplet. In the inset, the ratio of 
the two occupation numbers is calculated from the biased brightnesses according to 
Eq. 3.23. At low bleaching levels, the calculated ratio is unreliable since the normalized 
brightness of the low concentration droplet has virtually no bias.  
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To illustrate the bias on brightness caused by the decreasing fluorescence 
intensity, we recalculated the brightness of the first segment of the Alexa 488 
measurement presented in Figure 3.1, while progressively increasing the duration of the 
data segment.  The bias in the calculated brightness as a function of the length of the data 
segment is shown in Figure 3.3A.  If the data segment includes the whole data set, the 
brightness bias is ~800%.  The increase in brightness with data acquisition time is 
reproduced by a fit (solid line, Figure 3.3A) of the data to Eq. 3.21 with the remaining 
intensity fraction determined from Eqs. 3.8 and 3.9.  The theory predicts that two 
measurements of the same sample with different bleaching rates will report the same 
brightness as long as the remaining fluorescence intensity fraction 
Ir  defined by Eq. 3.9 
is identical.  Even if the fluorescence intensity decay is not exponential, the brightness 
 Ib r  is according to Eq. 3.21 determined by the remaining intensity fraction Ir .  Thus, 
from now on we graph the brightness as a function of 1-
Ir  as shown in the inset of 
Figure 3.3A.  We also reanalyzed the cell data of Figure 3.1D as a function of increasing 
segment time.  The resulting brightness bias as a function of 1 Ir  is shown in 
Figure 3.3B together with a fit to Eq. 3.21.  The agreement between data and fit 
demonstrates the feasibility of brightness analysis of cell experiments in the presence of 
photodepletion.  
We measured two different droplets containing Alexa 488 at different 
concentrations.  The biased brightness of the droplet with low concentration is graphed 
together with the brightness of the droplet with high concentration as a function of the 
lost intensity fraction 1-
Ir  (Figure 3.4).  The figure demonstrates that for equal fractional 
intensities the brightness bias is much stronger for the sample at high concentration.  
Both curves are fit to Eq. 3.21 which leads to an initial occupation number 
10 16N   for 
the high concentration sample, while 
20 0.69N   for the other droplet.  This dependence 
on concentration is predicted by Eq. 3.21 as illustrated by the inset of Figure 3.4, where 
we plot  
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with 
1b  and 2b  as the normalized brightness of the two samples.   
 We now focus on the effects of photodepletion in cell measurements.  Data will 
be analyzed on segments short enough that brightness bias is negligible.  For the previous 
cell data, Figures 3.1 and 3.3, the cell was exposed to two-photon excitation to 
simultaneously bleach EGFP and monitor its brightness.  However, because these 
experiments require rather long data acquisition times, in this part of the work the cells 
are measured by exposing the cell repeatedly for short periods to epifluorescence light.  
After each exposure the instrument performs a short two-photon FFS measurement to 
record the brightness and the remaining intensity fraction 
Ir .   
First, we wish to establish whether the fluorescent protein EGFP is well-behaved 
in photodepletion experiments.  The data collected from many different cells are 
summarized in Figure 3.5 for 0.3Ir  , which shows that the brightness of the fluorescent 
protein is stable, as expected from Eq. 3.11 for a monomeric fluorophore.  However, the 
inset to Figure 3.5 shows that the brightness decreases for 0.3Ir  in contrast to the 
simple bleaching model which predicts a normalized brightness of 1 all the way down to 
zero remaining intensity.  This divergence indicates that the fluorescent protein is not 
bleaching in a single step, but involves at least one additional state with dim fluorescence.  
From a practical point of view, this divergence from the model only occurs at extreme 
levels of photobleaching, and the data demonstrate that EGFP is well described by our 
simple model up to 70% bleaching of the initial intensity ( 0.3Ir  ).   
Now, we examine a dimeric fluorescent protein in a photodepletion experiment by 
expressing a tandem construct of the fluorescent protein EGFP in CV-1 cells.  The 
normalized brightness of the tandem construct, referred to as EGFP2, decreases as a 
function of the remaining intensity fraction (Figure 3.6).  This is expected, because 
photobleaching of different chromophores is statistically independent, which leads to a 
mixture of EGFP2 with two, one, or no fluorescing units as illustrated in Figure 3.2B.  
The normalized brightness in Figure 3.6 is fit to a straight line with a slope of 0.95 ± 0.05 
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and an intercept with the y-axis of 1.05 ± 0.07.  This result is in agreement with theory, 
which predicts a linear function with an intercept of one for 0Ir  .  The theoretical slope 
of Eq. 3.11 is 1n , where n  represents the number of fluorophores within the protein 
complex.  Thus, our experiment predicts that the measured protein contains 1.95 
fluorophores, which agrees within experimental error with the expected result, 2n  , for 
a dimer.  As is the case for the monomeric fluorescent protein, the brightness of the 
tandem protein diverges from the simple, two-state model for 0.3Ir   (inset of 
Figure 3.6). EGFP undergoing severe and prolonged photobleaching experiments in cells 
appear to require a more complex model to fully describe the data, a point we will 
address briefly in the discussion.  However, our present data and experimental approach 
lack the resolution to unambiguously distinguish between potential three-state models, 
and furthermore, such extreme photobleaching conditions are unlikely to occur in most 
fluorescence studies. 
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Figure 3.5  EGFP brightness of cells in the presence of photodepletion.   
EGFP in the nucleus of three different cell lines is bleached using epifluorescence light 
and monitored via two-photon excitation. The normalized brightness as a function of the 
remaining intensity fraction 
Ir  is shown for the range where the simple two-state 
bleaching model (Eq. 3.11) describes the data.  The inset graphs the normalized 
brightness for all measured 
Ir . The dashed line indicates the regime where the simple 
two-state bleaching model is applicable and monomeric brightness is stable. Below that 
regime, the behavior of the brightness is more complicated, but is still universal with 
respect to the remaining intensity fraction. The dashed line at b = 1 marks the range of 
fractional intensities where the simple analysis model is valid. 
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Figure 3.6  Dimeric EGFP brightness of cells in the presence of photodepletion.   
Dimeric EGFP is bleached with epifluorescence light and monitored by two-photon 
excitation. The apparent brightness decreases linearly as a function of remaining 
fractional intensity. The regression line agrees well with our model’s prediction of 
1 ( 1) In r    (Eq. 3.11).  The inset shows that for 0.3Ir   the simple bleaching model 
fails, and there is evidence of a dim state.  
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 Finally, with the theory developed and validated, we show the strength of the 
technique. E. coli is a broadly used model organism throughout the biological sciences, as 
the host organism for recombinant DNA, a test system for gene expression, and as a 
living test tube for still other lab experiments.
50–52
 However, due to the extremely small 
size of E. coli, most measurement methods are unavailable and any excitation light 
applied to an E. coli cell will cause photobleaching and therefore deplete a significant 
fraction of the sample during the measurement. Thus, absolute and quantitative 
measurements of the concentration and copy number of fluorescent proteins in living 
E. coli cells are feasible for the first time. Here, we show an initial application of the 
theory and technique to successfully extract correct brightness values. 
We investigate the oligomerization state of NTF2 directly in living E. coli cells. 
Although there has been some disagreement in the literature regarding the affinity of the 
NTF2 homodimer in cellular versus in vitro measurements, NTF2 has always behaved as 
a tight dimer in our hands, as will be explored further in the following chapters. However, 
most NTF2 solution experiments are performed on proteins purified from E. coli cells. 
Here, we are able to take advantage of our photodepletion corrections to directly measure 
NTF2 homo-oligomerization in the living test tube of E. coli.  
 Figure 3.7A shows the normalized brightness of NTF2 in E. coli for increasingly 
longer data segments (triangles), plotted as a function of the lost intensity or bleaching 
fraction. In our experience, 25% bleaching presents enough of a bleaching curve for 
reliable fitting without requiring the excessive data acquisition times required to approach 
complete bleaching. The data is then fit (solid line) using the non-stationary signal theory 
to acquire the corrected brightness of NTF2 for the given E. coli cell. For Figure 3.7B, we 
repeat this procedure for multiple E. coli expressing NTF2 (squares) as well as for E. coli 
expressing EGFP (triangles), to act as a control. The results of these experiments are 
plotted as brightness versus protein concentration. For the sake of simplicity, we will not 
discuss that in addition to photodepletion correction, geometric corrections need to be 
considered to achieve absolute concentration and brightness values. The foundation 
underlying geometric corrections are introduced in the next chapter. We conclude these 
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results by observing that over the concentration range measured, NTF2 shows good 
brightness doubling, indicating that NTF2 is dimeric in E. coli. 
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Figure 3.7  NTF2 Oligomerization in E. coli.  
(A) The normalized brightness of EGFP-labeled NTF2 in an E. coli cell plotted for 
increasingly longer data segments versus lost intensity fraction, as opposed to the 
remaining intensity fraction. These experiments and analysis were performed by Kwang 
Ho Hur. As before, longer data segments suffer from an increased photodepletion bias. 
By fitting the data to theory (solid line), we are able to recover the unbiased brightness. 
(B) Performing this type of experiment for many E. coli cells expressing both NTF2 
(squares) and EGFP (triangles), we are able to plot brightness of these two proteins in 
E. coli versus their concentration. The doubling of NTF2 brightness over EGFP indicates 
that NTF2 is dimeric.   
  50 
3.5  Discussion  
We introduced the term photodepletion to refer to experiments where the primary 
effects of photobleaching, namely reduction in diffusion time and brightness, are 
negligible.  In this case only the cumulative reduction in the concentration of 
fluorophores affects the interpretation of the data.  While the depletion of fluorophores is 
insignificant when dealing with a large sample volume, it is a relevant issue when 
measuring cells, droplets, and other closed systems with volumes on the order of 
picoliters.   
Fluorophore depletion leads to a bias in the calculated brightness because the 
decreasing fluorescence signal is non-stationary.  Formulas that account for the bias have 
been developed and experimentally verified.  While we focused here on brightness only, 
the fluctuation amplitude (0)g  is similarly affected by photodepletion, and it is 
straightforward to arrive at equations that describe the bias on (0)g  by repeating the 
derivation using (0)g Q k .  Theory and data show that the bias introduced by 
fluorophore depletion increases with concentration.  This result is especially important 
for cell experiments where measurements are often performed at much higher 
fluorophore concentrations than typically found in aqueous solution.   
The easiest way to avoid the bias due to photodepletion is to analyze short 
segments of the data as illustrated in Figure 3.1.  A practical method of determining the 
proper segment size is to start with a long segment that is successively shortened until the 
calculated brightness of the segment is constant.  Further shortening of the segment is 
counterproductive as the signal-to-noise ratio of the calculated brightness depends on the 
length of the data segment.  If the experiment demands a higher signal-to-noise ratio, the 
length of the segment must be increased.  In this case any bias introduced by lengthening 
the segment must be accounted for by the existing theory.   
Long measurement times in cells are desirable because they improve the signal-
to-noise ratio, which is the crucial factor determining if protein mixtures or interactions 
are detectable.  But photodepletion effects become important when increasing the data 
acquisition time beyond a critical value, which depends on the photostability of the 
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protein.  While EGFP is relatively photostable, other proteins, such as red fluorescent 
proteins, are much more photolabile.  Thus, photodepletion of red fluorescent proteins is 
readily observed in two-photon excitation measurements.
47
  While photobleaching by 
two-photon excitation is strictly confined to the focal volume, photobleaching by one 
photon excitation occurs also outside the focal volume, which potentially accelerates the 
appearance of artifacts introduced by photodepletion.   
FFS experiments often require the repeated measurement of the same cell under 
different conditions, such as after adding ligand or at different excitation wavelengths.
7
  
If these additional FFS or imaging measurements introduce bleaching, the brightness of 
the remeasured sample is affected by the degree of photodepletion present, which leads to 
a bias in the interpretation.  To avoid this problem it is possible to measure the brightness 
as a function of the remaining intensity fraction 
Ir  as shown in Figure 3.6.  The slope 
plus one of the data equals the undistorted brightness even if the sample experienced 
some bleaching, as long as the original intensity of the sample is known.  The slope 
recovered from Figure 3.6 predicts a protein complex containing two EGFP molecules.  
The same principle also works for mixtures of different oligomeric states.  The apparent 
brightness b of the mixture is, according to Eq. 3.12, equal to one plus the slope of the 
( )Ib r  curve.   
In this chapter we consider photodepletion of a single type of fluorophore, such as 
EGFP.  While this assumption is adequate in many cases, situations exist where more 
than one species bleaches.  In the latter case, the theory needs to be expanded to account 
for the individual bleaching rate of each species.  We further assumed a simple two-state 
bleaching model with a brightness that is   in the fluorescent state A and which drops to 
zero in the bleached state D.  The bleaching of EGFP is not described by this simple 
model (inset of Figure 3.5), which predicts a constant brightness for monomeric EGFP.  
The experimentally observed drop in brightness for 0.3Ir   is consistent with a three-
state bleaching model, where state A is converted into an intermediate state B before 
bleaching occurs.  The observed drop in Figure 3.5 requires that the brightness of state B 
is lower than that of state A.  Because the contributions to fluctuations by a single 
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molecule in state B are lower than that of a molecule in state A, the presence of state B is 
not observed until a majority of the proteins are converted.  For this reason our analysis 
with the simple bleaching model is successful as long as we limit ourselves to 
experimental situations where 0.3Ir  .  The presence of more than one brightness state 
of EGFP is supported by additional bleaching experiments.  Patterson et. al. measured the 
properties of EGFP and other fluorescent proteins by irradiating small isolated droplets of 
protein solution.
53
  Another study used immobilized EGFP on a surface to measure the 
decay characteristics of one- and two-photon photobleaching.
54
  In both of these studies, 
a multi-exponential model was used to describe the photobleaching data suggesting the 
existence of multiple states. Didier and Bardou developed a Lévy statistics model of 
photobleaching that suggests the existence of an unstable brightness state with an infinite 
lifetime.
55
 Finally, it is possible to formulate a more complex model that includes 
intermediate brightness states.  Comparing the predictions of such a model with the data 
presented in the inset of Figure 3.5 would provide information about the presence of 
intermediate states and their brightness, which is hard to obtain by other methods.  
The success of the photodepletion analysis is the ability to quantitatively establish 
accurate brightness and absolute concentration of fluorescent particles in living E. coli 
and other microorganisms or microdroplets. The ability of FFS to perform brightness 
titrations is a powerful tool, but lacks meaning if it cannot be correctly related to protein 
stoichiometry and concentration. Photodepletion theory brings the full strength of FFS 
and brightness analysis to the world of E. coli and other small sample compartments. 
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4.  Z-scan FFS 
 FFS, as introduced so far, has not included any discussion of the shape of the 
sample or of the excitation volume geometry. In this chapter, the contents of which have 
been previously published,
56,57
 we will discuss two common situations where geometry – 
either of the excitation light or the sample – leads to a biased or misinterpreted 
brightness. The first issue is related to instrumentation and arises from the index of 
refraction mismatch and the spherical aberrations typically found when performing FFS 
experiments with an oil-immersion objective.
58,59
  The focus of the chapter is the second 
issue dealing with thin layer sample geometries, like cell cytoplasm. When the focal 
volume of the excitation light is taller than the sample, the brightness of the sample 
appears larger than the actual value.  
 
4.1  Introduction 
The application of brightness analysis in cells requires caution because the 
cellular environment is far more complex than that in aqueous solution. Here we focus on 
the thickness of the cell and its influence on brightness. We show that this brightness 
artifact appears once the sample thickness approaches the axial size of the observation 
volume. The thickness of spreading cells, which are widely used in fluorescence 
microscopy, is sufficiently thin that brightness bias is of concern. In fact, we 
experimentally observe a thickness dependent bias of brightness in the cytoplasm of 
COS-1 cells. This bias is problematic, because it obscures the correct interpretation of 
protein interactions from the FFS data.  
We introduce a new data acquisition and analysis protocol to eliminate the 
thickness-dependence of FFS experiments and to restore the quantitative interpretation of 
brightness. Our approach relies, in addition to the FFS measurement, on a z-scan of the 
excitation light across the sample. Z-scan approaches to FFS have previously been used 
to study the diffusion of proteins in lipid bilayers and cell membranes.
60–62
 Here we use 
the z-scan to gain information about the geometry of the sample which is subsequently 
incorporated into FFS theory. We further characterize the axial shape of the excitation 
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light of the two-photon microscope and introduce a point spread function model to 
quantify z-scan FFS measurements. We experimentally verify the technique on cells 
expressing EGFP and demonstrate the elimination of the brightness bias in the cytoplasm. 
In addition, we apply z-scan FFS to investigate the oligomerization of the nuclear 
transport factor 2 (NTF2) in the cytoplasm of COS-1 cells.  
 
 
4.2  Demonstration of brightness bias 
The enhanced green fluorescent protein (EGFP) expressed by cells is found in 
both the cytoplasm and in the nucleus. We have previously shown by brightness analysis 
that EGFP exists as a monomer in the nucleus.
6
 Conventional FFS measurements were 
taken at different positions in the cell, starting in the nucleus and moving outwards to the 
edge of the cell, as depicted in Figure 4.1A. For each position, the excitation volume was 
focused at mid-height in the sample. The nucleus provides a thick region which, for many 
cell lines, completely contains the excitation volume and is free from bias. Beyond the 
nucleus, sample height falls off quickly as measurements are taken further out into the 
cytoplasm. We discuss later how the thickness of cells is experimentally determined. 
Figure 4.1B plots the normalized brightness of EGFP as a function of sample thickness. 
Normalized brightness, 
monomerb    , is determined by dividing the measured 
brightness   by the brightness of a single fluorophore tag in the nucleus; 1b   
corresponds to a monomeric protein and 2b  corresponds to a dimeric protein. In the 
thicker parts of the cell, FFS measurements identify monomeric EGFP ( 1b  ). As the 
cytoplasmic regions get thinner, the brightness values increase. At the thinnest part of the 
cytoplasm, conventional FFS data indicate dimeric EGFP ( 2b  ). The data suggest a 
thickness dependent dimerization of the protein. We show in the following that this result 
is an artifact introduced by ignoring the finite geometry of the sample in conventional 
FFS analysis. 
Brightness involves a spatiotemporal average of the photons emitted by a single 
fluorophore. Conventional FFS assumes that the fluorophore visits all regions of the 
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excitation volume with equal probability. This situation is realized by a sample which 
contains the entire excitation volume, which we refer to as the infinite sample case. The 
assumption of an infinite sample is problematic when considering cellular FFS 
experiments in which part of the excitation volume resides outside of the thin sample and 
excites no fluorophore. Focusing on the mid-section of a thin sample excludes access of 
the fluorophore to the outer edges of the excitation light, where the intensity is lowest. As 
a consequence, the fluorophore spends most of the time in the higher intensity, central 
areas of the excitation volume, and the resulting spatial average skews the brightness 
upwards. This brightness artifact poses a significant challenge for the quantitative 
interpretation of protein interactions in the cytoplasm.  
 
4.3  Formulation of z-scan FFS 
It is not difficult to modify the theory to account for finite sample geometry, but 
two practical difficulties are encountered. A priori, the specific geometry of the sample is 
frequently unknown, particularly in the case of cell experiments. Additionally, the exact 
position of the excitation volume relative to the sample along the optical- or z-axis is 
difficult to obtain. We will perform z-scan measurements to address these challenges and 
develop a quantitative method for measuring brightness in thin geometries.  
Scanning the beam uniformly along the z-axis extracts information about the z-
geometry of the sample via the resulting intensity trace. Figure 4.2A shows the 
fluorescence intensity trace for a z-scan through the cytoplasm of a cell expressing EGFP. 
A single intensity peak is observed, which represents the fluorescent layer of cytoplasm. 
Because the z-scan is based on a systematic movement of the excitation beam across the 
sample, modeling of the intensity trace determines the thickness and the z-position of the 
beam relative to the sample as a function of time. The overlaid cartoon in Figure 4.2A 
illustrates the position of the excitation light with respect to the sample.  
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Figure 4.1  Thin samples bias brightness in conventional FFS data.  
(A) Conventional FFS assumes a homogenous sample environment that contains the 
entire excitation volume. These conditions are easily met in the center of most cell nuclei. 
Measurements in thin geometries like the cytoplasm return biased results. (B) A cell 
containing EGFP is measured at different thickness positions. Normalized brightness, b, 
appears to increase by a factor of 2 as the sample thickness decreases. This is an artifact 
of conventional FFS measurement in thin geometries. 
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Figure 4.2  Z-scan approach to finite sample geometries of the living cell.  
(A) A COS cell containing EGFP was z-scanned through the cytoplasm. The average 
fluorescence intensity is plotted as a function of z-position. The overlaid cartoon 
indicates the position of the excitation volume with respect to the cytoplasmic slab. A z-
scan acquires information for many z-positions and provides an accurate description of 
the fluorescent signal from a thin sample which a single-point conventional FFS 
measurement cannot. (B) A cytoplasmic cell section is located a height h0 above the start 
of the z-scan and has a thickness h.  The position of the excitation light is described by 
the value of z .  
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We model each cytoplasmic section enclosed by the observation volume as a 
fluorescent slab. The diameter of a typical COS cell is ~50 μm in the x-y plane with a 
thickness that decreases from the center (~5 μm) to the periphery. The intensity of the 
excitation light is azimuthally symmetric. The axial direction is parallel to z, and the 
radial direction lies in the x-y plane (Figure 4.2). Compared with the size of the cell along 
the x-y plane, the radial beam waist (~0.5 μm) of the excitation light is small enough that 
the change in thickness of the cytoplasm section within the excitation light is negligible. 
Therefore, we model the cytoplasm section as a slab of constant height. The z-scan 
begins well below the cell such that sample is first encountered at a height   . The 
cytoplasmic slab has a height  , and the position of the excitation light is described by the 
z-coordinate of its center. 
We now introduce the geometry function      into FFS theory to account for a 
confined sample environment.  For the specific example of a slab (Figure 4.2B) as 
described above, the function       is given by  
 
0 0
0
1,    
( ; , )
0,          otherwise
h z h h
S z h h
  
 

 (4.1) 
The parameter h0 is important for fitting experimental data, because it determines the 
difference between the start position of the scan and the start position of the slab. 
However, including the offset parameter h0 into the theory development unnecessarily 
complicates the notation. We therefore set h0 to zero and hereafter leave it out of the 
notation. It is straightforward to include the offset in the final equations by a linear 
transformation of z to z – h0.  
We define the volume of the point spread function (PSF) raised to the r-th power 
by  
      PSF ,rrPSFV z S z d       (4.2) 
The variables   and ρ represent the local coordinates measured with respect to the center 
of the PSF. We explicitly make use of the cylindrical symmetry of the PSF with 
2d d d    . The position   in the local PSF-coordinate system translates to z   
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in the experimental setup coordinate system. In addition, we adopt the convention that in 
the absence of explicit integration limits variables are integrated over all space. 
This definition of  rPSFV z  explicitly includes the geometry function      to 
reflect that only part of the PSF is accessible to the fluorophore. The conventional FFS 
theory is recovered by choosing       , which corresponds to the infinite sample case, 
where the complete PSF is accessible. We explicitly refer to the infinite sample case by 
using the subscript . Thus,       is the volume of the PSF for the infinite case. The 
value of  rPSFV z  for the restricted geometry depends on       and the focus position z of 
the PSF. The fluorescence intensity ( , )F t z  of a solution of molecules with brightness λ 
confined in a finite sample is given by
4
 
  ( , ) ( , ) ( , , )F t z PSF c t S z d           (4.3) 
with concentration ( , , )c t   at position  ,   and at time t. The geometry function      
serves to restrict the sample size.  
We now specifically consider the slab-geometry defined by Eq. 4.1. The PSF 
volume depends for this case on the height h,  ;rPSFV z h . For a stationary process the 
average fluorescence and its variance is determined from Eq. 4.3 as  
 ( ; ) ( ; )PSFF z h c V z h  (4.4) 
and  
 2
2 2 2
2( ; ) ( ; ) ( ; ) ( ; )PSFPSFF z h c V z h z h c V z h          . (4.5) 
While the derivation of Eq. 4.4 is straightforward, Eq. 4.5 can be derived using the 
cumulants of the fluorescence
32
 or by following the method used by Thompson.
39
 Eq. 4.5 
also introduces a geometry dependent shape-factor  
 
2
2
( ; )
( ; )
( ; )
PSF
PSF
V z h
z h
V z h
  , (4.6) 
which is a generalization of the conventional shape factor.
39
 All of the above equations 
are equivalent to the equations of conventional FFS, which are obtained by replacing 
     by the value for the infinite sample case,       .  
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Brightness and concentration are independent of geometry and thus are good 
parameters for characterizing the sample of interest. The mean fluorescence intensity 〈 〉 
is an easily measured experimental quantity which is used to determine the size of the 
slab. Furthermore, we use Mandel’s Q parameter26,49  
  
 
 
   
2
2
;
; 0 ;
;
F z h
Q z h g F z h
F z h
 

     , (4.7) 
because it is a directly measurable quantity that relates to the brightness through the 
model-dependent shape factor   . Q is determined by the ratio of the first two moments 
of the fluorescence intensity, or, alternatively, by the product of the fluctuation amplitude 
 0g  and the average fluorescence intensity as measured in an FCS experiment. 
While we discussed the slab-model in the above section, it is straightforward to 
extend the model to other geometries by evaluating Eqs. 4.4 to 4.7 for other functions of 
    . Of particular interest is a sample thin enough that it resembles a layer with 
negligible thickness. We refer to this as a delta-layer sample, which has the 
corresponding shape-factor  
 ( ) ( )S z z . (4.8) 
The average fluorescence intensity for a delta-layer is  
 1( ) RIPSF ( )F z z     (4.9) 
where   is the area concentration of fluorophores within the delta-layer and 
rRIPSF ( )z defines the radially-integrated PSF raised to the r-th power  
 
r
0
RIPSF ( ) PSF ( , ) 2rz z d  

  . (4.10) 
Thus, 
1RIPSF ( )z  of Eq. 4.9 represents the radially-integrated PSF, which we also refer to 
as RIPSF( )z in this paper. 
 
4.4  PSF model 
The z-scan fluorescence intensity curve given by Eqs. 4.4 and 4.2 involves the 
convolution of the PSF and the sample geometry, as it is this overlap volume which 
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generates the fluorescent signal. To usefully model the convolution, it is first necessary to 
establish an accurate PSF of the experimental setup from fluorescence intensity curves. 
However, convolution of the PSF with the sample thickness obscures the features of the 
experimental PSF. To avoid this complication we choose a delta-layer sample, which 
according to Eq. 4.9 results in a fluorescence intensity curve that is directly proportional 
to the radially-integrated PSF, RIPSF( )z . This procedure directly evaluates the quality of 
a PSF-model in reproducing experimental data.  
For this study, z-scans are performed on a cytoplasmic section thin enough that it 
resembles a delta layer. In order to identify a cytoplasmic delta layer, we take a series of 
z-scans across the cell moving towards increasingly thinner sections of the cytoplasm. 
While intensity z-scans in the nucleus are broad, the width of the curve narrows as the 
cell height decreases. Below a certain thickness, the shape of the intensity z-scan ceases 
to change. When this condition is met, we have reached an effective delta layer. 
FFS theory employs simple model functions in order to approximate the 
experimental PSF. In the following, the parameter n is used to account for the difference 
in the PSF for two-photon excitation (TPE) and one-photon excitation (OPE). We define 
the PSF models where n = 1 for OPE and n = 2 for TPE. Two PSF-models widely used 
are the 3-dimensional Gaussian (3DG) PSF  
  
2 2
2 2
0 0
, exp 23DGPSF n
w z
 
 
  
     
  
 (4.11) 
and the Gaussian-Lorentzian (GL) PSF  
  
2 2
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2
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n
GL
w
PSF n
w w

 
 
  
   
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 (4.12) 
with  
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 
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 (4.13) 
The radial and axial beam waists of the PSF are given by    and   .While 
knowledge of the PSF is sufficient for TPE, the description of OPE is further complicated 
by the need to account for the effect of a pinhole on the collected fluorescence emission. 
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This effect can be approximated by multiplying the excitation PSF by a collection profile 
function  ,  .39,63 Because our experimental work uses TPE we analyze the 
experiments using a PSF-model with n = 2. 
We now evaluate the suitability of these two model functions for z-scan FFS. It is 
straightforward to integrate each PSF over ρ to determine their RIPSF. Figure 4.3 
contains the intensity z-scan of an effective delta layer based on a very thin cytoplasmic 
section of a COS cell expressing EGFP. Figures 4.3A and 4.3B display fits of the 
intensity curve to the RIPSF using the 3DG and GL model, respectively, plotted with a 
linear and logarithmic intensity axis to emphasize the tail of the radially-integrated PSF. 
Simple visual inspection of the fits reveals that neither the 3DG nor GL model lead to a 
correct description of the experimental RIPSF.  
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Figure 4.3  PSF models.  
A z-scan intensity trace is acquired from a thin section of cytoplasm in a cell containing 
EGFP. The same intensity trace is fit with three different point spread function (PSF) 
models. The intensity fits are plotted on a linear (upper panel) and semi-log scale (middle 
panel), along with the normalized residuals (lower panel). (A) The 3D Gaussian model 
and (B) the Gaussian-Lorentzian model are two PSF models commonly used in 
conventional FFS, but do not accurately fit z-scan data. (C) We show that our modified 
Gaussian-Lorentzian (mGL) model permits the more accurate fit necessary to 
successfully implement the z-scan technique. The mGL fit parameters for this data are 
z0=1.1 ± 0.048 µm and y=1.9 ± 0.056. (D) Z-scans were performed across thin sections 
of five cells and normalized to a peak intensity of 1. The overlaid data demonstrate that 
the z-scan profile is stable and repeatable.  
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It is desirable to establish a PSF model that faithfully reproduces the z-scan 
intensity curves. Such a model is a prerequisite for employing a chi-square goodness-of-
fit test to accept or reject the presence of protein interactions from brightness data. A far 
more sophisticated approach of modeling the PSF involves evaluating the EM-wave 
propagation through the microscope objective.
63,64
 However, such an approach requires 
extensive modeling and is numerically expensive. Ideally, we would like to establish a 
heuristic model function which has a simple analytical form and successfully reproduces 
the experimental data. Figure 4.3 shows that both the 3DG and GL fits have strong 
correlations in their residuals. These correlations are typical for all cells scanned (not 
shown). Correspondingly, the reduced chi-squared values for 3DG and GL fits are 
consistently greater than 4. Closer inspection of the fits reveals that the tail of the 3DG 
function decays too rapidly, while the tail of the GL function decays too slowly. This 
observation motivated the introduction of a modified Gaussian-Lorentzian (mGL) PSF  
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The mGL-PSF contains the additional parameter y, which varies the exponent of the first 
factor of the GL-PSF. This heuristic model allows us to tune the steepness of the z-decay 
of the PSF while maintaining a Gaussian cross-section of the PSF. Notice that for y = 1, 
the modified GL-PSF reduces to the original GL-PSF. The mGL-PSF successfully fits the 
experimental intensity curve (Figure 4.3C) with largely uncorrelated residuals and a 
reduced chi-square close to 1. The fit-parameters are         μm and      . 
Figure 4.3D shows overlaid z-scans through very thin slices of five different cells. The 
peak intensities have been normalized to 1 to demonstrate that the RIPSFs all have the 
same shape and are reproducible. Thus, we will use the mGL-PSF for modeling of all 
further z-scan FFS experiments. 
 
4.5  Oil- and water-immersion objectives  
In a practical consideration, it is important to consider what objectives are suitable 
for the technique before attempting z-scan experiments. FFS experiments are typically 
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undertaken using high numerical aperture water- or oil-immersion objectives, but 
properly designed water objectives are required for z-scan FFS, because oil-immersion 
objectives exhibit z-dependent changes in the PSF. We demonstrate that FFS parameters, 
such as intensity, brightness and diffusion, have a strong focal height dependence when 
measured by an oil-immersion objective making them unsuitable for z-scan FFS. Even 
setting z-scanning aside, this oil-immersion objective height dependence is not optimal 
for standard measurements which may involve focus changes as different locations in a 
sample are observed. Therefore, we also present a heuristic correction for brightness 
measurements when employing an oil-immersion objective. 
 High numerical aperture (NA) objectives require a substance to fill the gap 
between the objective and the coverslip, so that NAs of greater than 1 can be obtained. 
Immersion objective must therefore be designed carefully with regards to index of 
refraction.   The relevant layers are the immersion fluid (index of refraction   ), the 
microscope glass (  ), and the sample (  ) and objectives are designed with the criterion 
that      .
65
 The condition is broken when using an oil-objective to measure aqueous 
solution. For short focus heights (a few micrometers), the light path is not long enough to 
experience significant divergence of the rays, and so there isn’t much effect on the focal 
volume. As a result, oil-immersion objectives may be used with relative impunity for FFS 
measurements in the region close to the coverslip. However, the index of refraction 
mismatch leads to spherical aberrations which become seriously problematic when trying 
to focus deeper into solution, living cells, or tissue. The effect is a distortion of the PSF 
and so a change in the recovered FFS parameters. Other studies have demonstrated that 
the PSF is stretched dramatically in the axial direction and significantly in the lateral 
direction
66
 which has a very noticeable effect on brightness.  We recall that brightness   
is defined as: 
 
2
(0)F F G
N


  . (4.15) 
〈 〉 is average intensity;  ̅ is the average number of molecules in the excitation volume 
and is inversely proportional to       
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The enlarged PSF decreases the efficiency of the two-photon excitation and leads 
to decreasing intensity 〈 〉 as a function of focal depth. Figure 4.4A  shows intensity 
measurements at increasing focal depths for Texas Red dye in aqueous solution, using a 
Zeiss 63x Plan Apochromat Oil-immersion objective (NA =1.4). The intensity effect is 
pronounced, with a 15% decrease within 5 µm and a 70% loss of intensity at a depth of 
60 µm. Additionally, the larger PSF covers more area and excites a larger number of 
molecules. This is reflected in autocorrelation analysis through a decrease in the 
correlation amplitude      (Figure 4.4B).  Similarly, it takes longer for a particle to cross 
the inflated excitation volume, resulting in increasing diffusion times as shown in Figure 
4.4C. Since average brightness is reduced by both the decrease in intensity and the 
increase in number of molecules, brightness values are extremely sensitive to focal depth. 
Texas Red brightness values fall by 20% within 5 µm. Focal depth differences of     
micrometer cause brightness deviations that fall within the 10% noise typically associated 
with brightness experiments in living cells. However, for samples beyond a few 
micrometers in thickness, the effects of the changing PSF cannot be ignored.  
We note an observed relationship between average intensity and the correlation 
amplitude. Figure 4.4D shows  〈 〉  ⁄ plotted as a function of focal depth, where   is an 
experimentally determined parameter dependent on objective type, magnification and 
numerical aperture. For the Zeiss 63x oil objective, we find          . In the case of 
a 100x oil objective (not shown),           . Performing the above calibration on an 
objective provides a quick method for correcting the depth-dependent brightness bias in 
subsequent experiments. 
We perform the same experiments as above but now use a Zeiss 63x C-
Apochromat water-immersion objective (NA = 1.2). Note that the water objective comes 
equipped with a correction collar that is tuned to account for the thickness of the 
coverglass between the objective and the sample. This collar must be set to the proper 
position for the objective to function as designed.
67
 Intensity (Figure 4.5A), correlation 
amplitude (Figure 4.5B), and diffusion time (Figure 4.5C) are essentially constant over 
the measured range of 60 µm. The brightness measured with this water-immersion 
objective is independent of depth as illustrated in the final panel (Figure 4.5D). Thus, 
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water-immersion objectives that have been corrected for spherical aberrations are 
advantageous for brightness experiments where the focal depth is changed. The rest of 
the experiments in this section are performed with such an objective to take advantage of 
FFS measurements that are independent of focal depth. 
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Figure 4.4  Focal depth dependence of oil-immersion objective.  
A dye solution is measured with two-photon excitation FFS using an oil immersion 
objective. (A) The intensity falls off strongly as the laser is focused more deeply into the 
sample. This is the result of an index of refraction mismatch and spherical aberrations 
that change the shape of the excitation PSF. (B) The autocorrelation amplitude is also 
plotted as a function of penetration depth into solution. (C) The PSF stretches both in the 
lateral and axial directions, and fluorescent particles require a longer time to traverse the 
PSF. (D) Brightness values also decrease sharply as a function of depth, but a calibration 
experiment can be used to find a relationship between brightness and intensity for a given 
FFS instrument. For our setup, the brightness falls as the square of the fluorescence 
intensity.  
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Figure 4.5  Focal depth dependence of water-immersion.  
The dye solution experiment is repeated using a water-immersion objective. (A) 
Fluorescence intensity is shown to be independent of focal depth. (B) Autocorrelation 
amplitude G(0) and (C) diffusion time are also constant over focal depth. (D) Brightness 
is essentially constant throughout the 60-µm range measured, and is plotted directly as a 
function of focal depth. 
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4.6  Materials and methods 
Experimental Setup. A mode-locked Ti:sapphire laser (Tsunami, Spectra-Physics, 
Mountain View, CA) serves as a source for two-photon excitation of a modified Zeiss 
Axiovert 200 microscope (Thornwood, NY) as previously described.
6
  Each FFS 
measurement lasts 30 to 60 s and uses two-photon excitation of the sample at 905 nm. 
Excitation light is focused through a Zeiss 63x C-Apochromat water immersion objective 
(NA = 1.2). Control experiments (data not shown) confirm that 0.3 mW excitation power 
is sufficiently low to avoid saturation and photobleaching effects.  Photon counts were 
detected with an avalanche photodiode (APD) (Perkin-Elmer, SPCM-AQ-14) and 
recorded by a data acquisition card (ISS, Champaign, IL), which stores the complete 
sequence of photon counts using sampling frequencies ranging from 20 to 200 kHz.  The 
photon counts were analyzed with programs written in IDL 6.0 (Research Systems, 
Boulder, CO). 
 
Z-scan Setup. Intensity z-scans were obtained using a PZ2000 piezo stage (ASI, Eugene, 
OR) to move the sample in the z-direction. Scan voltages were controlled by an Agilent 
33250A arbitrary waveform generator (Agilent Technologies, Santa Clara, CA) running a 
linear ramp signal with a frequency of 100 mHz  and a peak-to-peak amplitude of 1.2 V. 
This voltage corresponds to an axial travel of 24.1 μm. 
 
Expression Vectors, Cell Lines, and Cell Measurements.  A tandem dimeric EGFP 
(EGFP2) was constructed as previously described.
6
  NTF2 was amplified from human 
NTF2 (Genebank accession number: BC002348) with a 5’ primer that encodes an XhoI 
restriction site and a 3’ primer that encodes an EcoRI site. The result was cloned into the 
pEGFP-C1 plasmid (Clontech, Mountain View, CA). COS-1 cells were obtained from 
American Type Culture Collection (ATCC) and maintained in 10% fetal bovine serum 
(Hyclone Laboratories, Logan, UT) and DMEM media.  Transfection was carried out 
using TransFectin reagent (Bio-Rad, Hercules, CA) according to the manufacturer’s 
instructions 24 hours before measurement.  Cells were subcultured into eight-well 
coverglass chamber slides (Nagle Nunc International, Rochester, NY) with the media 
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exchanged for Dulbecco’s PBS with calcium and magnesium (Biowhittaker, 
Walkersville, MD) immediately before measurement. 
 
4.7  Z-scan fluorescence intensity curves of cells 
We demonstrated that the mGL-PSF describes the z-scan intensity curve for a 
delta-layer geometry. Theoretically, we expect that knowing the radially-integrated PSF 
is sufficient to describe any sample geometry     , because the volume of      is 
related to RIPSF via  
      rRIPSFrPSFV z S z d     . (4.16) 
Thus, the z-scan fluorescence intensity curve may be written as  
    ( ; ) RIPSFF z h c S z d      . (4.17) 
To test our prediction experimentally, multiple intensity z-scans are taken at 
different positions in a single cell. Each cell position provides a different sample 
thickness, but brightness and concentration are expected to be identical within a given 
cell. Figure 4.6 shows eight intensity z-scans taken from a single cell expressing EGFP. 
The locations of the scans are roughly: {0} at the center of the nucleus, {1} next to the 
nuclear envelope at the nucleoplasmic side, {2} next to the nuclear envelope at the 
cytoplasmic side, {3} – {6} progressing radially outward through the cytoplasm, and {7} 
near the outer edge of the cell. Because EGFP is uniformly distributed in the cytoplasm 
and nucleus, all eight scans probe a geometry with a single fluorescent layer. The eight 
intensity z-scan experiments are simultaneously fit to a slab model with a variable 
thickness for each scan, but globally linked PSF-parameters    and  . The global fit 
resulted in a reduced chi-square of 1.2 with PSF-parameters                μm and 
            . The thicknesses for cell scans {0 – 7} are 6.50, 4.03, 2.46, 2.02, 1.40, 
1.18, 0.95, and 0.30 µm. Note that samples thinner than ~0.5 µm become effective delta 
layers, and the slab model cannot accurately determine their thickness. The same 
experiment was repeated on other cells and on individual cell slices (data not shown) with 
similar results. The PSF parameters that best describe all z-scan experiments are    
          μm and           .  
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Figure 4.6  Intensity z-scans fit with mGL PSF model.  
Eight intensity z-scans were taken in the same cell at different thicknesses. The locations 
are roughly: {0} at the center of the nucleus, {1} just inside the nuclear envelope, {2} 
just outside the nuclear envelope, {3} – {6} progressing radially outward through the 
cytoplasm, and {7} near the outer edge of the cell. All sections are fit using identical 
parameters for the modified GL PSF model, z0=0.986 ± 0.009 µm and y=2.000 ± 0.016. 
Thicknesses for cell sections {0-7} are 6.50,  4.03,  2.46,  2.02,  1.40,  1.18,  0.95,  and 
0.30 μm. The overall reduced chi-squared is 1.19. 
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4.8  Gamma factor 
We previously discussed that conventional FFS analysis leads to a spurious 
increase of the brightness of EGFP with decreasing sample thickness. This behavior is 
readily explained by considering Mandel’s Q-parameter, which in conventional FFS is 
related to the brightness by       .
26
 Inspection of Eq. 4.7 illustrates that the failure 
of conventional FFS lies in assuming a gamma-factor     of an infinite sample, which 
neglects the actual geometry-dependence of the gamma-factor 
2( ; )z h . Thus, the 
brightness increase reflects the ratio of 2 2,( ; )z h   , which is 1 for a thick sample, but 
grows larger as the sample thickness decreases and reaches a limiting value as the 
thickness approaches a delta layer. A suitable PSF-model needs to reproduce the 
experimentally observed change of 2 2,( ; )z h    with thickness. Because    cannot be 
directly measured, we determine the Q-parameter according to Eq. 4.7 from the first two 
fluorescence intensity moments. The ratio of the gamma-factors is simply the ratio of the 
corresponding Q-parameters,  
 2
2,
( ; ) ( ; )z h Q z h
Q

  
 . (4.18) 
We measure this ratio of the Q-parameter by taking FFS measurements in ten 
cells expressing EGFP. Each cell is measured at various positions while focusing the 
beam at mid-height on the cellular slab, which corresponds to 2z h , where   is the 
height of the cellular slab. The experimental Q-parameter ( 2; )Q h h  is divided by   , 
which is obtained from a measurement in the nucleus or in bulk solution. The 
experimental ratio for Q-parameters is identical to the experimental ratio of gamma-
factors which are plotted in Figure 4.7 as a function of thickness h. 
Next we derive equations (see published
56
 supporting material) for the theoretical 
ratio 2 2,( 2; )h h    using Eq. 4.6 as a function of thickness h for the GL-, the 3DG-, 
and the mGL-PSF and fit the expressions to the experimental data. The fits are shown 
together with the experimental gamma ratio in Figure 4.7. Neither the 3DG- nor the GL-
model fit the experiment. Only the mGL-PSF model reproduces the experimental data. 
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The gamma-factor ratio between a delta-layer and an infinite sample, 2 2,( 2;0)h   , 
provides a sensitive test of the PSF model since its value can be determined from the 
experimental data and compared to theory. The gamma ratios of the 3DG and GL models 
are √  and   ⁄ , respectively, while the experimental value approaches ~1.8 in the limit 
as h goes to 0. The mGL-model with         μm and      , on the other hand, 
yields a gamma-factor ratio of 1.86, which is in close agreement with the experimental 
data. These results show that the mGL-PSF is successful in reproducing the experimental 
gamma-factors for all different heights h of the sample. 
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Figure 4.7  Gamma ratio: experiment and theory.  
Gamma ratio data is plotted for different positions in several cells containing EGFP. The 
gamma ratio is defined as  2 2;h h  divided by 2,  , where  2 2;h h  is a geometry-
dependent shape factor and 2,   is the infinite sample shape factor assumed by 
conventional FFS. Thick sample sections, like the nucleus, have an effectively infinite 
volume, and thus a gamma ratio equal to 1. The opposite limiting case, when the sample 
becomes a delta layer, is sample independent and thus a useful measure to test the PSF 
model we have developed. The traditionally chosen 3D Gaussian and Gaussian-
Lorentzian models do not fit the experimental data, especially in approach to the delta 
layer limit. The mGL PSF model matches the behavior of experimental data. 
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4.9  Brightness by z-scan FFS 
The experiments described so far indicate that the mGL-PSF provides an accurate 
description of the experimental PSF. We therefore expect to furnish unbiased brightness 
values from thin cell sections by analyzing FFS experiments with the mGL-model. The 
most straightforward approach to achieve an accurate brightness measurement from cell 
data requires an intensity z-scan measurement followed by an FFS measurement at the 
midsection of the cellular slab to determine the Q-parameter. The intensity z-scan 
provides the thickness h and axial-offset h0 of the cellular slab, which is used to 
determine the gamma-factor for the mGL-PSF at the midsection of the cell, 
2, ( 2; )mGL h h . By using the proper gamma-factor, the correct brightness   is extracted 
from the Q-parameter, 2, ( 2; )mGLQ h h   . If the gamma-factor       for an infinite 
sample geometry is used instead, a biased brightness    is recovered,            
The above strategy is now tested experimentally. We refer to the intensity z-scan 
followed by an FFS measurement at the midsection of the cell as z-scan FFS. We report 
brightness in normalized form,            ⁄ , where          is the brightness 
recovered for monomeric EGFP from a sample thick enough to avoid any bias in its 
brightness. For comparison we first show in Figure 4.8A the biased EGFP data (triangles) 
originally displayed in Fig 4.1B. The overestimation of the brightness with decreasing 
thickness of the sample is a consequence of conventional FFS analysis, which 
erroneously indicates the presence of dimeric EGFP in the cell. We now determine the 
brightness of the same data using z-scan FFS. The fits of the z-scan intensity curves 
confirm that EGFP in the cell nucleus and cytoplasm is represented by a single, uniform 
layer that is accurately modeled by the mGL-PSF applied to a rectangular slab of height 
h  (data not shown). The gamma-factor 2, ( 2; )mGL h h  was determined from the z-scan 
intensity fit parameters and used to determine the brightness from the experimentally 
measured Q-parameter. The recalculated brightness (crosses) is displayed in Figure 4.8A 
after accounting for the geometry-dependent gamma-factor. As expected, the normalized 
brightness is 1 at all measured cell locations, meaning that EGFP is a monomer 
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throughout the cell. This result provides strong evidence that z-scan experiments provide 
a successful method for the unbiased determination of brightness in the cytoplasm.  
We repeated the z-scan FFS measurement on cells expressing the dimeric 
construct EGFP2. Because EGFP2 covalently links two EGFP molecules together, a 
normalized brightness of 2 is expected from this artificial dimer. Z-scan FFS 
measurements are performed at 5 different positions in each cell measured. In addition, 
we performed z-scan FFS measurements on cells expressing EGFP as a control. The 
corrected brightness for each protein was determined using the previously described 
method. Figure 4.8B plots the unbiased EGFP brightness (crosses) and the unbiased 
EGFP2 brightness (diamonds) as controls. As expected, these normalized brightnesses are 
all ~1 and ~2, indicating monomers and dimers, respectively. 
We now apply z-scan FFS to measure the oligomeric state of EGFP-labeled NTF2 
in the cytoplasm of COS-1 cells. NTF2 plays an important role in maintaining the Ran-
gradient, which is crucial for nucleocytoplasmic transport.
68
 In vitro data report that 
NTF2 exists as a dimer at concentrations exceeding 1 M,69 but a direct confirmation of 
the dimeric state of NTF2 in cells is not yet available. We therefore performed 
cytoplasmic z-scan FFS experiments on EGFP-NTF2 at concentration exceeding 1 µM 
and demonstrate that the brightness (asterisks) falls on top of the EGFP2 data, showing 
that NTF2 is a dimer (Figure 4.8B). Conventional FFS analysis of the data would lead to 
a large scatter of brightness values with an average that exceeds the value expected for a 
dimer. This behavior complicates proper identification of the degree of oligomerization, 
which is avoided by using z-scan FFS.  
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Figure 4.8  Z-scan corrected brightness analysis.  
(A) EGFP exists as a monomeric protein in cells (normalized brightness, b=1), and 
distributes uniformly throughout the nucleus and cytoplasm. Data was taken at different 
locations in the cells, from the center of the nucleus out to the edge of the cell. 
Conventional FFS ignores sample thickness and yields biased results (triangles). Z-scan 
FFS corrects for sample geometry and recovers the unbiased brightnesses (crosses). The 
corrected normalized brightnesses show a value of 1, accurately reporting the existence 
of monomeric EGFP throughout the cell. (B) Additional experiments were conducted on 
cells containing the artificial dimer construct EGFP2 (diamonds) and nuclear transport 
factor 2 (NTF2, asterisks). Z-scan corrected brightnesses are equal to 2 for NTF2 
measured in high concentration cells (> 1 μM), which indicates that NTF2 forms a 
homodimer in the cytoplasm of living cells. 
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4.10  Discussion 
This study demonstrates that once the sample thickness approaches the axial 
dimension of the optical observation volume, the brightness determined by conventional 
FFS experiences a sample thickness-dependent bias. The degree of bias depends on the 
optical setup and the cell type studied. Spreading cells typically have a thickness of a few 
micrometers at the center, which drops with distance from the center. The axial beam 
waist of the excitation light depends on the optical set-up, but is typically ~1 to a few m. 
Thus, the potential for brightness bias in cell experiments is a concern. Because the cell is 
usually thickest at the center, the likelihood of brightness artifacts increases for cell 
measurements taken at off-center positions.  
We define the thickness which leads to a 20% bias in brightness as critical 
thickness. The critical thickness depends on the instrument and needs to be evaluated on 
an individual basis. Our instrumental setup leads to a critical thickness of 2 m. We 
reported thicknesses of COS-1 cells in the cytoplasm of ~2.5 m to less than 1 m. Thus, 
we observe brightness bias in cytoplasmic FFS measurements. Only measurements 
conducted directly next to the nuclear envelope on the cytoplasmic side of COS-1 cells 
are generally thick enough to avoid significant brightness bias. However, this location 
contains the endoplasmic reticulum and Golgi complex. If these organelles need to be 
avoided experimentally, measurements have to be taken further away from the nuclear 
envelope, where the thickness falls below the critical value. For example, the 
phosphatidylinositol type II kinase (P14KII) interacts with endosomal membranes,
70
 
which prevents the quantitative FFS measurement of cytoplasmic P14KII next to the 
nuclear envelope. Thus, cytoplasmic P14KII has to be measured further away from the 
nucleus, where brightness corrections are important. The cell line used in the experiments 
is another important factor. We have found that CV-1 cells exhibit a shallower height 
profile than COS-1 cells. Thus, cytoplasmic FFS measurements in CV-1 cells are at the 
critical thickness even when conducted directly next to the nuclear envelope. It is also 
important to recognize that while a cell population has a typical height profile, cell-to-cell 
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variations exist. Thus, the same relative location may be above or below the critical 
thickness in different cells.  
The excitation beam profile is the chief factor in determining the critical 
thickness. The long axial tail of the GL-PSF makes it especially prone to thickness 
artifacts, which is an important consideration for 2-photon excitation experiments. For 
example, a GL-PSF with an axial beam waist of 1 m leads to a critical thickness of 
5 m. Because the thickness of COS-1 cells at the center is ~5 m, a GL-PSF would 
introduce a brightness bias for all cell measurements. Thus, underfilling the back aperture 
of the objective, which leads to a GL beam profile, should be avoided when performing 
cell measurements. Since the optics of each instrument differ and the presence of 
aberrations influences the PSF, it is necessary to characterize the critical thickness of 
each instrument separately.  
The presence of brightness bias is not necessarily easy to recognize. It becomes 
apparent when graphing the brightness versus thickness as shown in Figure 4.1B, but 
typical FFS experiments do not record this information. Because FFS studies in cells 
require the measurement of a large number of cells to acquire sufficient statistics, the 
variations of thickness of the sample simply increase the scatter of the measured 
brightness values. Because the bias always results in larger brightness values, the 
interpretation of the data are systematically skewed towards identifying stronger protein 
interactions than actually exist. For example, in a system where protein-protein 
interactions are absent, the bias results in a normalized brightness exceeding 1. This leads 
to the erroneous conclusion that the proteins do interact. Similarly, quantitative 
interpretation of binding curves and protein stoichiometries from brightness titration data 
is also compromised. Brightness corrections are especially important for FFS 
measurements of proteins at the periphery of the cell, such as would be required in the 
case of focal adhesion studies. A similar example is FFS in bacteria, such as E. coli., 
which have a diameter smaller than the critical thickness. In addition to FFS 
measurements at a single location, brightness measurements using imaging approaches
71
 
are susceptible to the same artifact. 
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To perform quantitative brightness experiments in thin environments, it is 
necessary to address the brightness bias. The problem is solved by performing a 
fluorescence intensity z-scan before the FFS measurement to characterize the thickness 
and correct the FFS analysis. It only takes ~5 s to execute the intensity z-scan, which is 
short compared to the FFS data acquisition time (~60 s). Thus, the additional 
measurement time for carrying out z-scan FFS is negligible. Z-scan FFS only requires a 
motorized microscope stage and is straightforward to implement. Z-scan FFS 
experiments should be carried out with a water-immersion instead of an oil-immersion 
objective, because spherical aberrations need to be minimized.  
We applied z-scan FFS to investigate the oligomeric state of NTF2 in the 
cytoplasm. Biochemical studies and an ultracentrifugation experiment report that NTF2 
forms a dimer.
69,72
 Our work confirms that NTF2 exists as a dimer in the cytoplasm of 
living cells. NTF2 is also known to interact with nucleoporin proteins at the nuclear 
envelope,
68,73
 which leads to nuclear rim staining. As a consequence, the fluorescence 
intensity at the nuclear envelope is enhanced, which prevents us from measuring the 
brightness of NTF2 in the nucleus. We performed cytoplasmic FFS measurements away 
from the nuclear envelope to avoid signal contributions from nuclear rim staining. 
Therefore, all these measurements had to be corrected for the finite thickness of the 
sample.  
NTF2 interacts with the nuclear pore complex and mediates active transport 
across the pore by an unknown mechanism. We are interested in extending z-scan FFS in 
the future to measure protein interactions and transport rates directly at the nuclear 
membrane in order to investigate the transport process. This will require an expansion of 
z-scan FFS to a multilayer geometry and should open up a number of interesting 
applications of the technique to the study of internal membrane interfaces. A multi-layer 
sample can no longer be characterized by a single FFS measurement at the midsection as 
performed in this paper. A natural extension of this work takes several FFS 
measurements as a function of the z-position. The geometry function      is easily 
modified to describe multiple layers, and z-scan FFS can be implemented for complex 
samples, only being limited by the resolvability of the layers through a fit to the model. 
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Thus, z-scan FFS should be able to make direct measurements of brightness at internal 
membrane interfaces like the nuclear envelope; these regions have been previously 
inaccessible to quantitative brightness analysis. 
Z-scans methods have been previously implemented into FFS to study diffusion 
in membranes like giant unilamellar vesicles and supported phospholipids bilayers.
60,62
 
These studies were performed in isolated membrane systems, but related z-positioning 
FCS techniques are now being used to study raft diffusion properties in the plasma 
membrane of living cells.
61,74
 Here, we extend the use of z-scanning to study the 
brightness in thin sample geometries. While this work focuses mainly on cell 
measurements, the same problem of brightness bias is encountered in micrometer and 
submicrometer fluidic devices. Thus, z-scan FFS has potential applications in thin 
microfluidic channels. 
While thin sample geometry limits the access of fluorophores to the excitation 
light, it also limits the possible movement of the particles. As the sample flattens out, 
diffusion of proteins is no longer accurately described by a 3D diffusion model. 
Gennerich and Schild deal extensively with the effect confined geometry has on 
diffusion, as calculated by FCS.
75
 Fortunately, brightness is independent of diffusion time 
provided that no undersampling occurs.
32
 All FFS measurements in this study are 
sampled sufficiently fast that undersampling is avoided. If necessary, brightness values 
may be corrected for undersampling effects as previously described.
32
  
In summary, this paper describes a sample thickness-dependent artifact of FFS 
data which leads to an increase in brightness. We report a brightness bias of cytoplasmic 
FFS measurements in COS-1 cells, which in the worst case leads to an approximate 
doubling of the brightness value. As brightness analysis is frequently used to detect 
protein association, a factor of 2 bias is a critical problem for quantitative measurements. 
The paper describes how the critical thickness is identified and provides advice on 
performing FFS measurements in the cytoplasm of cells. We introduced z-scan FFS as a 
simple method to assess the thickness of the sample and provide brightness values free of 
artifact. Z-scan FFS provides a general method for brightness determination in cases 
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where the finite thickness of the sample is of concern. We expect that z-scan FFS should 
prove especially useful for FFS applications in the cytoplasm and other thin geometries. 
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5.  Chromophore Maturation and Cell-Free Expression 
 Fluorescence measurements are founded upon the fluorophore. Brightness 
analysis, in particular, requires well-behaved, fluorophore brightness or FFS is no longer 
a useful tool to quantify protein stoichiometry. The literature continues to clarify the 
mechanisms by which fluorescent proteins mature into their fluorescent state, but it has 
been particularly conflicted over the rates of maturation. EGFP has been shadowed with a 
reputation for very slow maturation. In such a case, a significant fraction of the EGFP-
labeled sample might not fluoresce leading to a breakdown of the brightness-
stoichiometry relationship. Similarly, other reports allege that a large fraction of EGFP 
fluorophores simply never mature.
76
 Neither of these issues can be investigated in cells, 
as we have no control over the expression conditions. In this chapter, we seek to employ 
FFS in a cell-free expression system to address these types of questions. 
As indicated above, the main problem with measurements in cells is a lack of 
experimental control. The researcher cannot simply double the concentration or add a 
second protein or change the pH. Studies conducted in vitro do allow this control, but 
bring a host of other challenges. For instance, in this artificial environment, additional 
factors required for proper folding or function may be missing. The purification process 
to isolate the protein of interest is quite time consuming, and specifically labeling the 
protein 1:1 with an organic dye is a problem in itself, as its very difficult to effect 100% 
labeling and simultaneously prevent free-floating dye labels. Here, we investigate FFS in 
the cell-free expression environment as a bridge between cellular and aqueous protein 
measurements, and as a tool to better probe protein interactions with the benefits of both 
genetic labeling and direct control. This chapter has been previously published in 
Analytical Biochemistry.
77
 
5.1  Introduction 
Cell-free protein expression is a simple and flexible method for the rapid 
synthesis of folded proteins. These systems represent an attractive alternative for 
producing difficult-to-express proteins, such as membrane proteins or proteins that 
seriously interfere with cell physiology.
78
 Recently, cell-free systems have been used to 
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engineer complex biological processes.
79
 The inherent open nature of the cell-free system 
allows direct access and control of the biological system, which cannot be attained by cell 
experiments. Thus, the cell-free system is emerging as a versatile platform for systems 
biology experiments.
80
 In addition, cell-free expression has been used lately to study the 
maturation kinetics of fluorescent proteins.
80,81
 
The principle of brightness analysis should be directly applicable to FFS 
measurements of cell-free systems. Just as in cells, expression of EGFP-tagged proteins 
provides a convenient method to introduce fluorescent markers. However, there are a 
number of potential challenges for FFS studies in cell-free systems. The fidelity of cell-
free expression and of chromophore maturation needs to be checked, because the 
presence of non-fluorescent or incompletely expressed protein leads to biased 
interpretation of FFS experiments.
45
 We develop a droplet-based assay for FFS 
experiments in a cell-free extract. The droplet format not only ensures a small sample 
volume, but also provides sufficient oxygenation of the sample for efficient chromophore 
maturation.  
The widespread use of fluorescent proteins as markers in biological and medical 
research rests on the unique ability of the expressed protein to form a chromophore on its 
own. The formation of the chromophore is referred to as maturation and only requires 
molecular oxygen as an external reagent.
12
 Although the kinetics of chromophore 
formation has been the subject of numerous studies, there is significant inconsistency in 
the reported maturation times of individual fluorescent proteins. Here we investigate the 
temperature dependence of the maturation process, which has received little attention so 
far. Specifically, we conduct FFS experiments in batch-mode on EGFP, EYFP, and 
mCherry using an Escherichia coli-based cell-free system. We observe a pronounced 
temperature dependence of the maturation rates of the fluorescent proteins, model the 
kinetics by transition state theory, and compare our results with other maturation studies 
based on de novo protein synthesis. Because EGFP exhibits a very fast maturation at 
37
o
C, we consider EGFP to be a suitable reporter for many kinetic studies in the cell-free 
system. 
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We further use EGFP and a tandem-dimer EGFP (EGFP2) to check the fidelity of 
expression and maturation of the E. coli-based cell-free system and to demonstrate the 
feasibility of protein titration experiments with the droplet-based assay. Nuclear transport 
factor 2 (NTF2) is used as a model protein to explore brightness characterization of 
protein-protein interactions in the cell-free system. NTF2 plays a key role in 
nucleocytoplasmic transport and maintains the cellular Ran gradient which drives the 
transport process.
82
 Depletion of NTF2 affects the Ran gradient and can lead to cell 
death.
83
 The mechanism by which NTF2 performs its function is not well understood. 
Because there are conflicting reports regarding the oligomeric state of NTF2,
69,84,85
 we 
examine the stoichiometry and concentration dependence of NTF2 in cell-free solution 
and compare the result with the literature. 
 
 
5.2  Materials and methods 
Cell-Free Sample Preparation. We use the S30 T7 High-Yield Expression System 
(Promega, Madison, WI) as our cell-free solution system. We mix DNA into 5-15 µL 
samples of cell-free solution according to the Promega protocol, and let the synthesis 
reaction run at room temperature for 2-4 hrs. Reactions were subsequently stopped by the 
addition of 0.1% RNase A (Sigma-Aldrich, St. Louis, MO) and then spun down at 
18,000g for 20 minutes to remove any large particles. Samples were transferred into a 
ring of vacuum grease (Dow Corning, Midland, MI) to prevent spreading inside an eight-
well coverglass chamber slide (Nagle Nunc International, Rochester, NY). The eight-well 
chamber is sealed with a rubber stopper or an additional coverslip and vacuum grease 
seal. Glass surfaces are treated with SigmaCote (Sigma-Aldrich) and measurements are 
taken 10 µm above the coverglass to avoid surface adhesion effects. 
 
Expression Vectors, Purified Protein and Buffers. Cell-free: EGFP amplified from the 
pEGFP-C1 plasmid (Clontech, Mountain View, CA) with a 5’ primer that encodes a 
BamHI restriction site and a 3’ primer that encodes an XhoI site. The result was cloned 
into the pRSET B vector (Invitrogen, Carlsbad, CA). We refer to this plasmid as pB-G. A 
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tandem dimeric EGFP (EGFP2) was constructed by cloning a second EGFP between the 
EcoRI and HindIII restriction sites of the pB-G plasmid. NTF2 was amplified from 
human NTF2 (Genbank accession number: BC002348) and cloned into the 
EcoRI/HindIII site of pB-G. A monomeric NTF2 was generated by mutating the 
methionine residue 118 to glutamate.
69
 Solution: EGFP was expressed in E. coli and 
purified according to protocol using QiaExpress Ni-NTA Fast Start kit (Qiagen, 
Valencia, CA). Cell-free and aqueous dilution experiments were performed using HBS-
EP buffer (Biacore, Uppsala, Sweden) or Dulbecco’s PBS with calcium and magnesium 
(Biowhittaker, Walkersville, MD). 
Chromophore Maturation. Protein expression is stopped with 0.1% RNase and quickly 
transferred to the sample chamber. The observed increase in fluorescence intensity 
reflects chromophore maturation of previously synthesized proteins and is fit by 
    /0 1 tF t F F e      (5.1) 
where    is the average fluorescence intensity at the time the reaction is stopped,     is 
the change in average fluorescence intensity from the subsequently maturing 
chromophores, and   is the characteristic maturation time. The maturation rate coefficient 
k is the inverse of the maturation time,     ⁄ . 
 The temperature dependence of the maturation rate coefficient is modeled using 
transition state theory. The Eyring equation relates the reaction rate coefficient   to 
temperature  ,  
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  (5.2) 
where     is enthalpy of activation,     is entropy of activation,    is the Boltzmann 
constant,   is Planck’s constant, and   is the gas constant. The reaction rate data are 
plotted as      ⁄   vs   ⁄  and fit to a straight line. The slope and intercept of the fitted 
line determine the activation enthalpy and entropy. Sample temperatures are adjusted 
using an ASI 400 air stream incubator (Nevtek, Williamsville, VA) or a VWR 
Polyscience chiller recirculator (Niles, IL) connected to homebuilt coils around the 
microscope objective and sample holder. The sample temperatures reported in this work 
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were recorded using a thermocouple placed in a droplet or water reservoir adjacent to the 
measured sample. 
 
5.3  Cell-free synthesis of EGFP 
Because cell-free samples are typically 5-50 µL, the measurement protocols must 
be adapted for small volumes. Our first approach was to place the cell-free solution 
between two coverslips. Upon expressing EGFP we observed that the sample was only 
fluorescing around the edges of the sample, which is in contact with the surrounding air. 
Because oxygen is required for maturation of the chromophore, our result indicated that 
good contact of the sample with the surrounding air is crucial. To address this challenge 
we adopted a configuration where a drop of cell-free solution is placed on a chambered 
coverglass slide. Before placing the droplet a small circle of vacuum grease is applied on 
the glass surface to prevent spreading of the solution across the slide. This protocol 
results in a well-formed droplet with a large surface area in contact with air for efficient 
uptake of oxygen. Expression of EGFP in the droplet solution resulted in the appearance 
of fluorescence throughout the sample as confirmed by an axial scan
56
 through the 
sample with a long-working distance objective.  
Because the measurement of cell-free expression reactions may take several 
hours, we evaluated the long-term stability of the droplet sample. A droplet sample 
containing an aqueous solution of the fluorescent dye Alexa 488 was measured as a 
control by FFS for several hours (data not shown). We observed a continuous increase in 
the fluorescence intensity. FFS analysis showed that the brightness of the dye remained 
constant, but the dye concentration increased. The increase in concentration is consistent 
with the loss of sample volume due to evaporation. To circumvent this problem we place 
the droplet into a sealed chamber together with an additional water droplet (Figure 5.2D). 
The water serves to establish vapor pressure equilibrium after the top opening has been 
sealed with a rubber stopper, thereby preventing the evaporation of the sample. The 
sealed chamber and water reservoir are prepared in advance and the cell-free reaction 
mixture is added later via syringe through the rubber stopper. We tested the sealed 
chamber using an aqueous droplet sample containing the dye Alexa 488, which was 
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measured for more than 6 hours. The fluorescence intensity remained constant over the 
whole measurement period, demonstrating evaporation effects are negligible. Thus, all 
experiments described here have been performed using the sealed chamber configuration. 
We study cell-free expression of EGFP using FFS to monitor the course of protein 
synthesis in real time. Initial experiments established that the cell-free extract contains 
aggregates that interfere with later FFS analysis of the data. Fortunately, such complexes 
are relatively easily removed through centrifugation. Centrifuging the sample at 18,000g 
for 5-10 minutes pellets the detritus, and the clean cell-free supernatant is easily removed. 
The centrifugation step can be conducted before or after the protein expression reaction. 
Immediately after adding the DNA for EGFP to the centrifuged reaction mixture, the 
sample is placed on the microscope. Sixty second measurements are taken at regular 
intervals over the next five hours (Figure 5.1A). The intensity increases after an initial lag 
phase. The reaction eventually begins to run down as the synthesis process exhausts the 
available energy.
86
 Brightness analysis of this data allows us to extract time courses for 
the average number of molecules in the observation volume and the brightness of EGFP 
(Figures 5.1B&C). The number of molecules increases over time demonstrating that 
proteins are being produced as expected. More importantly, the brightness (Figure 5.1C) 
is constant throughout the reaction which shows that there are no transitional or alternate 
brightness states. Unfolded and unmatured EGFP proteins are non-fluorescent and so 
invisible to FFS measurements. Once the protein is completed, it “turns on” at the 
characteristic brightness of EGFP and remains stable and independent of protein 
concentration. This is further confirmed by comparing FFS measurements on cell-free 
expressed EGFP, recombinant EGFP purified from transformed E. coli, and EGFP in 
living mammalian cells (Table 1). Measured under the same excitation power, all three 
EGFP samples have the same brightness. This robustness of EGFP brightness makes it a 
useful and reliable tool for quantitatively examining protein interactions. Table 1 also 
displays the diffusion time or average residence time within the optical volume. This 
information is acquired through autocorrelation analysis of the data and reflects the 
differing solution environments of the three methods. Purified EGFP in aqueous buffer 
solution has the fastest diffusion time. Both EGFP in cells and in cell-free solution have a 
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slower diffusion time. Fluorescent dye added to both the buffer solution and to basic cell-
free solution shows a similar change in diffusion time (data not shown). This indicates 
that the difference in diffusion time reflects the changes in viscosity of the solutions. 
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Figure 5.1  Cell-free protein synthesis.  
(A) EGFP DNA plasmid is added to the cell-free reaction mixture and FFS measurements 
are taken at intervals. The average fluorescence intensity is plotted as a function of time.  
(B) Further analysis of the data shows that the number of EGFP molecules tracks with 
intensity and increases with time as new proteins are synthesized. (C) The normalized 
brightness, however, remains stable throughout the reaction demonstrating a single, 
robust EGFP brightness state. 
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Sample Brightness (photon counts/s) Diffusion time (ms) 
Cell-free EGFP 3300  ±  110 0.75  ±  0.09 
Purified EGFP 3200  ±  200 0.27  ±  0.05 
Cellular EGFP 3200  ±  330 1.26  ±  0.38 
 
 
 
 
 
Table 5.1  EGFP brightness in different environments.  
EGFP is expressed in cell-free solution, is His-tag purified from E. coli into PBS buffer, 
or is expressed in U2OS cells. FFS measurements on all three samples report the same 
brightness within error. The changes in the diffusion time reflect the changes in viscosity 
of each sample.  
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5.4  Kinetics of chromophore maturation 
We investigate the kinetics of chromophore maturation using cell-free expression 
in a free-standing droplet (~10 µL). After spinning down the cell-free solution, DNA is 
added and left to synthesize for 10-30 minutes. The reaction is stopped with 0.1% RNase 
and quickly transferred to the sample chamber. By adding RNase to the droplet the 
synthesis reaction is rapidly stopped.
80
 Any subsequent increases in the fluorescence 
intensity can be attributed to chromophore maturation of previously synthesized proteins. 
Since each chromophore’s maturation is independent, fluorescence intensity increase can 
be described by a single-exponential model. Figure 5.2A shows the EGFP maturation 
intensity as a function of time fit with Eq. 5.1. At room temperature (20˚C), the 
characteristic maturation time,                , is established by repeating the 
experiment several times (n = 6). In addition to EGFP, we also investigated the 
maturation of EYFP (n = 3) and mCherry (n = 4).  We found EYFP at 19˚C to have a 
significantly longer maturation time,                , and mCherry at 20˚C to be 
rather slow at                 (Figures 5.2B&C). 
Oxygen diffuses within ~100 s from the edge to the center of a 10 µl droplet. As 
such, we anticipate that oxygen availability is not a limiting factor for maturation 
reactions with reaction times longer than 100 s. As a control experiment we measure 
maturation of EGFP in a smaller droplet (1 µl). With a diffusion time to the center of 
only ~20 s the rate to replenish oxygen is much faster than for the large droplet. The 
maturation time of EGFP measured in the 1 µl droplet at 19
oC (τEGFP = 15 min) is 
identical to the time observed in the 10 µl droplet. This result demonstrates that oxygen 
availability is not a limiting factor for our assay. 
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Figure 5.2  Chromophore maturation time.  
Cell-free EGFP synthesis is initiated at room temperature and then stopped with RNase. 
Any subsequent intensity increase is the result of a previously synthesized protein 
completing the maturation process. The curve is fit with a single exponential rate process.  
(A) Single maturation curve of EGFP with fit.  (B) Single maturation curve of EYFP with 
fit.  (C) Single maturation curve of mCherry with fit. The mean maturation time of each 
protein and its standard deviation are determined from repeated measurements at the 
same temperature and are quoted in the text.  (D) The final panel shows an EGFP sample 
maturing at 37
o
C with τ = 3 min. Overlaid is a cartoon of the sample setup. A small 
sample droplet (~10 µL) is injected into a sealed chamber slide containing a water 
reservoir to establish vapor pressure equilibrium.  
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Figure 5.3  Temperature dependence of maturation rate coefficient k.  
The fitted maturation rate coefficient   and sample temperature   are graphed in an 
Eyring plot for EGFP (crosses), EYFP (triangles), and mCherry (asterisks). The fitted 
curve determines the activation enthalpy      and activation entropy     of the reaction.  
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Literature values for chromophore maturation times of EGFP cover a broad range 
of values and involve a variety of experimental approaches.
13,87–90
 To further complicate 
matters individual studies have been performed at different temperatures. However, a 
quantitative study that evaluates the influence of temperature on maturation is not readily 
available. We decided to expand our study in order to address the temperature 
dependence of chromophore maturation. Measurements of the fluorescence intensity of 
the maturation process were taken at selected temperatures up to 37
o
C and fit with 
Eq. 5.1 to recover the characteristic maturation time   and rate coefficient      . The 
results of the temperature study are plotted as      ⁄   versus   ⁄  (Figure 5.3). The 
Eyring plot shows that maturation rates increase with temperature. Maturation of EGFP 
at 37
o
 C proceeds sufficiently fast (Figure 5.2D) that we approach the practical limit of 
the experimental setup. Thus, the temperature-dependence of EGFP maturation was 
performed by cooling the solution below room temperature. The straight lines through the 
data points of Figure 5.3 represent a fit of the rate coefficients to transition state theory. 
The slope and y-axis intercept determine the activation enthalpy ΔH‡ and activation 
entropy ΔS‡ of the maturation process of each protein. The activation enthalpies for 
EGFP, EYFP, and mCherry are 65±1.6, 46±4.3 and 43±1.7 kJ/mol, respectively. These 
values fall in the range expected for solution oxidation reactions. The differences in 
activation enthalpy between the proteins are relatively small, particularly between EYFP 
and mCherry. The differences in the activation entropies (–79±5, –156±15, –
175±6 J/(mol K) for EGFP, EYFP, and mCherry) follow a similar pattern. Overall, the 
ratios of the maturation kinetics for different fluorescent proteins are approximately 
independent of temperature, because of the similarity of the activation enthalpies. 
Calculating from the fits, the characteristic maturation times at 20˚C are τEGFP = 15 min, 
τEYFP = 82 min, τmCh = 157 min, and at 37˚C these values become τEGFP = 3 min, τEYFP = 
27 min, τmCh = 57 min. Note that the fast maturation rate measured for EGFP at 37
o
C 
(Figure 5.2D) agrees with the prediction from transition state theory (upper leftmost cross 
in Figure 5.3). 
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5.5  Brightness and titration studies 
After a protein is expressed and matured, its properties can be studied by FFS. 
Here we focus on demonstrating the feasibility of brightness measurements as a function 
of protein concentration with the droplet setup. For the simple addition of a ligand, 
enzyme or other chemical, the rubber stopper and syringe method is very effective. 
However, this approach is inconvenient for performing repeated dilutions of the droplet. 
Thus, instead of the rubber stopper a coverslip was placed as a lid on top of the 
chambered coverslide. A thin layer of vacuum grease applied to the contact area of the 
coverslip seals the sample chamber. A 10 µL droplet of purified EGFP is placed onto the 
coverslide. Dilutions are performed by unsealing the coverslip, adding additional buffer 
with a pipette, pipetting up and down, and finally removing an equivalent volume of the 
mixture and replacing the coverslip. At each dilution step an FFS measurement is taken 
to determine brightness and concentration (Figure 5.4 inset). The brightness is 
concentration independent and reflects that EGFP is a monomeric protein. The same 
result is obtained for EGFP expressed in cell-free solution (Figure 5.4). An important 
control for brightness experiments is the demonstration of brightness doubling with the 
tandem-dimer EGFP2, formed by encoding two EGFPs connected with a short linker 
sequence.
6
 After expressing EGFP2 in cell-free solution, a droplet was placed on the 
coverslide followed by FFS measurements in between dilution steps. The brightness of 
EGFP2 is concentration independent and twice the brightness of monomeric EGFP, 
because of the presence of two EGFP molecules. These results demonstrate that the 
droplet sample provides a quick and reliable method for titration experiments. It further 
establishes that the quality and fidelity of the cell-free expression system is suitable for 
brightness studies. 
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Figure 5.4  Droplet dilutions.  
Cell-free expressed and E. coli purified EGFP are measured in 10 µL droplets. The 
dilutions are performed using HBS buffer.  The inset shows E. coli purified EGFP 
(crosses) with a normalized brightness of ~1 plotted over 4 orders of magnitude of 
concentration. The FFS measured concentrations are in good agreement with the 1.5x and 
2x dilutions that were executed. The main plot is the dilution of cell-free expressed 
proteins. EGFP (diamonds) and EGFP2 (triangles) are plotted with normalized brightness 
versus concentration. EGFP2 has b = 2 independent of concentration, demonstrating that 
cell-free brightness is a robust parameter that reports protein stoichiometry. 
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With the cell-free system characterized and brightness analysis validated, we 
apply this method to a biological system.  The protein NTF2 establishes the cellular Ran 
gradient, which is crucial for nucleocytoplasmic transport.
91
 Ran exists in the form of 
RanGTP at high concentration in the nucleus and at low concentration in the cytoplasm, 
where RanGTP is converted to RanGDP. This gradient provides directionality for 
nucleocytoplasmic transport. The transport factor NTF2 maintains the gradient by 
returning RanGDP to the nucleus, where it is converted back into RanGTP. NTF2 has 
been identified as a dimer in previous studies
84,85
 with one study reporting a monomer / 
dimer equilibrium with a dissociation constant of ~1 µM.
69
 A recent FFS study of NTF2 
from our lab finds NTF2 to be a dimer in cells.
56
 However, only cells with high protein 
concentration were used for the cell study. We now take advantage of the cell-free system 
to measure the oligomeric state of NTF2 over a wide concentration range using the same 
FFS approach as the cell study. We perform brightness titration studies on EGFP and 
EGFP2 expressed in cell-free solution (Figure 5.5) as control experiments. Next, we 
repeat the dilution experiment on EGFP-NTF2 expressed with the cell-free system. The 
brightness of EGFP-NTF2 aligns with EGFP2 (Figure 5.5), indicating that NTF2 is 
dimeric over the entire measured concentration range (~30 – 1400 nM). We also 
performed a brightness titration of the mutant EGFP-NTF2.M118E expressed in cell-free 
solution, because it has been previously reported that the point mutation M118E prevents 
dimerization of NTF2.
69
 Our brightness data confirm that the point mutation abolishes 
dimerization and show that EGFP-NTF2.M118E is a monomer at all measured 
concentrations (Figure 5.5). Thus, the brightness analysis of NTF2 in the cell-free system 
agrees with the earlier cell data
56
 and indicates that NTF2 continues to be a dimer well 
below 1 µM.  
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Figure 5.5  Cell-free NTF2.  
EGFP (asterisks) and EGFP2 (crosses) are expressed in cell-free solution and act as 
brightness controls plotted as normalized brightness versus concentration. We show that 
EGFP-NTF2.M118E (squares) is also monomeric in our cell-free system. EGFP-NTF2 
data (diamonds) lie on top of EGFP2 revealing that NTF2 is dimeric over the observed 
concentration range (~30-1400 nM).  
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5.6  Discussion 
There are several factors that are crucial for FFS measurements on cell-free 
systems. The presence of aggregates in cell-free expression systems is an obstacle to FFS 
measurements. Some of the aggregates are fluorescent, which leads to spikes in the 
fluorescence intensity and prevents meaningful brightness analysis. In the case of two-
photon excitation we occasionally trapped large fluorescent aggregates in the laser beam. 
Furthermore, some of the non-fluorescent aggregates are large enough to exclude 
sufficient volume when passing through the observation volume, so that the fluorescence 
signal is reduced. While this effect is less noticeable in the raw data, because no spikes 
are generated, it biases brightness analysis. The presence of large particulates (≥ 1 µm) 
was directly confirmed by viewing the sample solution through a 63x objective under 
bright-field conditions. Aggregates seem to be present in most cell-free systems. It is 
speculated that some of these aggregates build up because cell-free solutions do not have 
the active processes which clean up unused or discarded reaction material. The bulk of 
the aggregates can be removed by an additional centrifugation step after reaction solution 
has been reconstituted and/or after the reaction has finished. Without this step, it is 
difficult to perform FFS experiments in the cell-free environment.  
A unique feature of fluorescent proteins is their ability to form a chromophore by 
posttranslational modifications. This maturation process only requires molecular oxygen 
as an external reagent. The amount of oxygen dissolved in air-saturated water under 
normal atmospheric conditions is ~200 µM at room temperature, which exceeds the 
concentration of expressed fluorescent protein by more than two orders of magnitude. 
Despite this apparent excess of oxygen over protein, we observe that a cell-free 
expression solution sandwiched between two coverslips failed to develop fluorescence 
except at the edges of the solution that were in contact with air. This observation 
indicates that other processes exhaust the oxygen reservoir of the solution. In fact, it has 
been previously reported that oxygen is efficiently depleted within minutes in a cell-free 
reaction.
92
  We choose a droplet as our sample geometry to ensure efficient oxygen 
transfer at the solution/air interface. The volume of droplets (typically 10-15 µl) permits 
oxygen to diffuse from the interface to the center of the droplet in ~100 s. Oxygen 
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diffuses from the periphery to the center of a 1 µL droplet 5 times faster than through a 
10 µL droplet. Measurement of EGFP maturation under both conditions returns the same 
results and demonstrates that oxygen is not a limiting factor in our experiments. In fact, 
we succeeded in measuring maturation rates as fast as 3 min with the droplet setup 
(Figure 5.2D). A hydrophobic ring prevents spreading of the sample droplet across the 
hydrophilic coverglass. This setup is important for the titration experiments, because by 
preserving the droplet shape it is straightforward to add, mix and remove solution. 
Measurements on droplets can be performed for many hours (Figures 5.1 and 5.2) 
without loss of sample. Evaporation is prevented by sealing the measurement chamber as 
described earlier.  
The process of chromophore formation, particularly of GFP, has been carefully 
studied. The green chromophore pathway (GFP, EGFP, EYFP) has 3 primary stages: 
cyclization, oxidation and dehydration. The red chromophore pathway (DsRed, mCherry) 
includes an additional oxidative step for the formation of an acylimine linkage in the 
polypeptide backbone. Studies suggest that the primary rate-limiting step is oxidation for 
the green pathway. While the steps for the red pathway are less distinctly time separated, 
a recent report states that the final dehydration is partially rate-limiting.
93–95
 We model 
EGFP and EYFP maturation with a single exponential rate process, consistent with prior 
studies. The maturation kinetics of mCherry is also well-modeled by an exponential 
process. However, the intensity traces of chromophore maturation are affected by 
experimental imperfections, such as drift in the axial focus and variations in the laser 
power. These imperfections, although minor, currently limit our ability to investigate 
whether any small deviation from the single-exponential rate model exists. Nevertheless, 
the analysis of the maturation kinetics and its temperature dependence demonstrates that 
a single-exponential kinetic model provides a satisfactory description of the data. 
While a coherent mechanism of chromophore formation has emerged, a consistent 
picture of the overall kinetics is not yet available. The maturation kinetics of fluorescent 
proteins has been studied by various methods, such as i) de novo protein expression, ii) 
triggered protein folding of solubilized inclusion bodies, and iii) reoxidation after 
chemical reduction of the chromophore. The results obtained by each method are 
  103 
inconsistent with each other. For example, the maturation time of EGFP is reported as 
~60 min (by folding of solubilized inclusion bodies), as ~130 min (by reoxidation), and 
as ~8 min (by de novo protein expression).
80,90,96
 Although it is not clear why the reported 
rates differ that widely, each method requires unique sample conditions, which may 
contribute to the diversity of reported values. It seems prudent to compare studies that 
utilize the same experimental method. Because our study is based on cell-free expression, 
we focus in this paper on de novo protein expression methods. 
However, even studies based on the same method report different maturation rates 
for the same fluorescent protein. Thus, additional experimental factors influence the 
maturation process. Although it has been noted that the kinetics of maturation of GFP is 
different at 25°C and 37°C,
97
 the influence of temperature on chromophore maturation has 
not received further attention. We performed, to the best of our knowledge, the first 
quantitative characterization of maturation kinetics as a function of temperature. 
Published maturation studies have been conducted at specific temperatures, ranging from 
room temperature to 37
o
C. Because the rate of maturation changes ~5-fold over this 
temperature range, one needs to account for this change when comparing maturation 
experiments.  
Chromophore maturation by de novo protein expression is usually performed in 
one of two ways. Most studies employ anaerobic expression conditions followed by the 
addition of oxygenated solvent to complete the maturation process. Some studies utilize 
aerobic expression conditions and terminate protein expression while monitoring the 
subsequent increase in fluorescence due to maturing protein, as was done in this case. 
Adding RNase A to the solution stops gene expression almost instantly and allows the 
determination of maturation times of less than one minute as has been previously 
demonstrated.
80
  
A large number of experiments probing maturation kinetics exist in the literature. 
To ensure a meaningful comparison we only consider studies based on de novo protein 
expression of the proteins EGFP, EYFP, or mCherry. We make no distinction between de 
novo protein expression by bacterial, cell-free, or eukaryotic cell expression systems. For 
EYFP a maturation time τ of 56 min measured at 25oC has been reported, while a second 
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study determined a time constant of 23 min measured at 37
o
C.
81,98
 These published data 
are in excellent agreement with the values determined from Figure 5.3 with τ = 58 min at 
25
o
C and τ = 27 min at 37oC. The maturation of mCherry has been measured 
independently by two groups at 37
o
C, who reported values of 22 min and 57 min.
15,99
 Our 
maturation time for mCherry at 37
o
C is τ = 57 min, which matches the value reported by 
Merzlyak et al.
99
 Finally, the maturation lifetime of EGFP by cell-free expression has been 
reported as τ = 14 min at 37oC and as τ = 8 min at 29oC,80,81 while our own data yield 
lifetimes of τ = 3 min at 37oC and as τ = 7 min at 29oC. Thus, our result is in close 
agreement with the value reported by Shin et al.
80
 Surprisingly, EGFP is the fastest 
maturing protein among the ones tested. This observation is in contrast to its reputation of 
being a relatively slow maturing protein as established by previous denaturation and 
refolding studies. Because EGFP exhibits very fast maturation kinetics with de novo 
protein synthesis, it is important to ensure that a sufficiently fast rate of solvent 
oxygenation is guaranteed. Otherwise, the measured kinetics could be slowed down by 
the limited availability of oxygen.  
EGFP’s rapid maturation makes it an excellent reporter for studies of protein 
reactions and interactions conducted in a cell-free expression system, ensuring that the 
delay between expression and onset of fluorescence is minimal. In addition to traditional 
fluorescence methods, such as fluorescence lifetime and polarization, it is feasible to 
conduct fluorescence correlation experiments with cell-free systems. Expanding the 
repertoire of techniques in cell-free systems to FFS measurements of brightness requires 
a few precautions. The quality of protein expression of the cell-free system has to be 
fairly good. Misfolding of the fluorescent protein or failure to mature creates a non-
fluorescent component that interferes with the interpretation of brightness experiments. 
Similarly, the presence of long-lived dark states would bias the interpretation of 
brightness studies. Observing the brightness of EGFP2 provides a sensitive test of the 
completeness of protein maturation. For example, if 30% of EGFP molecules did not 
mature or existed in a long-lived dark state, a subpopulation of EGFP2 would exist with 
only one of the two EGFPs fluorescing. This, in turn, lowers the brightness from 2 to 1.7. 
A detailed discussion of the influence of dark states and flickering of fluorophores on 
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brightness experiments is available.
45
 The brightness of EGFP and EGFP2 in mammalian 
cells is routinely measured as a control to establish that maturation and protein expression 
are not compromised. The brightness doubling observed with EGFP2 (Figure 5.4) ensures 
that virtually all EGFP molecules of the cell-free system mature and acquire 
fluorescence.
45
 The result further confirms the absence of long-lived dark states for the 
EGFP-fluorophore in two-photon excitation. In addition, our brightness experiments on 
NTF2-EGFP establish that protein interactions can be quantitatively assessed in a cell-
free system over a wide concentration range.  
In summary, cell-free expression offers a quick and convenient method to perform 
fluorescence studies of protein-protein interactions with no need for further purification 
of the product. The commercial E. coli-based cell-free system has proven to be suitable 
for brightness studies. Combining cell-free expression with the droplet setup ensures 
sufficient oxygenation of the sample and provides an excellent platform for chromophore 
maturation studies of fluorescent proteins as a function of temperature. Maturation 
kinetics exhibits a pronounced temperature dependence, which is conveniently 
characterized by determining the activation enthalpy and entropy. This information 
should prove useful for future comparison of maturation measurements and hopefully 
provides a first step towards establishing definitive rate coefficients for individual 
fluorescent proteins.  
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6.  APOBEC 
 This chapter is motivated by a biological application. Building on some of the 
technical advances from the previous chapter, FFS experiments are conducted in aqueous 
solution to characterize the oligomerization behavior of an important enzyme and its 
interactions with DNA and RNA. We demonstrate that RNA induces strong 
oligomerization of A3G, depending on the RNA sequence, but that DNA, while also 
showing sequence dependence, does not cause significant oligomerization. These studies 
were performed in collaboration with the Reuben Harris lab at the University of 
Minnesota, from which Ming Li, Michael Carpenter and Judd Hultquist were the main 
contributors, as well as with Jinhui Li and Yan Chen from our own lab.  
 
6.1  Introduction 
 APOBEC3G (apolipoprotein B mRNA-editing catalytic-like 3G) is the first 
human enzyme protein discovered that is capable of restricting HIV-1. This makes it an 
exciting target for research, although APOBEC3G (A3G) successfully restricts HIV-1 
only in the absence of the HIV-1 virion infectivity factor (Vif), which HIV-1 has evolved 
to block this immune defense. Nevertheless, in Vif-deficient HIV-1, A3G is a key 
inhibitory factor and has been the focus of a great deal of study.
100,101
 It has since been 
discovered that there are a family of APOBEC3 proteins, A3A, A3B, A3C, A3D/E, A3F, 
A3G, and A3H, several of which have innate immune activity against retroviruses, 
notably HIV-1 and HTLV.
101,102
 Because of the importance of the APOBEC3 enzymes 
and the detrimental effects of Vif on their function, it is very important that we 
understand their immune defense mechanisms at the molecular level. This chapter 
focuses on A3G and also includes measurements of A3A, which does not restrict HIV-1. 
In its primary function against HIV-1, A3G is a DNA cytidine deaminase that changes C 
to U, thus causing degradation or debilitative mutation in the retrovirus. A3G is known to 
package into viral particles,
103,104
 although the mechanism is not understood. It is also 
known to form high molecular mass (HMM) complexes, although they are reported to be 
enzymatically inactive.
105
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RNA is believed to play an important role in both the viral packaging and the 
formation of these HMM complexes.
106,107
 Indeed, it has been shown that treatment of the 
HMM A3G complexes with RNase can restore the enzymatically active low molecular 
mass (LMM) form.
108
 From our lab’s cellular studies, described in the following section, 
we believe that HMM A3G and interaction with RNA play a role in the viral packaging 
of A3G. Furthermore, it has been shown that A3 proteins which do not package into the 
virion do not restrict HIV-1.
109
 We therefore apply FFS to quantitatively study the 
oligomerization of A3G, its interactions with RNA and DNA, and to develop a clearer 
understanding of the functional mechanism of this important enzyme. 
  
6.2  A3G in cells 
 Two members of the Mueller lab, Jinhui Li and Yan Chen, employed FFS to study 
the oligomerization of APOBEC3 proteins in living cells. Analysis of the data revealed 
that the APOBEC3 family members essentially fall into two categories of behavior. One 
set, including A3G, shows strong oligomerization as a function of protein concentration, 
saturating at approximately an average stoichiometry of a 20-mer homocomplex. The 
other set, including A3A, show almost no oligomerization and predominantly exists in a 
monomeric state. We single out A3G and A3A because they have been successfully 
purified for in vitro experiments and have also, consequently, received greater study.  
Figure 6.1 shows the average oligomerization of A3G and A3A as a function of 
concentration to illustrate the two behavioral categories. Collaborative efforts with the lab 
of Reuben Harris, Department of Biochemistry, Molecular Biology, and Biophysics at the 
University of Minnesota, revealed that the APOBEC3 proteins which show 
oligomerization in cells are packaged into the assembling HIV-1 virus.
109
 The monomeric 
APOBEC3 members are not packaged and fail to restrict the virus. Since packaging is a 
prerequisite for HIV-1 restriction, these observations leads us to hypothesize that the 
oligomerization has a necessary and functional role in the packaging of APOBEC3 
proteins into the budding virus and thus ultimately in the restriction of HIV-1.  
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Figure 6.1  A3G and A3A in cells. 
The plot displays normalized brightness measurements of EGFP-labeled A3G and A3A 
in U2OS cells in experiments performed by Jinhui Li. The inherent variation in protein 
expression levels creates a wide concentration range, and each point represents a different 
cell. A3G shows concentration dependent oligomerization in cells. A3A, contrastingly, 
remains essentially monomeric. 
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Because of the previously mentioned results that show RNA is involved in A3G 
oligomerization and packaging, we wish to make a closer study of A3G-RNA 
interactions. However, the cell is full of RNA and various other factors which may be 
interacting with A3G. Therefore, as previous chapters have discussed, we do not have the 
necessary control in the cell environment to conduct the desired experiments. We have no 
influence on the RNA population in cells, nor are those RNAs labeled. We therefore 
apply the droplet protocols from chapter 5 to study purified A3G and its interactions with 
RNA and DNA in an aqueous solution environment. 
 
6.3 Materials 
 Purified proteins: A3G-H248A/H250A-Myc-His was transiently transfected into 
HEK 293T cells and purified by Ming Li of the Harris lab as previously described.
110
 
EGFP-labeled A3G, and labeled and unlabeled A3A samples were also provided by the 
Harris lab. Solution experiments were performed using the following buffers. Protein 
buffer: 50 mM Tris-Cl, pH 7.4, 150 mM NaCl, 10% glycerol, 0.5% Triton-X 100. Oligo 
buffer: 50 mM Tris-Cl, pH 7.4, 10 mM EDTA. NEB3 buffer: 50 mM Tris-Cl, pH 7.9, 
100 mM NaCl, 10 mM MgCl2, 1 mM Dithiothreitol (New England Biolabs, Ipswitch, 
MA). Experiments are conducted in a 1:1 mixture of protein and oligo buffer or in purely 
NEB3 buffer. No differences were observed between these two buffer systems. 
RNA/DNA oligonucleotides: All oligonucleotides were purchased from Integrated DNA 
Technologies (Coralville, IA).  
 
Single-stranded RNA oligonucleotides - 
 Test+ RNA (27b): GUGAGCAAGG GCGAGGAGCG GGAGGGA 
is a short sequence from EGFP with the addition of two GGGA repeats. 
 Test- RNA (25b): GACAAGGUCU UUACUGGGUG UAUUU 
is derived from the bar domain of APPL1 membrane adaptor protein. 
 CA RNA (25b): AACCAACCCAAACAACCCACACACC 
GA RNA (25b): AAGGAAGGGAAAGAAGGGAGAGAGG 
GU RNA (25b): UUGGUUGGGUUUGUUGGGUGUGUGG 
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CU RNA (25b): UUCCUUCCCUUUCUUCCCUCUCUCC 
 
Single-stranded DNA oligonucleotides - 
TCCCA ssDNA (21b): AGATCCCATAATAGATAATGT 
is the A3G deaminase target oligo used in Shlyakhtenko et al.
110
 
GT ssDNA (25b): TTGGTTGGGTTTGTTGGGTGTGTGG 
CT ssDNA (25b): TTCCTTCCCTTTCTTCCCTCTCTCC 
Fluorescently-labeled oligonucleotides –  
 5’-labeled Texas Red. TCCCA ssDNA 
5’-labeled Texas Red.Test+ RNA 
5’-labeled Cy5.GA RNA 
5’-labeled Cy5.CA RNA  
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Figure 6.2  A3G in solution. 
In solution, A3G appears to be a tight dimer. The average normalized brightness value 
measured is approximately 2.3, which we interpret as a predominantly dimeric population 
with a small percentage of higher order complexes mixed in. There is a weak 
concentration dependence as well as some variation from one batch of purified A3G to 
another, but average brightness values slightly greater than 2 are very repeatable. A3A 
measurements fall directly on top of the EGFP values, indicating that A3A is monomeric 
and independent of concentration. Thus, in aqueous solution as in cells, differences are 
observed in the behavior of A3G and A3A. 
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6.4  A3G in solution 
 In order to study A3G-RNA interactions in solution, we must first characterize the 
behavior of A3G alone in solution. Initially, we perform dilution studies of purified A3G 
in aqueous buffer. Figure 6.2 shows that from nanomolar to micromolar concentrations, 
the brightness stays close to 2 with only a weak concentration dependence. A3G in 
solution is therefore primarily dimeric. A close inspection of the data reveals that the 
normalized brightness values are slightly above 2, which we interpret as the presence of a 
small population of higher order complexes. For instance, an 8% population of tetramers 
would return the observed apparent brightness, as would lower percentages of higher 
order complexes. Individual purification batches may generate slightly different 
percentages of the larger complexes in the stock solution, explaining the brightness 
variations at the highest concentrations. A3G in solution can also be sensitive to 
temperature (see Appendix B). Nevertheless, below ~1 µM, the brightness values are 
independent of preparation and are very repeatable. We note that Salter et al. also found 
A3G to be predominantly dimeric in solution with a small percentage of monomers and 
tetramers, and that their mix of A3G oligomers would also yield an apparent brightness 
slightly above 2.
111
 Figure 6.2 also shows a dilution study of A3A in solution. 
Throughout this chapter, we will use A3A as a control and to emphasize that A3G and 
A3A exhibit different behaviors. As in the cell measurements, A3A is revealed to be a 
monomer, independent of concentration, provided the solution is a reducing environment 
(Appendix A). 
 
6.5 A3G interactions with RNA 
 As previously mentioned in the introduction, A3G has been shown to interact 
with RNA, although little has been reported about specific RNA targets.
112
 A few studies 
have suggested that certain broad RNA sequences have a preferred association with A3G, 
such as 7SL RNA and HIV-1 RNA, which are also packed into the HIV-1 virion.
113–115
 
We were intrigued by a paper which reported a more general RNA-sequence dependence 
to interactions with A3G. Bogerd and Cullen found that the interaction of A3G and the 
nucleocapsid (NC) domain of HIV-1 is dependent on single-stranded RNA and, more 
  113 
specifically, on RNA containing guanine bases.
116
 However, their method could only 
probe the effect of RNA on A3G-NC complexation. Inspired by this result, we have 
constructed our study to explore the direct effect of RNA on A3G. We wish to determine 
if RNA sequence plays a functional role in A3G oligomerization and therefore, as 
hypothesized, with viral packaging and HIV-1 restriction. Thus, we conduct solution 
experiments of purified A3G with short RNA oligonucleotides. Studies have shown that 
A3G has difficulty binding oligonucleotides shorter than 10 bases,
108,116
 so we select 
sequences of greater than 20 bases. The experiments are conducted by mixing different 
RNA sequences with A3G in a series of 4 µL droplets. A3G is always added to a final 
concentration of 200 nM, and RNA to final concentrations of 200 nM or 2 µM, for a 1:1 
and 1:10 ratio of A3G to RNA. The first two sequences displayed in Figure 6.3 are 
simply test cases, Test+ RNA and Test– RNA. The sequence of Test+ RNA is mostly 
drawn from EGFP and is selected to have a high percentage of guanine bases. Test- RNA 
is part of the APPL1 gene sequence and is selected to have a more uniform distribution of 
the four RNA bases: adenine (A), guanine (G), cytosine (C), and uracil (U). Figure 6.3 
reveals that, for this experiment, A3G alone has a normalized brightness of 2.1, but in the 
presence of Test+ RNA, the oligomerization noticeably increases. Interestingly, 10 times 
excess of Test+ RNA over A3G leads to an even stronger multimerization of A3G than 
the 1:1 mixture. Test– RNA, on the other hand, effectively has no influence on the 
oligomerization of A3G.  
Because of this observed sequence dependence, we perform experiments 
involving more precise control in the composition of the RNA oligonucleotides. We 
construct a series of 25 base RNA strands containing combinations of only two 
nucleobases: CA, CU, GU, and GA RNA.  Each sequence has an identical pattern of 
repeats, only varying the bases involved, as described in the Materials section. These 
limited-base sequences are similar to the sequences used in the Bogerd and Cullen paper. 
Similarly to Bogerd and Cullen’s report that “G-rich” RNA is required for NC domain 
binding, we observe that “G-rich” RNA induces A3G oligomerization. The two 
sequences without any guanines fail to cause oligomerization, but closer inspection of the 
data reveals divergent behavior for the two different sequences. While CU RNA exhibits 
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no effect on A3G oligomerization, CA RNA appears to cause dissociation of the A3G 
dimer. This is a surprising and exciting result, for it demonstrates that not only does the 
composition of the RNA affect A3G’s response, but that different sequences can generate 
entirely different A3G behaviors.  
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Figure 6.3  Sequence dependent RNA interactions with A3G. 
In this plot, we show the response of EGFP-labeled A3G to the introduction of different 
RNA oligonucleotides. These experiments are conducted in solution droplets at room 
temperature. Each RNA sequence (25-27 bases long) is mixed with A3G at a 1:1 and a 
1:10 ratio. The normalized brightness value, or height of the column, indicates the 
average number of A3Gs that complex together through interaction with RNA. Here, the 
control measurement of A3G returns a value of 2.1, again confirming that A3G alone 
forms a dimer. The addition of Test+ RNA, derived from an EGFP sequence, causes 
significant oligomerization and appears correlated with the amount of RNA. On the other 
hand, Test– RNA, derived from an APPL1 protein sequence, show effectively no change 
in oligomerization. Test+ RNA has a predominance of guanine bases, while Test– RNA 
is much more evenly distributed amongst the four: guanine (G), cyostine (C), adenine 
(A), and uracil (U). The remaining four RNA sequences are constructed of only two 
bases each, and again the two “G-rich” sequences show oligomerization behavior, while 
the other sequences do not. In fact, the CA sequence appears to have a dissociative effect. 
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To investigate this response more carefully and to explore the role of RNA 
concentration, we single out Test+ RNA and CA RNA for droplet titration experiments 
as described in chapter 2. EGFP-labeled A3G and A3A are held fixed at a 200 nM 
concentration in a series of droplets with varying concentrations of RNA. Figure 6.4 
shows that at low concentrations of Test+ RNA, the A3G oligomerization (diamonds) is 
slightly above 2, just as it is in the absence of RNA. However, starting at about a 1:1 ratio 
of A3G to Test+ RNA, complexes form that grow with increasing RNA concentration to 
an average size of about 20 copies of A3G per complex. We note that this complex size 
falls in a similar range to that found in the A3G cell experiment (Figure 6.1). Figure 6.4 
also shows that A3A (circles) remains monomeric in the presence of Test+ RNA. A3A 
behaves as expected, based on the cellular measurements, but the details of the A3G 
response do not match the hypothesized model. This will be addressed in the discussion 
section. 
In startling contrast, Figure 6.5 shows that CA RNA does not induce 
oligomerization of A3G (squares), but rather has precisely the opposite effect. Increasing 
concentrations of CA RNA appear to dissociate the A3G dimer, which we believe to be 
very tight (see Appendix C). At low RNA concentrations, A3G has a brightness slightly 
above 2 as expected, but the average oligomerization of the A3G sample shifts towards 
the monomer as CA RNA achieves 100 times excess concentrations. At very high 
concentrations of RNA (> 30 µM), this trend breaks down, possibly due to Mg
2+
 
dependent RNA homo-interactions.
117
 We note that Chelico et al. report that the DNA 
substrate sequence ‘AAACCCAAA’ shows the highest deamination activity in their 
sequence-dependent study,
108
 a point that may be relevant to the above experiment and 
will be discussed in a later section. Finally, we again include A3A (circles) as a control 
which does not show any effect from CA RNA. 
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Figure 6.4  EGFP-labeled APOBEC and Test+ RNA droplet titration. 
Purified, EGFP-labeled A3G and EGFP-labeled A3A are fixed at 200 nM in a droplet 
titration with Test+ RNA. The bottom axis shows the final concentration of RNA in each 
droplet while the top axis shows the ratio of RNA to APOBEC. As before, A3G shows 
strong oligomerization that appears to initiate at about a 1:1 ratio of A3G to RNA and to 
saturate at 1:10. We also show A3A data which exhibits no response to the presence of 
the RNA, and remains monomeric. 
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Figure 6.5  EGFP-labeled APOBEC and CA RNA droplet titration. 
Purified, EGFP-labeled A3G and EGFP-labeled A3A are fixed at 200 nM in a droplet 
titration with CA RNA. Here, we see that CA RNA does induce dissociation of the A3G 
dimer. At the lowest RNA concentration measured, A3G has a normalized brightness of 
2.2 similar to A3G alone. Increasing the CA RNA concentration leads to clear 
dissociation of the A3G dimer and begins to approach a monomeric value. Again, A3A 
shows effectively no response to the presence of RNA. 
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6.6 A3G interactions with ssDNA 
 Although our study has dealt thus far with the interaction of A3G and RNA, the 
role of A3G in restricting HIV-1 is based on its interaction and enzymatic deamination of 
single-stranded DNA (ssDNA). For deamination of ssDNA, A3G’s preferred target 
(5’-…CCC) is the third C in a sequence coming from the 5’ end.104,118,119 Shlyakhtenko et 
al. have reported a small increase in oligomerization as a result of interaction with 
ssDNA and, as mentioned above, Chelico et al. found that the sequence of bases flanking 
the CCC target have significant effects on deamination efficiency.
108,110
 We now use FFS 
and brightness analysis to study the oligomerization response of A3G to the ssDNA 
versions of the previously used RNA sequences (CA, CT, GT, GA). We see in Figure 6.6 
that while there is a sequence dependent response, it does not precisely match that of 
RNA. Only the GT ssDNA sequence appears to induce oligomerization, and the effect is 
rather weak compared to RNA. The GA ssDNA sequence does not seem to have any 
effect at all. We note, however, that GU ssDNA, containing deoxyuracil, causes 
oligomerization to a comparable level with “G-rich” RNA. Figure 6.7 shows the earlier 
A3G oligomerization data for CU/GU RNA plotted alongside CU/GU ssDNA and 
CT/GT ssDNA. It becomes apparent that ssDNA is not influencing A3G oligomerization, 
except in the guanine-deoxyuracil sequence. This may be evidence that it is not merely 
guanine, but a combination of bases that triggers oligomerization. As expected, neither 
CT nor CU ssDNA have any oligomerization effect on A3G. Interestingly, CA ssDNA 
induces dissociation of A3G (Figure 6.6), which agrees with the observed effect of CA 
RNA.  
Overall, it seems that ssDNA does not induce A3G oligomerization, and indeed 
that certain sequences dissociate the dimeric A3G subunit. On the other hand, we have 
strong evidence that “G-rich” RNA sequences induce large oligomeric A3G complexes. 
These results appear to fall in line with the two disparate A3G oligomeric roles discussed 
in the introduction. We have hypothesized that A3G oligomers are necessary for 
packaging into the virion which, in turn, is required for restriction. Yet A3G enzymatic 
deamination, the primary restrictive function, can only be efficiently completed by LMM 
A3G complexes. Taken together with our results, these data suggest a model.   “G-rich” 
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RNA assists A3G to oligomerize and package into the virion. As the retrovirus undergoes 
reverse transcription and degrades RNA via ribonuclease H,
120
 the oligonucleotide 
population shifts from RNA to DNA. DNA does not cause A3G oligomerization and may 
cause A3G dissociation. Thus, the A3G oligomers will reduce to LMM complexes and 
can complete their enzymatic deamination to restrict HIV-1.  
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Figure 6.6  Sequence dependent ssDNA interactions with A3G. 
In this plot, we show the response of EGFP-labeled A3G to different ssDNA constructs. 
The four sequences are the DNA analogs of the RNA sequences described previously, 
with thymine (T) replacing uracil. We see that CA ssDNA also has a dissociative effect 
on the A3G dimer. Only GT ssDNA increases oligomerization, but it is a much weaker 
effect than GU RNA. 
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Figure 6.7  GU ssDNA versus GT ssDNA A3G oligomerization. 
The A3G oligomerization in the presence of CU/GU RNA (from Figure 6.5) is plotted 
alongside A3G in the presence of CU/GU ssDNA, containing deoxyuracil bases, as well 
as the natural ssDNA analogs CT/GT (from Figure 6.6). Overall ssDNA does not have 
much effect on oligomerization except when it contains deoxyuracil. This may indicate 
that “G-rich” sequences require particular base combinations, or perhaps that the 
deoxyuracil causes ssDNA to bind in the RNA pocket and thus generates the 
corresponding oligomerization effect.  
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6.7 FFS diffusion studies 
 The previous sections focus on the main goal of this study, answering the question 
of A3G oligomerization as dependent on RNA and ssDNA. The next two sections contain 
preliminary experiments exploring the direct interaction of A3G with RNA and DNA, 
which will be necessary for constructing a more realistic interaction model of these 
biomolecules. Thus far in our APOBEC studies, we have always had fluorescently-
labeled APOBEC and unlabeled oligonucleotides. This means all of our data only 
provide information about APOBEC copy numbers, and furthermore, those data never 
directly measure the interaction with nucleotides, but only assume interaction with 
RNA/DNA because of a change in the A3G stoichiometry. Therefore, we change gears 
and work with unlabeled protein and fluorescently-labeled RNA and ssDNA. In these 
experiments, brightness values will provide information about RNA/DNA copy numbers, 
and we can take advantage of diffusion information to study interactions. The 25-base 
oligonucleotides we use in this experiment are small (~ 9 kDa) and therefore diffuse 
quickly. EGFP-labeled A3G (~ 73 kDa) and EGFP-labeled A3A (~ 50 kDa) move much 
more slowly through solution, so that when the fluorescent oligonucleotide binds to the 
larger protein, the slowing in diffusion rate is detectable. Figure 6.8 shows 
autocorrelation curves for EGFP-labeled A3G and Texas Red-labeled RNA, along with 
their respective fits. This method for studying interactions is much less sensitive than 
brightness because diffusion time goes approximately as the cube root of molecular 
weight,        
 
 ⁄ , a relationship that assumes hydrodynamically spherical proteins. 
The interaction between two similar weight proteins leads to only a 25% change in the 
diffusion coefficient, which is close to the intrinsic uncertainty in diffusion coefficient 
measurements. In the case of interaction between two objects with sufficiently different 
molecular weights, however, it is a very useful method. For an oligonucleotide binding 
dimeric EGFP-labeled A3G, the molecular weight relationship predicts nearly a 3-fold 
increase in the time required for the complex to diffuse through the observation volume 
compared to that of the free oligonucleotide.   
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Figure 6.8  Autocorrelation curves for A3G and RNA. 
We display the normalized autocorrelation curves for EGFP-labeled A3G (squares) and 
Texas Red-labeled Test+ RNA (diamonds). Note the strong difference in the 
characteristic diffusion time for the RNA oligonucleotide and the A3G dimer. This 
change makes it possible to use diffusion to study interaction. 
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 We begin with a mainly qualitative experiment to confirm the interaction of A3G 
with RNA and ssDNA, and to assess the corresponding interactions with A3A, for which 
our previous experiments have not provided any direct information. Figure 6.9 displays 
the diffusion time controls for ssDNA (dotted outline) and RNA (solid outline). The 
TCCCA ssDNA is labeled with a Texas Red organic dye and is derived from the 
deamination assay used in Shlyakhtenko et al.
110
 The Test+ RNA is the same sequence 
used in the previous sections but now including a Texas Red label on the 5’ end. Both 
labeled oligonucleotides have a diffusion time           in their unbound state. If the 
ssDNA or RNA binds APOBEC, we expect to see an increase in the diffusion time since 
the larger complex takes longer to pass through the observation volume. We emphasize 
that these preliminary experiments are somewhat qualitative. Because both the bound and 
unbound fluorescently-labeled oligonucleotides will contribute to the signal, the 
measured diffusion time represents an average, and a single measurement cannot resolve 
the two subpopulations. Nevertheless, an increase in diffusion time is a firm indication of 
interaction between A3G and oligonucleotide since the effect of the unbound population 
is to reduce the average diffusion time back toward the control value. Samples contain 5-
fold excess of proteins over oligonucleotides to shift the oligonucleotide population 
towards the bound state.  
The next set of columns in Figure 6.9 show the interaction of A3G with TCCCA 
ssDNA and Test+ RNA. Having measured a diffusion time of      for an EGFP-
labeled dimer (Figure 6.8), we estimate        for the unlabeled A3G dimer. 
Therefore, the diffusion time of       for the 5:1 A3G/ssDNA sample clearly 
demonstrates the presence of interactions, but since the value is below      , not all 
ssDNA is bound. The interaction of A3G and Test+ RNA, on the other hand, reveals that 
the RNA is almost completely bound, having a diffusion time of       , which suggests 
that A3G has a stronger affinity for RNA than for ssDNA. However, these experiments 
have to be confirmed with RNA and DNA that share the same sequence.  
A3A is known to interact with ssDNA because it is a very efficient deamination 
enzyme.
121
 However, we were unable to detect interaction until we increased the 
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A3A/ssDNA ratio to 100:1 in order to shift the equilibrium towards the bound state. 
Under such a condition, the ssDNA is always surrounded by binding partners and thus 
spends most of its time in the bound state, even if the average duration of the binding is 
very short. A3A’s transient binding is likely an important aspect of its enzymatic 
efficiency, in that it is always free to bind a new substrate. Finally, we are able to 
establish that A3A does indeed bind to Test+ RNA, despite the fact that there is no 
change in oligomerization. This supplies further evidence that A3G and A3A 
substantially differ in their behavior. The diffusion time of        indicates that RNA 
binds to A3A with less affinity than to A3G. We note that A3A also shows a stronger 
affinity for RNA than ssDNA, but again, this needs to be confirmed with RNA and DNA 
of identical sequence. 
 The labeled oligonucleotide method can also be used to gain additional 
information about the interaction of A3G and Test+ RNA. We know Test+ RNA induces 
oligomerization and that oligomerization initiates at about a 1:1 ratio of protein to RNA. 
The questions become whether RNA oligonucleotides are, in fact, included in the large 
A3G complexes and why the 1:1 ratio is required for complex formation. A more 
quantitative diffusion study with labeled RNA can address these points using diffusion to 
identify RNA interaction with the complexes, and oligonucleotide brightness to 
investigate RNA copy number.  
In Figure 6.10 we display a droplet titration in which A3G is unlabeled and thus 
invisible to FFS. The data is plotted as diffusion time versus the ratio of RNA to A3G; 
the top axis shows absolute RNA concentration which is varied while A3G concentration 
is held fixed. A control measurement was made in a sample droplet containing only the 
labeled RNA construct, and the resulting diffusion time is represented by the gray line in 
the figure. Clearly, even at the lowest RNA/A3G ratio measured, the observed diffusion 
time is significantly larger than the control. Therefore, when there is excess A3G protein 
the Test+ RNA is binding, but apparently not causing oligomerization. Normally, we 
would expect the diffusion time to reduce or stay approximately constant as the ratio of 
labeled RNA increases, since we are increasing the level of unbound RNA. Recalling the 
~20% uncertainty, the data show a roughly constant diffusion time until we reach the 1:1 
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ratio. We do, however, expect an increase in diffusion time around the 1:1 ratio because 
A3G starts to oligomerize. The measured diffusion time of        clearly indicates the 
inclusion of RNA in large complexes. Additionally, the diffusion value is consistent with 
the size of oligomer complexes observed in the EGFP-labeled A3G experiments, 
although we mustn’t overinterpret this numerical value because it is averaged over a 
mixture of A3G-RNA complexes and free RNA oligonucleotides. The experiment should 
be repeated over a broader range of mixtures in which we expect the higher RNA ratios 
to show reducing average diffusion times as the free oligonucleotides dominate the 
signal. Nevertheless, the data do show that RNA is bound into the large A3G complexes 
and agree with the labeled A3G experiments (Figure 6.4) that this oligomerization occurs 
at ~1:1 ratio. The simplest explanation for this transition point is that more than one RNA 
per A3G are required for complex formation, a hypothesis we will return to in the next 
section of this chapter. 
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Figure 6.9  Diffusion studies: APOBEC-oligonucleotide interaction 
The first two columns are the control measurements for the fluorescently-labeled ssDNA 
(dotted outline) and RNA (solid outline) samples. TCCCA ssDNA and Test+ RNA are 
used throughout this experiment. Both have similar diffusion times,          . These 
preliminary experiments are conducted with 5 times excess APOBEC over 
oligonucleotide to reduce the probability of unbound fluorescent oligonucleotides. A3G 
shows clear interaction with the deamination target, TCCCA ssDNA, by evidence of the 
slower diffusion time. By comparison, the significantly slower motion of the A3G-Test+ 
RNA sample indicates a stronger affinity and therefore a higher fraction of bound 
oligonucleotide. The interaction of A3A with ssDNA displays an even weaker affinity, 
and requires a higher concentration of protein to “catch” the oligonucleotides in a bound 
state. This very transient binding is likely an important aspect of A3A’s enzymatic 
efficiency. Finally, we observe that A3A does indeed bind Test+ RNA, though we know 
from previous experiments that this binding does not change its oligomerization state. 
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Figure 6.10  Diffusion study binding of A3G and Test+ RNA. 
Unlabeled or “dark” A3G is mixed in droplets with varying concentrations of 
fluorescently labeled Test+ RNA. The data are plotted as diffusion time versus the RNA 
to A3G concentration ratio, while the top axis shows the absolute concentration of RNA. 
Since even the smallest RNA/A3G ratio measured shows a diffusion time much slower 
than that of “free” labeled RNA control, it is clear that A3G and Test+ RNA are bound 
prior to the oligomerization response. Again, at roughly a 1:1 ratio, we observe a 
dramatic increase in diffusion time as the large, slow complexes are formed. However, 
this experiment has been performed only once and the data are rather noisy. Thus, it will 
be important to repeat the experiment.  
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Figure 6.11  Diffusion study binding of A3G and CA RNA. 
The labeled CA RNA concentration (20 nM) was held fixed across the droplets, and the 
dark A3G concentration was varied. The data are plotted as a function of RNA/A3G ratio 
to correspond with the previous figure. We see that on the left side of the plot, in the case 
of excess protein, most of the CA RNA is bound because of the slow diffusion time of the 
complex. As we decrease the concentration of unlabeled A3G, there are fewer binding 
targets and more free RNA, thus the measured diffusion times eventually fall to the 
control value of free RNA. Note that this data is convolved with the A3G dissociation 
reaction induced by CA RNA. 
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 We also performed a droplet titration diffusion study on the interaction between 
unlabeled A3G and labeled CA RNA (Figure 6.11). The CA RNA sequence is the same 
as before, now with a Cy5 dye attached to the 5’ end. Here, we hold the concentration of 
the labeled CA RNA fixed and vary the A3G concentration, which differs from the 
experimental designs from the first half of the chapter. This approach prevents variation 
in the fluorescence signal strength from droplet to droplet. The diffusion times are plotted 
as a function of RNA/A3G concentration ratio to correspond with the previous figure, 
and the top axis shows the absolute A3G concentration. In this case, we observe a simpler 
and more typical diffusion binding model. At an excess protein or low RNA/A3G ratio, 
most of the labeled CA RNA is bound, and we measure a slow diffusion time. As the 
concentration of dark A3G decreases and there are fewer protein binding targets, the 
signal is dominated by free, unlabeled CA RNA, and the measured diffusion times drop 
to the control value. We’ve previously demonstrated that CA RNA causes dissociation of 
A3G, a process which also reduces the diffusion time. However, the difference between 
diffusions times of the dimer and monomer is only ~25%, thus this effect on the above 
experiment is small. The lowest RNA/A3G ratio measured is about 30:1 at which ratio 
the A3G is still fully dimeric according to Figure 6.5. Therefore the measured diffusion 
time at this ratio        , compared to the fully bound estimated diffusion time of 
      , indicates that CA RNA is bound to A3G with weaker affinity than either Test+ 
RNA or TCCCA ssDNA.  
 
6.8 Oligonucleotide brightness 
 The previous section focused only on diffusion times. However, each of those 
experiments also recorded brightness values for the oligonucleotides during interaction 
with APOBEC. These brightness results are summarized Table 6.1. Because A3A has 
weak affinity, we show the ssDNA brightness for the 100-fold excess A3A case. We 
estimate from the diffusion time ratio (       ) that about 25% of the ssDNA is bound. If 
that 25% ssDNA had a possible two binding sites per A3A and the remaining 75% 
ssDNA stayed unbound, the average measured brightness would have a value of      . 
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The flat brightness       is a strong indication that A3A only has one ssDNA binding 
site. This appears to hold true for Test+ RNA and CA RNA as well, although additional 
measurements should be taken to determine CA RNA brightness in the case of excess 
A3A. These data are consistent with the facts that A3A is monomeric and has only a 
single catalytic domain.
122,123
 A3G has two domains, CD1 which is necessary for RNA 
binding, and CD2 which catalyzes ssDNA.
115,124
 Additionally, A3G exists as a dimer in 
our solution studies, yet this dimer only appears to bind one ssDNA strand. One might 
speculate that in the formation of the dimer, one of the CD2 domains is blocked. Salter et 
al. have performed small-angle x-ray scattering (SAXS) experiments on A3G and suggest 
a “tail-to-tail” model that puts the two CD2 domains in close proximity.125 Finally, there 
is the interaction of A3G with RNA. Both CA and Test+ RNA, in cases of excess protein, 
show a brightness greater than 1. As the inherent uncertainty in brightness measurements 
is     , brightness values of 1.3 and 1.2 indicate that some A3G complexes are binding 
more than 1 RNA. We confirm this observation by measuring the CA RNA brightness in 
a 1:1 CA/A3G mixture. The brightness       matches precisely with the brightness of 
A3G alone, which seems to indicate that each A3G dimer has bound two molecules of 
CA RNA. The 1:1 A3G/Test+ RNA experiment indicates the same binding 
stoichiometry, but this datapoint (*, Table 6.1) is more difficult to interpret. The 1:1 ratio 
is also the regime in which Test+ RNA causes strong oligomerization of A3G which 
would tend to bias the average brightness upwards.  
 To identify RNA copy number, we have labeled the RNA and left the A3G dark. 
Therefore, in higher Test+ RNA/A3G ratio experiments, we can no longer identify the 
A3G copy number, and hence the number of potential RNA binding sites. Furthermore, 
triggering A3G oligomerization requires excess RNA which means a large amount of 
unbound RNA. All the non-interacting or unbound RNA will have a brightness of 1, thus 
reducing the measured copy number of RNAs in complexes. Nevertheless, in several 
experiments containing excess Test+ RNA, and therefore presumably A3G oligomers, we 
have observed RNA copy numbers of 2-4 (data not shown). Further studies are required, 
but this preliminary evidence strongly suggests that the A3G dimer binds more than 1 
RNA and that large A3G complexes contain multiple copies of “G-rich” RNA.  
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  Normalized Oligonucleotide Brightness 
TCCCA ssDNA CA RNA Test+ RNA 
A3G 
(400 nM) 
      
(1 µM) A3G 100:1 ssDNA 
      
 (30:1) 
      
(1:1) 
b=1.2 
(10:1) 
     * 
(1:1) 
A3A 
(400 nM) 
       
(1 µM) A3A 100:1 ssDNA 
      
A3A 1:2 RNA 
      
A3A 4:1 RNA 
 
 
 
 
 
Table 6.1  RNA/DNA copy number in APOBEC complexes. 
This table reports the copy numbers for RNA and ssDNA as they interact with A3G and 
A3A. The experiments are conducted at approximately 400 nM protein, except in the 
case of TCCCA ssDNA which required a higher protein concentration to achieve the 
large APOBEC/ssDNA ratio and still have detectable ssDNA signal. A3A shows 
evidence of only a single binding site. Note that additional A3G-RNA experiments 
should be conducted at higher A3A/RNA ratios to confirm this observation. The A3G 
dimer appears to bind only 1 ssDNA, but data indicate that it binds more than 1 RNA. 
The 1:1 A3G/CA RNA displays 2 RNAs per A3G dimer. The 1:1 A3G/Test+ RNA 
shows a similar result, but the interpretation is potentially complicated by the onset of 
A3G oligomerization in this regime. 
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6.9 Discussion 
 Using both A3G brightness experiments and RNA diffusion studies, we have 
shown that “G-rich” RNA induces the formation of complexes in A3G. The next step is 
to model this A3G-RNA interaction. Our original hypothesis was that multiple A3Gs 
would bind an RNA strand like “beads on a string.” Under this model, however, Figure 
6.4 should have shown A3G oligomerization when A3Gs outnumbered RNAs rather than 
the reverse. We also performed an experiment with a shorter RNA strand—only the first 
half of the Test+ RNA (not shown)—but the final oligomer size did not differ from that 
with the full length Test+ RNA. Therefore, the “beads on string” model is conclusively 
eliminated.  
The other potential models involve multiple RNAs. One such model is that A3G-
RNA chains are being formed, perhaps with the A3G dimer acting as a connector 
between two RNA segments. In this “co-polymer chain” model, the upper limit of the 
A3G complexes     copies, would represent the average of a distribution of A3G chains 
limited in length by the increased probability of “link” failure in the larger complexes. 
Most of the A3G experiments in this study have been conducted at 200 nM, but we have 
varied concentration from 40 to 1200 nM with little, if any, effect on the final average 
oligomer size in the presence of Test+ RNA. However, other models involving multiple 
RNAs are feasible as well. We have established that “G-rich” RNA helps A3G to form 
complexes, but we do not have experimental data to identify by what mechanism or via 
what connections the RNA strands and A3G assemble.  
Regardless of the molecular details of the A3G-RNA model, we still cannot 
satisfactorily explain the data from Figure 6.4. All the evidence indicates that the RNA 
strands are providing binding targets for A3G which somehow ‘glue’ the complex 
together. Furthermore, excess RNA over A3G appears to be required to form the 
complexes. However, at very high ratios of excess RNA, we would expect to see a 
reduction in A3G complexes. Very high numbers of RNA strands should effectively 
‘screen’ the A3G dimers from one another, providing a wealth of targets for protein-RNA 
interactions, but drastically decreasing the probability that individual RNAs can 
encounter and facilitate protein-protein interactions between 2 or more A3Gs. However, 
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at the highest RNA/A3G ratio in our experimental data (>100), the oligomer size remains 
at about 20 copies of A3G. As a result, we feel it necessary to propose cooperativity 
between protein-protein and protein-RNA interactions that make the formation of such 
large complexes in the presence of excess RNA energetically favorable. Additional 
experiments will be required to fully characterize the A3G-RNA interaction model. 
Alternative methods are required to further elucidate a binding model for A3G-
RNA complexes. Dual-color FFS studies offer an attractive route that will provide 
additional information about the composition of the complex. If both A3G and the RNA 
have labels, it is easier to identify the interacting species, although Förster resonance 
energy transfer (FRET) between the two fluorescent labels may complicate such 
measurements. Very preliminary dual-color data indicate approximately two RNA copies 
per A3G monomer in the large A3G-RNA complexes (Appendix E). However, these data 
have not been corrected for FRET or quenching effects and should be taken with a grain 
of salt. The A3G-RNA binding mechanism is clearly non-trivial, and developing an 
understanding of the model could provide valuable information about the biological 
function of this interaction. 
 Another important aspect to understanding A3G oligomerization is to develop an 
interaction model of the A3G subunit. Our studies, along with other reports from the 
literature, have observed A3G to form dimers in solution.
107,111,125
 In fact, prior to 
discovering the effect of CA ssDNA and RNA, we found it to be such a tight dimer that 
is was difficult to take apart. We performed mixing experiments between labeled and 
unlabeled A3G that did not yield the expected results (see Appendix C). This also 
complicates matters because the labeled and unlabeled, or bright and dark, A3G mixing 
experiment is one of our best tools to eliminate the possibility of label interactions. We 
have performed studies in which Test+ RNA is added to a 1:1 mixture of bright and dark 
A3G, and the resulting oligomers yielded roughly half the brightness of a 100% labeled 
sample (Appendix C), which demonstrates that both bright and dark A3G form 
complexes with RNA. We know from other work that the fluorescent protein label does 
not interfere with A3G deamination,
126
 nor do label interactions appear to cause the 
aggregation observed at higher temperatures (Appendix B). However, we are still left 
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with some questions about the A3G dimer, as we have discovered that when purified 
A3G is placed in E. coli extract or HeLa cytosol, the average normalized brightness 
reduces from        to        (Appendix D). It is not clear what element or elements of 
the lysate environments lead to this result. Our present knowledge on the nature of the 
monomeric and dimeric protein state remains woefully incomplete, and the set of current 
experimental data is difficult to reconcile with a physical model of binding interactions. 
Additional work is clearly needed to tease out the underlying mechanism governing A3G 
oligomerization.  
  The most significant result of this study is the sequence dependence of A3G 
interactions with RNA and DNA. “G-rich” RNA (Test+ RNA, GA RNA, GU RNA) 
cause A3G to form higher order oligomers, while ssDNA does not—except for GU 
ssDNA, containing deoxyuracil. CA RNA and CA ssDNA cause dissociation in the A3G 
dimeric subunit. We add to these results the previously mentioned literature reports that 
HMM A3G complexes are enzymatically inactive. Finally, sequence dependent 
deamination experiments of Chelico et al.
108
 show almost a 20-fold increase in 
deamination activity for 5’-AAACCCAAA as compared to 5’-TTTCCCTTT, and several 
other flanking combination sequences containing adenines also showed high deamination 
activity. Our own CA ssDNA oligonucleotide does not have this identical sequence, but 
does contain two separate target sequences, ‘AACCCAAA’ and ‘AACCCA’, which 
fairly closely fit the description. Therefore, the CA ssDNA sequence mimics the 
preferred deamination target of A3G and also causes dissociation of dimeric A3G. We 
observed from the diffusion studies (Figures 6.10 & 6.11) that CA RNA had a lower 
binding affinity than Test+ RNA. This probably means that CA sequences have a higher 
off rate, or shorter binding duration, leaving the A3G protein enzyme free to catalyze 
more targets, which would agree with the results of Chelico et al. In addition, CA-
induced dissociation creates two A3G molecules in the place of one dimer, increasing the 
effective concentration of independent A3G enzymes, which would also lead to an 
increase in deamination activity.  
We have shown that CA RNA can cause dissociation of the A3G dimer. 
However, our hypothesis is that the large oligomeric complexes are the form packaged 
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into the virion. Therefore, the important question becomes whether this dissociation 
effect also applies to HMM A3G complexes. We perform an experiment in which we mix 
labeled A3G with unlabeled Test+ RNA at a 1:4 ratio (200 nM A3G, 800 nM RNA). 
Figure 6.12 shows that, for this experiment, the final A3G oligomerization is      . 
Subsequently in individual droplets, we add CA RNA and CA ssDNA (800 nM, 1.6 µM) 
for 1:1 and 1:2 ratios of Test+ RNA to CA oligonucleotide. The A3G oligomerization is 
reduced in all 4 cases (Figure 6.12), but it was particularly exciting to see the very low 
value of      in the final CA ssDNA condition. Note that all four samples are very 
inhomogeneous, containing some intensity spikes which are presumably large A3G 
complexes that did not dissociate, thus the data sets presented in Figure 6.12 were 
intentionally selected to avoid those containing large spikes that skew the average 
brightness upwards. Nevertheless there is a clear dissociative response for HMM A3G 
complexes in the presence of their deamination target ssDNA.  
With these results, we strengthen our earlier hypothesis. “G-rich” RNA in the 
cytoplasm causes A3G to oligomerize which, in a process that is not yet understood, 
allows it to package into the virion. Once inside the virion, reverse transcription causes a 
shift from an RNA-containing environment to a DNA-containing environment which 
does not promote complex formation. Additionally, it appears that “CA-rich” ssDNA can 
actively out-compete the effects of “G-rich” RNA. These processes, presumably, result in 
the dissociation of the HMM A3G complexes back into the LMM form which are 
enzymatically active, mutate the viral DNA, and are thus able to restrict HIV-1. 
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Figure 6.12  CA ssDNA dissociates A3G oligomers. 
These data shows that the dissociation effect of the CA sequences can assist in taking 
apart the HMM A3G complexes formed with Test+ RNA. The first two columns show 
the A3G control (200 nM) and A3G-RNA complexes formed with Test+ RNA (800 nM). 
Subsequently, CA sequences were added to droplets of the A3G-RNA sample in four 
different conditions: CA RNA at equal and twice the amount of Test+ RNA, and CA 
ssDNA at equal and twice Test+ RNA. All four conditions show A3G-RNA complex 
dissociation, but 1:2 Test+ RNA/CA ssDNA shows that a small excess amount of the 
deamination target can effectively take apart the complex and reduce it to a, presumably, 
enzymatically active form. The above data represent a single experiment which should be 
repeated, along with similar experiments to test the effect of other ssDNA sequences on 
HMM A3G complexes.  
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7.  Summary 
 FFS is a powerful technique for studying biomolecular interactions inside living 
cells. Because the technique is quantitative, non-invasive and measures in real time, it has 
a very broad range of applications and broader scope yet to be realized. We demonstrated 
that quantitative FFS can be performed in new territory, such as small sample reservoirs 
and thin sample geometries, and further established that the same technique can be 
applied in a consistent manner across multiple sample environments (cellular, cell-free 
and aqueous solution). 
We extended the reach of quantitative FFS to small sample volumes where 
photodepletion is present. Our analysis showed that photodepletion clearly biases FFS 
brightness measurements. Of particular interest is the extension of quantitative FFS to 
E. coli cells which are the most popularly studied prokaryotic model organism. As an 
example, systems biology questions often depend on knowledge of protein copy numbers 
per cell and the variation in those numbers across a cell population.
127,128
 FFS in E. coli 
presents a useful tool for providing exactly this type of information and should be broadly 
applicable for quantitative studies in the fields of biotechnology and microbiology. 
 We demonstrated that thin geometry biases FFS brightness measurements by as 
much as a factor of 2, a fact which ought to be noted by anyone using FFS in E. coli, 
microfluidic devices, or in thin cell sections. The same bias appears not only in stationary 
FFS experiments, but also in related fluorescence imaging techniques applied to thin 
samples. It is often more difficult to detect in these circumstances. We developed 
modifications to FFS theory, and coupled the theory with a z-scan approach that allows 
us to identify thin samples by their intensity profile, fit the data, and recover an unbiased 
brightness. An exciting new direction for this technique is its application to cell 
membranes. Fluorescent membrane studies are very difficult to conduct because the 
membranes are so much thinner than the excitation light. Total internal reflection 
fluorescence (TIRF) microscopy uses an evanescent field to limit excitation depth to 
~100 nm, but this technique can only be applied to the membrane in contact with the 
coverglass. Z-scan FFS provides access to internal membranes for the first time. Other 
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members of the lab are already pursuing z-scan FFS to differentiate between cytoplasmic 
and membrane fraction of proteins, as well as to study protein interaction directly at the 
nuclear membrane. These applications require further development, but z-scan FFS can 
bring quantitative measurement of protein interaction to the wide-ranging and important 
field of membrane proteins, and do so directly in living cells. 
Although the ability to take quantitative measurements in living cells is the chief 
strength of FFS, when trying to carefully characterize a protein, control over the 
environment to systematically change conditions is an important component. Since our 
ability to change cellular conditions is extremely limited, we combined FFS and cell-free 
expression to create an environment that offers the same convenience of genetic labeling 
as a cell, while providing direct access and control of the sample. We exploited these new 
capabilities by conducting a maturation study of three common fluorophores (EGFP, 
EYFP, and mCherry) as a function of temperature. The result revealed that much of the 
scattered literature values may be in closer agreement than is apparent at first glance, and 
that EGFP is a fast maturing protein and a good candidate for FFS and brightness 
experiments. We have also confirmed that temperature and oxygenation are important 
factors in maturation, and that fluorescence researchers must consider these conditions 
since very slowly maturing fluorophores present a problem. mCherry is the only red 
fluorescent protein we’ve found that is suitable for FFS brightness experiments. Having 
established its slow maturation, the development of a fast red protein is important. FFS 
and cell-free expression provide a quick and simple test that would be useful in screening 
new red fluorescent protein candidates. 
Additionally, FFS and cell-free expression can be used to address the role of the 
medium in protein-interaction assays. An enormous number of standard protein assays 
are currently conducted in vitro or in aqueous buffers containing only a few salts. 
However, cell cytoplasm is a crowded environment of biomolecules, and cell-free 
solution maintains some of this characteristic. The literature has demonstrated that 
molecular crowding can affect binding affinities. The cell-free environment is partially 
composed of extracted cytoplasm and, for the purposes of molecular crowding 
experiments, can be enhanced with the addition of biocompatible macromolecules like 
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polyethylene glycol (PEG), so that FFS and cell-free solution can study crowding 
phenomena. The combination of FFS and cell-free expression also lends itself to the 
exploration of gene regulation networks.  An important and still developing approach is 
the attempt to build these networks from the ground up. FFS in cell-free expression can 
play an important role in identifying components of such a minimal model, as proteins 
and transcription factors assemble into the machine complexes that make the networks 
function.  
We also applied FFS to study APOBEC3G oligomerization and its interactions 
with DNA and RNA. Surprisingly, we found that A3G oligomerization in the presence of 
DNA and RNA differs and, additionally, depends on the sequence of the oligonucleotide. 
This has not been previously demonstrated, and could not have been identified in cellular 
studies. The data presented in the chapter 6 and the appendices demonstrate that A3G 
exhibits complex behavior. In the absence of DNA and RNA, A3G demonstrated 
oligomerization behaviors in response to increased temperature and mixing experiments 
that we have been unable to explain and require further attention. However, the differing 
oligomerization responses, thus far identified, of A3G to DNA and RNA might be a very 
important part of the mechanism by which A3G packages into the virus and executes its 
enzymatic function against HIV-1. A3G and selected members of the APOBEC protein 
family are promising drug targets for the fight against HIV-1, and FFS provides a 
powerful tool in the characterization and quantification of APOBEC proteins. 
In this work, we have developed FFS techniques for small volumes and thin 
samples. We’ve used FFS to perform brightness measurements in E. coli, mammalian 
cytoplasm, cell-free expression systems and aqueous buffers, thus improving the potency 
and reach of FFS for the study of protein interactions. Proteins are the building blocks of 
the biological world, and FFS can identify how many there are in the system and how 
they are put together, building up our understanding to the larger protein machines, the 
assembly lines, and perhaps to the network connecting them all, that makes the whole 
system run—and produces life. 
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Appendices 
Appendix A.  APOBEC and reducing environments 
 
 In cells, A3A is monomeric, and we expected similar results in solution. 
However, our initial measurements showed A3A appearing with a normalized brightness 
of nearly 3, which would indicate a trimer. After consultation with Michael Carpenter, we 
suspected that the exposed cysteine residues of A3A might lead to disulfide bonds 
between A3A molecules. Providing a reducing environment in solution would prevent 
these bonds as it does inside the cell. We used both mercaptoethanol β and dithiothreitol 
(DTT) to show that this was, in fact the case. Below we present the data for the DTT 
experiment. 
 
 
Figure A.1  A3A and A3G in a reducing environment. 
  
 
 It is clear that in a reducing environment A3A is monomeric as expected, but A3G 
remains unaffected. Thus, all of the A3A experiments in chapter 6 are conducted in a 
solution containing DTT, as are most of the A3G experiments (NEB3 buffer).  
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Appendix B.  Temperature-induced A3G oligomerization 
 
 We observe a temperature-induced aggregation phenomenon of EGFP-labeled A3G 
in solution (50 mM Tris-HCl). No significant alteration in the phenomenon were 
observed when using Tris-HCl buffer with additional salts, or when using a 10 mM 
HEPES buffer. At room temperature, we consistently recovered an average brightness 
      as previously stated. However, if we incubate the A3G-EGFP sample at 37C, 
and then cool and measure it at 20C, we see an increase in oligomerization (Figure B.1).  
 
 
 
Figure B.1  Temperature-induced A3G aggregation. 
 
 
 A higher starting concentration of A3G-EGFP  and/or a longer time spent 
incubating results in larger aggregates. The trend of this phenomenon has been very 
consistent although successive trials return scattered brightness results. Note again that 
the aggregate does not dissociate when the sample is cooled back down to room 
temperature (or below), indicating that the aggregation is irreversible.  
 
200 nM 200 nM 
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Figure B.2  37C A3G runaway aggregation. 
 
 
Figure B.2 shows a sample of room temperature A3G placed into a 37C environment at 
time 0. The sample rapidly begins to aggregate with no obvious endpoint, except perhaps 
a lack of additional A3G molecules. This response suggests that A3G experiments 
performed in 37C solution may be difficult to conduct or interpret. We also perform an 
experiment in which the temperature is slowly increased while the sample is being 
measured. Figure B.3 shows that the aggregation reaction does not appear to initiate until 
the temperature rises above ~35C. The temperature of the sample was determined by 
inserting a thermocouple wire into a buffer droplet located in the well neighboring the 
actual sample. 
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Figure B.3   Temperature threshold of A3G oligomerization. 
 
 
 To explore whether this temperature-induced aggregation might be the result of the 
EGFP label, we would like to test the temperature effect on an A3G sample without the 
EGFP label. However, without the label, there is nothing for our fluorescence technique 
to measure. Our strategy was to create a sample that is mostly unlabeled but has a small 
percentage of EGFP-labeled A3Gs. The bulk of the interactions should take place 
between unlabeled A3G proteins, but the smattering of labeled A3G proteins still permit 
us to extract information using FFS. To this end, we created a mixture of labeled and 
unlabeled A3G at a 1:9 ratio, and conducted an experiment using two samples:  
600 nM A3G  – 100% labeled with GFP 
600 nM A3G  – 10% labeled with GFP 
At room temperature, the 100% labeled sample has a brightness of 2.4 and the diffusion 
time is 1 ms ± 20%. After a 60 minute incubation at 37C, the sample now has a 
brightness of 33, and a diffusion time of 3.2 ms (Table B.1). The normalized brightness 
of 33 indicates large aggregates, as does the increased diffusion time. A quick estimate 
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(assuming spherical particles) relates the change in the diffusion time to increased mass 
(Stokes-Einstein relation). Because of the 20% error in measured diffusion times, the 
observed increase from     to       could indicate anything from a 12x to 68x 
increase in mass, the low end of which is in approximate agreement with the brightness 
data. It is important to recall, however, that this is a crude estimate based on the 
assumption that the A3G complexes are spherical in shape. 
 
 
Sample 
Non-incubated 
Measured at 20°C  
Incubated for 60 min 
Measured at 20°C 
Normalized 
Brightness 
Diffusion Time 
(ms) 
 
Normalized 
Brightness 
Diffusion Time 
(ms) 
100% labeled A3G 
(600 nM) 
2.4 1 
 
33 3.2 
10% labeled A3G 
(600 nM) 
1.4 0.7 
 
3.1 2.5 
Table B.1  Labeled and mostly unlabeled A3G shows temperature aggregation. 
 
 
 When we examine the 10% labeled sample at room temperature, we find a 
brightness of     and a diffusion time of      . According to theoretical calculations, a 
10% fluorescently-labeled dimer should have a brightness of 1.1. Appendix D addresses 
the fact that the A3G dimer does not exchange subunits as expected. Nevertheless, the 
reduction from       to       confirms that the A3G sample is only partially 
labeled. We now consider the diffusion parameter. A3G has a molecular weight of about 
     , and GFP has a molecular weight of      , so EGFP-labeled A3G has    
     .  From molecular weight arguments, we expect a diffusion time of the 
fractionally-labeled sample to be reduced because many of the A3G moleucles are 
smaller and faster. A theoretical estimate of the reduced diffusion time, based on the 
assumption of hydronamic spheres, yields          for the 10% labeled A3G sample. 
This is approximately in agreement with the measured result      . 
 We will demonstrate in Appendix C that while mixing labeled and unlabeled A3G 
dimers should result in a predictable distribution of labeled, unlabeled, and half-labeled 
A3G dimers, we do not observe the expected behavior. However, this issue will not 
obscure the results of the following experiment, in which we are forming large 
aggregates. The temperature-induced aggregate will contain a statistical mix of labeled, 
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unlabeled and mixed A3G dimers. Because the number of A3G molecules in the 
aggregate is large, the fraction of labeled and unlabeled A3G molecules within the 
complex will reflect the population fractions of labeled and unlabeled A3G molecules of 
the sample at large. For example, large oligomers generated from a 50/50 mix of labeled, 
unlabeled and mixed A3G dimers will contain an average of 50% labeled and 50% 
unlabeled A3G molecules, regardless of the specific distribution of the A3G dimer 
populations. 
 After incubating the sample at 37C for 60 minutes, we observe a strong increase in 
the diffusion time of the sparsely labeled sample (Table B.1). The increase indicates the 
formation of large complexes and, within uncertainty, agrees with the increase observed 
for the 100% labeled sample. More importantly, when we compare the final diffusion 
times of the aggregated 10% and 100% labeled samples, we see that the sparsely labeled 
aggregates move about 20% faster than the fully labeled aggregates. A diffusion time of 
       is consistent with same-sized aggregates as the fully labeled sample (~3.2 ms), 
once we factor in that most of the A3Gs are not carrying the extra mass of an EGFP label. 
Most convincingly, however, is the comparison of brightness values from the 10% 
labeled and 100% labeled A3G samples. The 100% labeled A3G form temperature-
induced aggregates with an average brightness     . The incubated 10% A3G sample 
has a brightness       which is approximately 10% of 33 and indicates that the mostly 
unlabeled A3G is also producing temperature-induced aggregates of approximately the 
same size as the fully labeled sample.  
 After incubation, the 10% labeled sample showed an increase in diffusion time and 
in brightness, both indicative of an increase in aggregation. In short, this experiment 
provides two independent measures that suggest (mostly) unlabeled A3G is still 
producing large aggregates when subject to 37C incubation.  
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Appendix C.  Bright and Dark A3G studies 
 
 In this appendix we present results that we have thus far been unable to 
satisfactorily explain regarding the nature of the A3G dimer in solution. This research is 
an ongoing project, and further experiments are being designed to carefully investigate 
the issues involving the stoichiometry of A3G. The following experiments should serve 
as a foundation to guide the design of future experiments. 
 In FFS measurements of the oligomeric state of A3G in solution (50 mM Tris-HCl), 
we have consistently recovered an average brightness slightly above 2. We interpret this 
as population composed of dimeric A3G with a small percentage of higher order 
oligomers mixed in. Since the field has reported a range of oligomers for A3G in 
solution, from monomeric to tetrameric, we wish to confirm our observations. Because 
we are unable to take apart the dimer through dilution, we perform a quick check to 
assure ourselves that the brightness       really does indicate a predominantly dimeric 
population. In chapter 3, we discussed that oligomeric brightness species demonsrate a 
predictable decrease in brightness as a function of photobleaching. Therefore, we used 
epifluorescence light to bleach an EGFP-labeled A3G sample in stages, using 2-photon 
FFS to take monitoring measurements between each photobleaching step. The 
normalized brightness values of A3G as a function of intensity relative to the unbleached 
intensity are plotted in Figure C.1 below. 
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Figure C.1  A3G sample photobleaches as a dimer. 
 
 
The plot also includes theoretical bleaching curves for pure monomer, dimer, and 
trimer samples. The A3G data falls very nicely along the dimeric curve, confirming that 
A3G is mostly dimeric as our initial experiments indicated. 
 To further characterize this dimeric population, we conduct mixing experiments 
with “bright”, or EGFP-labeled, A3G and “dark”, or unlabeled, A3G. By observing the 
exchange of monomer units between the dimers through brightness, we can gain 
information about the affinity of the dimers. Recall that apparent brightness is given by 
          
∑     
 
 
∑      
 
where    is the brightness of each species and    is the fraction of the total population that 
species represents. For a 50/50 mix of bright and dark A3G (Figure C.2), we expect a mix 
of dimers with two labeled A3G proteins (  ), 1 labeled and 1 unlabeled (  ), and two 
unlabeled proteins (  ).  From binomial probability, the population should be 
approximately 
                                        
which gives an apparent brightness of  
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for a 1:1 mixture. 
 
 
 
Figure C.2  Bright & Dark dimeric protein mixing. 
 
 
Similarly, for a mix of 1 bright A3G to 10 dark A3G we get an apparent brightness 
        
                                                    
                          
     
reflecting the 1:10 bright to dark sample. 
 However, our measurements for a 1:1 mixture of bright and dark A3G recover an 
apparent brightness of      which, within uncertainty, would indicate the absence of 
mixing. Further experiments with a 1:10 mixture resulted in a brightness of      which 
indicates the presence of mixing. Both these values are much higher than expected for 
thermodynamic mixing, and the values do not change over a period of 6 hours. Table C.1 
shows one example of a mixing experiment which demonstrates that the measured 
brightness does not change appreciably with time. (Note: the increase in brightness 
observed at the 20 hour timepoint is likely due to significant sample evaporation which 
results in increased protein concentration as well as substantial increases in the salt and 
glycerol concentrations of the solution buffer.) More careful experiments to explore 
mixing kinetics are still to be undertaken, but the current results are baffling and seem 
irreconcilable with thermodynamic equilibrium models. 
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Time (hr) 
Labeled 
A3G 
Labeled: Unlabeled 
1:1 1:2 1:4 1:9 1:30 
1 2.21 2.04 1.97 1.88 1.69 1.61 
5 2.20 1.94 1.80 1.70 1.67 1.49 
6 2.10 1.90 1.80 1.72 1.70 1.54 
7 2.20 1.84 1.80 1.64 1.75 1.51 
10 2.20 1.90 1.80 1.70 1.80 1.50 
20 2.40 2.03 2.01 1.95 2.10 1.65 
Table C.1  Bright & Dark A3G mixing study. 
 
 
 Below, Figure C.3 shows a compilation of brightness results from several bright 
and dark mixing experiments. Viewed in this figure, there seems to be a clear trend in 
brightness reduction as a function of dark/bright A3G ratio. However, we have no direct 
evidence that the reduction in brightness is a result of monomer protein exchange as 
opposed to some other mechanism causing dissociation or quenching. Furthermore, 
especially in combination with the kinetic data, we can offer no thermodynamically-
sound explanation for the observed results.  
 The most confusing and most recent experiment involved the comparison of 
brightness between the standard EGFP-labeled A3G and a copurified labeled/unlabeled 
A3G sample. Ming Li cotransfected unlabeled and EGFP-labeled A3G into mammalian 
cells and then purified the result. Having run the copurified sample on a gel, he reports 
that it is approximately 28% labeled. Bafflingly, we observe a brightness       for this 
sample just as we do for the 100% sample. At present, there is no explanation for this 
result. 
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Figure C.3  Compiled Bright & Dark A3G mixing data. 
 
 
Finally, we present a related experiment that does behave as expected. In 
appendix B, we performed temperature-induced aggregation studies with fractionally 
labeled samples. In that case, the large A3G aggregates were composed of multiple A3G 
dimers. We explained that the distribution of labeled, unlabeled, and mixed dimers is 
irrelevant for predicting the brightness of the aggregate. The average labeled protein 
fraction of these complexes is simply equal to the fraction of labeled A3G molecules in 
the sample. Similarly, the formation of large A3G complexes with “G-rich” RNA should 
also be independent of the dimer mixing issue. The following experiment (Figure C.4) 
shows 100% labeled A3G interacting with excess Test+ RNA. The same experimental 
conditions were then applied to a 50% labeled and 28% labeled A3G sample. The latter 
of these is the copurified sample from the previous paragraph, and the results demonstrate 
that this sample does contain unlabeled A3G. As the figure shows, the measured 
brightnesses are reduced by approximately the correct fractions, indicating that RNA 
complexes are composed of both labeled and unlabeled A3G dimers. 
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Figure C.4  Bright & Dark A3G mixtures complex with Test+ RNA. 
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Appendix D.  A3G dimer dissociation in cytosol analogs 
 
 We have been unable to take apart A3G dimers using dilution, mixing with 
unlabeled A3G, and even adding relatively high concentrations (0.3%) of sodium dodecyl 
sulfate (SDS), a surfactant we have used to disassemble dimers in the past. However, 
looking more closely at our low concentration cellular A3G measurements seemed to 
reveal A3G with an average oligomerization of less than 2. 
 
Figure D.1  Low concentration cellular A3G. 
 
 
 We must be careful about interpreting the above data. Because this experiment 
focuses on low concentrations of A3G, the fluorescence intensity signal strength is weak. 
As a result, the cell’s autofluorescent background contributes a large fraction of the 
measured signal, which has a tendency to reduce the apparent brightness. Nevertheless, 
based on our estimates of the background bias effect, the data seem to indicate brightness 
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values less than 2. However, the data shown does not give irrefutable evidence of A3G 
monomers.  
 We therefore wondered if some quality or element of the cytoplasmic environment 
might lead to the dissociation of the A3G dimer. To that end we placed purified A3G—
the same material we have been measuring in aqueous solution—into cell free E. coli 
lysate and HeLa cell cytosol extract. Neither of these solutions is identical to cell 
cytoplasm but, being derived from the cytosol, contain many cytoplasmic proteins. In the 
following experiment, we dilute aqueous solution A3G into the cytoplasmic extracts by 
volume ratios, keeping the final A3G concentration fixed at 200 nM. 
 
EGFP controls 
aqueous 
solution 
 75%  
E. coli extract 
 75%  
HeLa cytosol 
1.00  1.01  1.02 
 
A3G oligomerization 
aqueous 
solution 
25%  
E. coli extract 
75%  
E. coli extract 
25%  
HeLa cytosol 
75%  
HeLa cytosol 
2.10 1.50 1.35 1.80 1.45 
Table D.1  A3G dimer dissociation in cell extract. 
 
 
 The upper panel of Table D.1 shows EGFP brightness controls in the two lysate 
environments. Both lysates have slightly greater autofluorescent background compared to 
aqueous buffer, but for 200 nM A3G this background has a negligible effect on 
brightness. In the bottom panel, A3G shows clear dissociation in both E. coli and 
mammalian cell extracts, although we are currently unaware of the cause. The following 
contain descriptions of the extract preparations acquired through personal 
communication: 
 
The HeLa cell cytosol extract (S-100) was prepared from HeLa S3 cells. There is 
no addition of micrococcal nuclease in the preparation protocol. A HeLa cell 
suspension of high concentration was lysed by osmotic pressure in the presence of 
a high salt concentration, followed by dialysis against HEPES buffer in the 
presence of 20% of glycerol.  The extract contains splicing factors and has a 
limiting amount of SR proteins.  
 
The E. coli lysate is a cytoplasmic extract from E. coli, containing all of the 
inherent proteins. It is resuspended in 5-10 mM Tris buffer with 14 mM 
magnesium, 60 mM potassium, and 1mM DTT, pH 8.2.  
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Since the E. coli extract was provided to us by the lab of Vincent Noireaux, University of 
Minnesota, rather than being purchased, we have a better knowledge of its contents. The 
E. coli extract contains 1 mM spermidine, a charged (3+) polyamine, which we 
considered might be interfering with a charge interaction or might sequester small RNAs 
necessary for A3G dimerization. However, we observed only minimal dissociation at 
20 mM of spermidine, a concentration well above that in the extract. We have not yet 
tested other candidates, but this dissociation of A3G in lysates does provide us with an 
experimental avenue to explore the behavior of the A3G dimer and its monomer 
exchange in the labeled/unlabeled studies. 
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Appendix E.  Dual-color FFS of A3G-RNA 
 
 In the discussion section of chapter 6, we addressed the model of A3G-RNA 
interaction and complex formation. One of the difficulties in the experiments presented in 
that chapter is that we only labeled either the A3G or the RNA, and thus could only infer 
the behavior of the unlabeled reactant. The solution is to conduct more advanced studies 
using dual-color FFS. The underlying principles are identical, but now both reactants are 
labeled with differently colored fluorescent labels, and the collected fluorescence light is 
split into two channels using a dichroic mirror and sent to two separate APD 
detectors.
33,47
  
 We have conducted one preliminary experiment with EGFP-labeled A3G and 
Texas Red-labeled Test+ RNA. Similarly to the initial experiments in chapter 6 (Figure 
6.4), we keep the A3G concentration fixed and mix a series of droplets containing 
different amount of Test+ RNA. We record the data from each detector, perform 
brightness analysis, and then run the resulting data through an additional filter that 
separates out the signal for heterospecies complexes. Because both the red and the green 
channels are synced in time, we can identify and separate the signal contributions that 
contain both a red and green component. This is called heterospecies partition analysis 
and allows us to analyze protein complexes separately from the unbound protein 
background.
46
  
 Thus the data presented in Figure E.1 show brightness values only for A3G 
(squares) and RNA (triangles) that are part of an A3G-RNA complex. As before, we 
observe that A3G starts at slightly above a dimer when the RNA concentration is low, 
and then forms oligomers at approximately a 1:1 ratio of RNA/A3G. Now, however, we 
can also see the copy number of RNA. The lower panel of the figure shows the ratio of 
red to green brightness from the main plot, or in other words, the ratio of RNA to A3G. 
At low RNA concentrations, there is less than 1 RNA per A3G, as expected from the 
relative concentrations in the mixture. In regime of large A3G-RNA complexes, we see 
that the RNA/A3G ratio falls between 2 and 3. This indicates that for every A3G 
monomer in the complex there are 2 or more Test+ RNA oligonucleotides. 
 When performing dual-color FFS studies, one must contend with two primary 
issues that affect quantitative analysis. Most label pairs, including EGFP and Texas Red, 
do not have complete spectral separation, which means that in our experiment, some of 
the light from EGFP (~ 3%) ends up in the red detection channel. We have purposely 
constructed our system (610 nm dichroic mirror) with a red bandpass filter (HQ670, 630-
710 nm, Chroma) to minimize the EGFP spillover into the red channel, and with a green 
bandpass filter (FF02-520, 506-534 nm, Semrock) to prevent any Texas Red contribution 
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to the green channel. Secondly, the EGFP and Texas Red fluorescent labels will undergo 
FRET if they are in close proximity (<10 nm). In FRET, energy is transferred from the 
donor (EGFP) to the acceptor (Texas Red) which results in an increase in Texas Red 
brightness and a decrease in EGFP brightness. Finally, organic dyes, like Texas Red, are 
vulnerable to quenching effects when the dye environment changes or when two dyes are 
brought into close proximity. Figure E.1 contains corrections for none of the above 
issues, so quantitative results must be taken with a grain of salt. However, since all of 
these effects will reduce the measured RNA copy number, the data are still suggestive 
that more than 1 RNA per A3G is to be found in A3G-RNA complexes. 
 
 
 
Figure E.1  Average A3G and RNA copy numbers in A3G-RNA complex. 
 
